[
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          1414,
          1784
        ],
        "answer": "This agreement shall begin upon the date of its execution by MA and acceptance in writing by Company and shall remain in effect until the end of the current calendar year and shall be automatically renewed for successive one (1) year periods unless otherwise terminated according to the cancellation or termination provisions contained in paragraph 18 of this Agreement."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.7012,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 14806,
        "filepath": "maud/HMS Holdings Corp._Veritas Capital.txt",
        "span": [
          142522,
          142985
        ],
        "text": ". Between January 1, 2018 and the date of this Agreement, there have been no transactions, or series of related transactions, or Contracts, that would be required to be reported prior to the date hereof by the Company pursuant to Item 404 of Regulation S-K promulgated by the SEC (each, and \u201cAffiliate Arrangement\u201d) that have not been disclosed in the Company SEC Documents.   Section 4.22       Material Customers; Material Vendors.   (a)               Section 4"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          1414,
          1784
        ],
        "answer": "This agreement shall begin upon the date of its execution by MA and acceptance in writing by Company and shall remain in effect until the end of the current calendar year and shall be automatically renewed for successive one (1) year periods unless otherwise terminated according to the cancellation or termination provisions contained in paragraph 18 of this Agreement."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.7571,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 3358,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17621,
          17964
        ],
        "text": ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 723,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24985,
          25342
        ],
        "text": ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          22066,
          22221
        ],
        "answer": "This Agreement may be terminated by either party at the expiration of its term or any renewal term upon thirty (30) days written notice to the other party."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9836,
        "readability": "expert",
        "readability_score": 12.57
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 3358,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17621,
          17964
        ],
        "text": ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
      },
      {
        "chunk_id": 1496,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          22066,
          22220
        ],
        "text": "This Agreement may be terminated by either party at the expiration of its term or any renewal term upon thirty (30) days written notice to the other party"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          28704,
          28895
        ],
        "answer": "This Agreement is accepted by Company in the State of Nevada and shall be governed by and construed in accordance with the laws thereof, which laws shall prevail in the event of any conflict."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.5342,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 20326,
        "filepath": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
        "span": [
          1835,
          2302
        ],
        "text": "Section 3.26 Brokers 36 Section 3.27 Affiliate Arrangements 36 Section 3.28 Acknowledgement of No Other Representations or Warranties 36   Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND SUB   Section 4.01 Organization 36 Section 4.02 Authority 37 Section 4.03 No Conflict; Required Filings and Consents 37 Section 4.04 Information Supplied 38 Section 4.05 Litigation 39 Section 4.06 Capitalization and Operations of Sub 39 Section 4.07 Financing 39 Section 4"
      },
      {
        "chunk_id": 9548,
        "filepath": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
        "span": [
          2207,
          2661
        ],
        "text": ". Opinion    31  Section 4.24. No Vote Required    32  Section 4.25. Affiliate Transactions    32  Section 4.26. No Other Representations and Warranties    32  ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER    32  Section 5.1.  Organization and Corporate Power    32  Section 5.2.  Authorization; Valid and Binding Agreement    33  Section 5.3.  No Breach    33  Section 5.4.  Consents    33  Section 5.5.  Litigation    33  Section 5.6"
      },
      {
        "chunk_id": 7760,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          231935,
          232311
        ],
        "text": "\u201cAffiliate\u201d when used with respect to any Person, means any other Person who is an \u201caffiliate\u201d of that first Person within the meaning of Rule 405 promulgated under the Securities Act, except as otherwise set forth in Section 4.8. \n\n\n\u201cAgreement\u201d has the meaning set forth in the preamble. \n\n\n\u201cAlternative Acquisition Agreement\u201d has the meaning set forth in Section 6.1(b)(vi)."
      },
      {
        "chunk_id": 10247,
        "filepath": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
        "span": [
          199966,
          200425
        ],
        "text": "\u201cAffiliate\u201d of any particular Person means any other Person controlling, controlled by or under common control with such particular Person. For the purposes of this definition, \u201ccontrolling,\u201d \u201ccontrolled\u201d and \u201ccontrol\u201d mean the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise. \n\n\n\u201cAgreement\u201d has the meaning set forth in the Preamble."
      },
      {
        "chunk_id": 11234,
        "filepath": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
        "span": [
          10930,
          11420
        ],
        "text": "\u201cAffiliate\u201d has the meaning given to such term in Rule 12b-2 under the Exchange Act; provided, that (a) no Purchaser Party nor any other member of the Purchaser Group shall be deemed to be Affiliates of any of the Acquired Companies and (b) the Acquired Companies shall not be deemed to be Affiliates of any Purchaser Party or any other member of the Purchaser Group for any purpose hereunder. \n\n\n\n\n\u201cAgreement\u201d has the meaning set forth in the Preamble.   2\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n________________"
      },
      {
        "chunk_id": 759,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          35325,
          35803
        ],
        "text": "For the purposes of this Agreement, \"Affiliate\" shall mean another entity that controls, is controlled by or is under common control with such party; provided, however, that such entity is not a human being. For purposes of this definition, the terms \"controls,\" \"is controlled by,\" or \"is under common control with,\" refer to the power to direct the policies and day-to-day operations of an entity, whether by virtue of ownership of a voting securities, contract, or otherwise."
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          27529,
          27698
        ],
        "answer": "MA may not assign, sell, lease or otherwise transfer in whole or in party any of the rights granted pursuant to this Agreement without prior written approval of Company."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.8924,
        "readability": "expert",
        "readability_score": 13.24
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      },
      {
        "chunk_id": 2855,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          24467,
          24884
        ],
        "text": "12.      Assignment. Either party may, at its election, assign this Agreement or          any of its rights or delegate any of its obligations hereunder, in          whole or in part, to any person, firm or corporation owning or          acquiring all or a substantial portion of its assets, to any person,          firm or corporation that is related to it as an affiliate,\n\n                                    7\n\n10"
      },
      {
        "chunk_id": 11185,
        "filepath": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
        "span": [
          212878,
          213298
        ],
        "text": ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          32195,
          32356
        ],
        "answer": "INITIAL ORDER COMMITMENT - MA commits to purchase a minimum of 100 Units in aggregate within the Territory within the first six months of term of this Agreement."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9913,
        "readability": "expert",
        "readability_score": 12.89
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      },
      {
        "chunk_id": 14805,
        "filepath": "maud/HMS Holdings Corp._Veritas Capital.txt",
        "span": [
          142169,
          142522
        ],
        "text": "., there is no investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who will be entitled to any fee or commission from the Company or any of its Subsidiaries in connection with the Transactions.   Section 4.21       Affiliate Arrangements"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          1993,
          2816
        ],
        "answer": "Subject to the terms and conditions of this Agreement, Company hereby grants to MA the right to advertise, market and sell to corporate users, government agencies and educational facilities (\"Clients\") for their own internal language learning, soft skills and communication purposes only, and not for remarketing or redistribution, and not for use in a data center environment for multiple users Clients, unless otherwise agreed to by Company prior in writing, the Technology listed in Schedule A of this Agreement, and to sell and/or bundle Technology Maintenance for the Technology and to provide first line technical support and implementation services for the Technology in the territories listed in Schedule A of this Agreement, providing MA meets the criteria required for delivering services according to Schedule A."
      },
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          14690,
          14913
        ],
        "answer": "Company hereby grants MA, during the term of this Agreement, the right to use Company and/or Company trade names, trademarks or service marks on Technology or in advertising or promotion relating directly to these products."
      },
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          33649,
          33769
        ],
        "answer": "MA is authorized to resell Technology within the following territory according to the terms of the Agreement:\n\nWorldwide"
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.6911,
        "readability": "expert",
        "readability_score": 12.94
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      },
      {
        "chunk_id": 1756,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          37488,
          37862
        ],
        "text": ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          5924,
          6182
        ],
        "answer": "MA shall keep accurate records of the sales of the Technology and Maintenance, including Client Registration Cards and shall make these records available for review by a representative of Company within ten (10) business days following the end of each month."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.5092,
        "readability": "expert",
        "readability_score": 12.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1628,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          1225,
          1666
        ],
        "text": "(c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.\n\n(d) \"Confidential Information\" shall have the meaning specified in Section 14(a) [Confidential Information].\n\n(e) \"Indemnified Party\" shall have the meaning specified in Section 13."
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          14096,
          14399
        ],
        "answer": "Company is not liable for incidental, special or consequential damages for any reason (including loss of data or other business or property damage), even if foreseeable or if MA or Customer has advised of such a claim. Company's liability shall not exceed the fees that MA has paid under this Agreement."
      },
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          16147,
          16261
        ],
        "answer": "The foregoing states the entire liability of Company with respect to infringement of intellectual property rights."
      },
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          20020,
          20494
        ],
        "answer": "COMPANY'S SOLE AND EXCLUSIVE LIABILITY FOR THE WARRANTY PROVIDED IN SUBPARAGRAH (A) HEREOF SHALL BE TO CORRECT THE TECHNOLOGY TO OPERATE IN SUBSTANTIAL ACCORDANCE WITH ITS THEN CURRENT SPECIFICATIONS OR REPLACE, AT ITS OPTION, THE TECHNOLOGY NOT IN COMPLIANCE WITH COMPANY'S AND COMPANY' PUBLISHED SPECIFICATIONS REGARDING THE TECHNOLOGY; PROVIDED, ANY CLAIM FOR BREACH OF WARRANTY UNDER SUBPARAGRAPH (A) HEREOF MUST BE MADE IN WRITING WITHIN (90) DAYS FROM DATE OF SHIPMENT"
      },
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          20497,
          20884
        ],
        "answer": "IN NO EVENT SHALL COMPANY BE LIABLE TO \"MA\", ITS CLIENTS, OR ANY THIRD PARTY FOR ANY TORT OR CONTRACT DAMAGES OR INDIRECT, SPECIAL, GENERAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS OR ANTICIPATED PROFITS AND LOSS OF GOODWILL, ARISING IN CONNECTION WITH THE USE (OR INABILITY TO USE) OR DISTRIBUTION OF THE TECHNOLOGY FOR ANY PURPOSE WHATSOEVER."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9553,
        "readability": "expert",
        "readability_score": 11.63
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 1928,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          51427,
          51762
        ],
        "text": "; except that, either Party shall be permitted, without any need for the other Party's   consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an   Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party)"
      },
      {
        "chunk_id": 14805,
        "filepath": "maud/HMS Holdings Corp._Veritas Capital.txt",
        "span": [
          142169,
          142522
        ],
        "text": "., there is no investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who will be entitled to any fee or commission from the Company or any of its Subsidiaries in connection with the Transactions.   Section 4.21       Affiliate Arrangements"
      }
    ]
  },
  {
    "query": "Consider the Marketing Affiliate Agreement between Birch First Global Investments Inc. and Mount Knowledge Holdings Inc.; What is the duration of any warranties provided in this contract?",
    "snippets": [
      {
        "file_path": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          20020,
          20495
        ],
        "answer": "COMPANY'S SOLE AND EXCLUSIVE LIABILITY FOR THE WARRANTY PROVIDED IN SUBPARAGRAH (A) HEREOF SHALL BE TO CORRECT THE TECHNOLOGY TO OPERATE IN SUBSTANTIAL ACCORDANCE WITH ITS THEN CURRENT SPECIFICATIONS OR REPLACE, AT ITS OPTION, THE TECHNOLOGY NOT IN COMPLIANCE WITH COMPANY'S AND COMPANY' PUBLISHED SPECIFICATIONS REGARDING THE TECHNOLOGY; PROVIDED, ANY CLAIM FOR BREACH OF WARRANTY UNDER SUBPARAGRAPH (A) HEREOF MUST BE MADE IN WRITING WITHIN (90) DAYS FROM DATE OF SHIPMENT."
      }
    ],
    "file_set": [
      "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Marketing Affiliate Agreement Birch First Global Investments Inc. Mount Knowledge Holdings Inc.",
        "similarity_score": 0.5086194276809692,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9906,
        "readability": "expert",
        "readability_score": 12.27
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1426,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          0,
          221
        ],
        "text": "Exhibit 10.27\n\nMARKETING AFFILIATE AGREEMENT\n\nBetween:\n\nBirch First Global Investments Inc.\n\nAnd\n\nMount Knowledge Holdings Inc.\n\nDated: May 8, 2014\n\n1\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\n2.\n\n2.1\n\n2.2"
      },
      {
        "chunk_id": 1427,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          223,
          716
        ],
        "text": "This Marketing Affiliate Agreement (the \"Agreement\") is entered into this 8th day of May 2014, by and between BIRCH FIRST GLOBAL INVESTMENTS INC., a corporation incorporated in the U.S. Virgin Islands, with its main place of business located 9100 Havensight, Port of Sale, Ste. 15/16, St. Thomas, VI 0080 (referred to as \"Company\") and MOUNT KNOWLEDGE HOLDINGS INC. and/or assigns, a corporation incorporated in the State of Nevada, with its main place of business located at 228 Park Avenue S"
      },
      {
        "chunk_id": 1526,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          30940,
          31429
        ],
        "text": "COMPANY\n\nBIRCH FIRST INVESTMENTS INC. A US Virgin Islands corporation\n\nBy: /s/ Pier S. Bjorklund Pier S. Bjorklund, President\n\nThis Agreement was executed as of the date set forth above.\n\nMA\n\nMOUNT KNOWLEDGE HOLDINGS INC. A Nevada corporation\n\nBy: /s/ James D. Beatty  James D. Beatty, CEO and President\n\n14\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n1.\n\nNote 1:\n\nNote 2:\n\nNote 3:\n\nNote 4:\n\nNote 5:\n\nNote 6:\n\n2.\n\n(a)\n\nSCHEDULE A\n\nMARKETING AFFILIATE Technology PRICING AND TERMS"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6970,
          7157
        ],
        "answer": "The term of this Agreement (the \"Initial Term\") shall commence as of the Effective Date and, unless earlier terminated in accordance with this Agreement, shall terminate on June 30, 2010."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9759,
        "readability": "expert",
        "readability_score": 14.32
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 914,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          18259,
          18759
        ],
        "text": ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      },
      {
        "chunk_id": 873,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7692,
          7966
        ],
        "text": ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7158,
          7299
        ],
        "answer": "At Rogers' option, this Agreement shall renew for a subsequent term of two (2) years on the terms and conditions herein (the \"Renewal Term\")."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9003,
        "readability": "expert",
        "readability_score": 14.32
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      },
      {
        "chunk_id": 914,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          18259,
          18759
        ],
        "text": ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
      },
      {
        "chunk_id": 873,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7692,
          7966
        ],
        "text": ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
      },
      {
        "chunk_id": 871,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6964,
          7298
        ],
        "text": ".     The term of this Agreement (the \"Initial Term\") shall commence as of the Effective Date and, unless earlier terminated in accordance with this Agreement, shall terminate on June 30, 2010. At Rogers' option, this Agreement shall renew for a subsequent term of two (2) years on the terms and conditions herein (the \"Renewal Term\")"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7300,
          7967
        ],
        "answer": "Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry, such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9972,
        "readability": "expert",
        "readability_score": 14.79
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 873,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7692,
          7966
        ],
        "text": ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
      },
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      },
      {
        "chunk_id": 914,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          18259,
          18759
        ],
        "text": ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
      },
      {
        "chunk_id": 907,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          16702,
          16900
        ],
        "text": ".   Notwithstanding any other provision of this Agreement, Rogers may terminate this Agreement, at any time, upon sixty (60) days' prior written notice to Licensor.     19. MUTUAL TERMINATION RIGHTS"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          23438,
          23556
        ],
        "answer": "This Agreement shall be governed by laws of the Province of Ontario and the federal laws of Canada applicable therein."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          26865,
          27208
        ],
        "answer": "This Agreement is subject to all laws, regulations, license conditions and decisions of the Canadian Radio-television and Telecommunications Commission (\"CRTC\") municipal, provincial and federal governments or other authorities which are applicable to Rogers and/or Licensor, and which are now in force or hereafter adopted (\"Applicable Law\")."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.97,
        "readability": "expert",
        "readability_score": 14.32
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 916,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          19251,
          19719
        ],
        "text": ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a most favored nation clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          2600,
          2971
        ],
        "answer": "In the event that Licensor grants to another VOD or Pay-Per-View (\"PPV\") service provider in the U.S. or the Territory the right to distribute or exhibit any Licensed Program on an earlier availability date, then Licensor shall also grant to Rogers the right to distribute and exhibit such Licensed Program on such earlier availability date, on the terms provided herein."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          18888,
          20432
        ],
        "answer": "If Licensor enters, or has entered, into an agreement or series of agreements (including side letters, understandings or arrangements, whether oral or written, whether formal or informal, whether now or hereafter effective, or whether on a long-term basis or short-term basis) with a third party for the distribution and exhibition of Licensed Programs in the U.S. or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be, such term or terms into this Agreement, effective as of the date on which such term or terms were accorded to the third party and for the balance of the period such term or terms are applicable to such third party. Licensor shall provide to Rogers, no later than February 28 in each year, a sworn statement of a senior officer of Licensor, or a certificate of the auditors of Licensor, confirming that, during the immediately preceding calendar year, Licensor did not enter into such an agreement or series of agreements or, if it did enter into such agreement(s), confirming the effective date thereof and identifying the terms contained therein that are more favourable than those contained in this Agreement."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9578,
        "readability": "expert",
        "readability_score": 14.79
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 4160,
        "filepath": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
        "span": [
          78874,
          79343
        ],
        "text": ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area"
      },
      {
        "chunk_id": 851,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          284,
          686
        ],
        "text": "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 858,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          2596,
          2970
        ],
        "text": "(b) In the event that Licensor grants to another VOD or Pay-Per-View (\"PPV\") service provider in the U.S. or the Territory the right to distribute or exhibit any Licensed Program on an earlier availability date, then Licensor shall also grant to Rogers the right to distribute and exhibit such Licensed Program on such earlier availability date, on the terms provided herein"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Can this contract be terminated for convenience, and under what conditions?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          16706,
          16866
        ],
        "answer": "Notwithstanding any other provision of this Agreement, Rogers may terminate this Agreement, at any time, upon sixty (60) days' prior written notice to Licensor."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 14.39
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      },
      {
        "chunk_id": 914,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          18259,
          18759
        ],
        "text": ".   If either party terminates this Agreement prior to its expiration, Rogers shall be entitled to continue to distribute and exhibit all Licensed Programs then being distributed and exhibited on the ROD Service, in each case, for a period of sixty (60) days from the effective date of termination or the expiry of the relevant License Period, whichever is earlier, and, in such event, Rogers shall continue to be bound by its payment obligations set forth herein in respect of such Licensed Programs"
      },
      {
        "chunk_id": 908,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          16900,
          17142
        ],
        "text": ".   Either Rogers or Licensor may, at its option and without prejudice to any other remedies available to it, immediately terminate this Agreement by giving written notice thereof to the other party for any one or more of the following causes"
      },
      {
        "chunk_id": 873,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7692,
          7966
        ],
        "text": ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          23757,
          24404
        ],
        "answer": "This Agreement may not be assigned, sold or transferred without the prior written consent of the other party. Notwithstanding the foregoing, Rogers may, without consent, assign its rights and obligations under this Agreement in whole or in part to: (i) a person that directly or indirectly controls, is controlled by or is under common control with Rogers; or (ii) a purchaser of all or substantially all of the assets used in connection with the ROD Service. A change of control of Rogers shall not be considered an assignment of this Agreement. Any purported assignment, sale, or transfer in contravention of this Section shall be null and void."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9864,
        "readability": "expert",
        "readability_score": 15.69
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 916,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          19251,
          19719
        ],
        "text": ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 851,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          284,
          686
        ],
        "text": "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          4052,
          4163
        ],
        "answer": "Rogers shall pay to Licensor a fee (the \"License Fee\"), which shall be equal to fifty (50)% of Retail Revenues."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          12278,
          12557
        ],
        "answer": "In consideration for various services and activities that Rogers performs for the benefit of Licensor during the Term, Licensor agrees to pay to Rogers an amount which shall be equal to ten (10)% of License Fees, calculated on a rolling basis during the Term and payable monthly."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          12585,
          12978
        ],
        "answer": "For so long as Rogers is required by Applicable Law to contribute a percentage of its gross annual revenues from the ROD Service to an independently-administered Canadian program production fund, Licensor shall reimburse Rogers for 50% of the amount required to be remitted to such production fund by Rogers in respect of the exhibition of Licensed Programs (the \"Production Fund Commitment\")."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          16318,
          16591
        ],
        "answer": "For so long as Rogers is required by Applicable Law to pay copyright royalties relating to Licensed Programs hereunder, Licensor shall reimburse Rogers for 50% of any such royalties actually paid by Rogers, calculated on a rolling basis during the Term and payable monthly."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 16.53
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 869,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6175,
          6567
        ],
        "text": ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
      },
      {
        "chunk_id": 916,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          19251,
          19719
        ],
        "text": ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
      },
      {
        "chunk_id": 851,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          284,
          686
        ],
        "text": "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          10444,
          10739
        ],
        "answer": "Licensor shall make available to Rogers, on a free trial basis and at no cost to Rogers, not less than ten (10) Licensed Programs at all times during the Term (each, a \"Promotional Program\") for distribution and exhibition on the ROD Service to promote the Licensed Programs and the ROD Service."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9981,
        "readability": "expert",
        "readability_score": 15.22
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 869,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6175,
          6567
        ],
        "text": ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
      },
      {
        "chunk_id": 872,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7298,
          7692
        ],
        "text": ". Notwithstanding the foregoing, if, at the expiry of this Agreement following the Initial Term or the Renewal Term (if any), as applicable, Licensor and Rogers have not executed a new agreement governing the VOD distribution and exhibition of Licensed Programs and Rogers (or its permitted assigns) continues to distribute and exhibit Licensed Programs on the ROD Service following such expiry"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          304,
          687
        ],
        "answer": "Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis."
      },
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          3284,
          3540
        ],
        "answer": "During the Term, Rogers shall have the non-exclusive right to distribute and exhibit each Licensed Program on a VOD basis for a period of ninety (90) consecutive days, or such longer period as may be agreed to by Rogers and Licensor (the \"License Period\")."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9817,
        "readability": "expert",
        "readability_score": 15.48
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 851,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          284,
          686
        ],
        "text": "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 852,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          686,
          1052
        ],
        "text": ". For clarity, the VOD service that Rogers provides to such subscribers shall hereinafter be referred to as the \"ROD Service\".     2. LICENSED PROGRAMS.     (a) Subject to Section 3, Licensor shall forthwith provide to Rogers a comprehensive list (including title, length of program, license period and availability date) of all currently available Licensed Programs"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Does this contract include an unlimited or all-you-can-eat license?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          3772,
          4022
        ],
        "answer": "Multiple viewings of the Licensed Program shall be permitted during the Viewing Period for no additional fee and all such viewings shall be considered a single exhibition of the Licensed Program for the purposes of calculating License Fees hereunder."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 14.56
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 869,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6175,
          6567
        ],
        "text": ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
      },
      {
        "chunk_id": 1963,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          494,
          836
        ],
        "text": ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters"
      },
      {
        "chunk_id": 851,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          284,
          686
        ],
        "text": "1. RIGHTS GRANTED   Licensor grants to Rogers the non-exclusive license and right to distribute and exhibit in Canada (the \"Territory\") all entertainment programming to which Licensor owns or controls the VOD distribution and exhibition rights in the Territory (collectively, \"Licensed Programs\") to residential subscribers of Rogers' digital cable television service on a Video-on-Demand (\"VOD\") basis"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          20433,
          20763
        ],
        "answer": "During the Term, and for a period of twelve (12) months thereafter, Rogers (and its representatives) shall have the right, upon reasonable prior written notice to Licensor, and during regular business hours, to inspect and/or audit Licensor's books and records to confirm compliance with Licensor's obligations under this Section."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9714,
        "readability": "expert",
        "readability_score": 15.0
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 3100,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62720,
          62988
        ],
        "text": "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 919,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          20431,
          20882
        ],
        "text": ". During the Term, and for a period of twelve (12) months thereafter, Rogers (and its representatives) shall have the right, upon reasonable prior written notice to Licensor, and during regular business hours, to inspect and/or audit Licensor's books and records to confirm compliance with Licensor's obligations under this Section. This Section shall survive the expiry or other termination of this Agreement for a period of twelve (12) months.   -8-"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15954,
          16203
        ],
        "answer": "Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind."
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9953,
        "readability": "expert",
        "readability_score": 15.48
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 904,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15356,
          15833
        ],
        "text": "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and/or other promotional materials provided by Licensor to Rogers hereunder"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 916,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          19251,
          19719
        ],
        "text": ". or the Territory on a VOD basis, or any other basis that permits the downloading of such Licensed Programs and the subsequent viewing of such Licensed Programs by a residential subscriber, on terms (including, without limitation, license fees, copyright royalty payments, encoding fees and obligations, and marketing support) that are more favourable than those contained in this Agreement, then Rogers has the right to incorporate, or substitute, as the case may be"
      },
      {
        "chunk_id": 869,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6175,
          6567
        ],
        "text": ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
      }
    ]
  },
  {
    "query": "Consider the Video-on-Demand Content License Agreement between Rogers Cable Communications Inc. and EuroMedia Holdings Corp.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15954,
          16202
        ],
        "answer": "Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind"
      }
    ],
    "file_set": [
      "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Video-on-Demand Content License Agreement Rogers Cable Communications Inc. EuroMedia Holdings Corp.",
        "similarity_score": 0.5382912755012512,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9941,
        "readability": "expert",
        "readability_score": 13.9
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 850,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          0,
          280
        ],
        "text": "Exhibit 10.B.01 EXECUTION COPY\n\nVIDEO-ON-DEMAND CONTENT LICENSE AGREEMENT between Rogers Cable Communications Inc. (\"Rogers\") and EuroMedia Holdings Corp. (\"Licensor\") offering EurocinemaSM Video-on-Demand service made as of July 11 , 2006 (the \"Effective Date\") (the \"Agreement\")"
      },
      {
        "chunk_id": 904,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15356,
          15833
        ],
        "text": "(b) Rogers shall indemnify Licensor and its affiliates from and against any and all claims, damages, liabilities, costs and expenses (including, without limitation, reasonable legal fees) arising out of or caused by:     (i) any breach by Rogers of any material term of this Agreement; and     (ii) any claim by a Rogers customer, except a claim related to the content of any Licensed Program, trailer and/or other promotional materials provided by Licensor to Rogers hereunder"
      },
      {
        "chunk_id": 869,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          6175,
          6567
        ],
        "text": ".     (d) In the event that Retail Revenues in a particular month are not sufficient to fully reimburse Rogers for the Rogers Costs incurred in such month, Rogers shall be entitled to recover such amounts against Retail Revenues generated by other Licensed Programs in subsequent months.     (e) There shall be no minimum License Fee or retail viewing fee with respect to any Licensed Program"
      },
      {
        "chunk_id": 896,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          13895,
          14280
        ],
        "text": ";     (iii) it has obtained, and shall maintain throughout the Term, all approvals and/or ratings from provincial authorities necessary to distribute and exhibit each Licensed Program, trailer and other promotional materials provided to Rogers hereunder;     (iv) it unilaterally owns or controls the VOD distribution and exhibition rights to all Licensed Programs within the Territory"
      },
      {
        "chunk_id": 900,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          14777,
          15207
        ],
        "text": ":     (i) any breach by Licensor of any material term of this Agreement;     (ii) the content of any Licensed Program, trailer and/or other promotional materials provided by Licensor to Rogers hereunder (including, without limitation, any libelous, slanderous or obscene material, violations of copyright, trade- mark rights or other intellectual property rights, personality right, right of privacy or literary or dramatic right)"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          702,
          787
        ],
        "answer": "License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012"
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "What is the renewal term for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1963,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          494,
          836
        ],
        "text": ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters"
      },
      {
        "chunk_id": 1982,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6721,
          6974
        ],
        "text": ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      },
      {
        "chunk_id": 2003,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11694,
          11743
        ],
        "text": ": (i) any information contained in this Agreement"
      },
      {
        "chunk_id": 1969,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2307,
          2717
        ],
        "text": ".     (a) For the License Term and within the Licensed Territory, Producer hereby grants to ConvergTV a right and license to Distribute the program, file or video listed on the Deal Terms above (the \"Program\") consisting of (check one) \u00a8 episodes (series) or x one-offs, for unlimited runs for the License Term through ConvergTV channels and/or other distribution outlets, in accordance with the License Rights"
      },
      {
        "chunk_id": 2012,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14210,
          14506
        ],
        "text": "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein"
      },
      {
        "chunk_id": 2018,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16298,
          16765
        ],
        "text": ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
      },
      {
        "chunk_id": 1985,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          7307,
          7351
        ],
        "text": "5. Producer's Representations and Warranties"
      },
      {
        "chunk_id": 1970,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2717,
          2943
        ],
        "text": ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
      },
      {
        "chunk_id": 2023,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17531,
          17931
        ],
        "text": "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          15422,
          15596
        ],
        "answer": "All questions with respect to the construction of this Agreement, and the rights and liabilities of the Parties hereto, shall be governed by the laws of the State of Florida."
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2018,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16298,
          16765
        ],
        "text": ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
      },
      {
        "chunk_id": 2023,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17531,
          17931
        ],
        "text": "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument"
      },
      {
        "chunk_id": 2013,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14506,
          14748
        ],
        "text": ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
      },
      {
        "chunk_id": 1992,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          8565,
          8836
        ],
        "text": ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder"
      },
      {
        "chunk_id": 2021,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17190,
          17466
        ],
        "text": ". If any term, provision, covenant or condition of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the provisions shall remain in full force and effect and shall in no way be affected, impaired or invalidated."
      },
      {
        "chunk_id": 2024,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17931,
          18353
        ],
        "text": ". All counterparts so executed shall constitute one agreement binding upon all Parties, notwithstanding that all Parties are signatory to the original or the same counterpart. The Parties may execute this Agreement by facsimile and/or electronic means and such signatures shall be treated as original signatures for all purposes.   IN WITNESS WHEREOF the Parties hereto have caused this Agreement as of the Effective Date."
      },
      {
        "chunk_id": 2012,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14210,
          14506
        ],
        "text": "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein"
      },
      {
        "chunk_id": 2003,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11694,
          11743
        ],
        "text": ": (i) any information contained in this Agreement"
      },
      {
        "chunk_id": 2015,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          15242,
          15696
        ],
        "text": ". A Notice shall be deemed served and received on the date executed on a receipt of acceptance or if by personal delivery, upon physical delivery of the same.   15. Governing Law. All questions with respect to the construction of this Agreement, and the rights and liabilities of the Parties hereto, shall be governed by the laws of the State of Florida. The Parties also agree that the venue for this Agreement shall be in the County of Brevard, Florida"
      },
      {
        "chunk_id": 2020,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16826,
          17190
        ],
        "text": ".   17. Modification, Severability & Waiver . This Agreement may not be altered, modified, or changed in any manner except by a writing executed by the Party against whom it is to be enforced. Waiver of the breach of any of the provisions of this Agreement shall not be deemed to be a waiver of any other breach of the same or any other provision of this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6977,
          7244
        ],
        "answer": "During the License Term (which is identified in the Deal Terms), Producer agrees that ConvergTV has the exclusive right to exercise the rights granted to it under this Agreement with respect to the Program, including those in Section 1, within the Licensed Territory."
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "Does this contract include an exclusivity agreement?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 13.01
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2013,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14506,
          14748
        ],
        "text": ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
      },
      {
        "chunk_id": 2003,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11694,
          11743
        ],
        "text": ": (i) any information contained in this Agreement"
      },
      {
        "chunk_id": 2012,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14210,
          14506
        ],
        "text": "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein"
      },
      {
        "chunk_id": 1992,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          8565,
          8836
        ],
        "text": ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder"
      },
      {
        "chunk_id": 1982,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6721,
          6974
        ],
        "text": ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
      },
      {
        "chunk_id": 2018,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16298,
          16765
        ],
        "text": ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
      },
      {
        "chunk_id": 1970,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2717,
          2943
        ],
        "text": ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 1963,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          494,
          836
        ],
        "text": ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          860,
          938
        ],
        "answer": "Revenue Share as specified in this CONTENT DISTRIBUTION AND LICENSE AGREEMENT."
      },
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6665,
          6722
        ],
        "answer": "The revenue share for the Program is stated in Exhibit B."
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "Does this contract include any revenue or profit-sharing arrangements?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 14.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2003,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11694,
          11743
        ],
        "text": ": (i) any information contained in this Agreement"
      },
      {
        "chunk_id": 1992,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          8565,
          8836
        ],
        "text": ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder"
      },
      {
        "chunk_id": 1982,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6721,
          6974
        ],
        "text": ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
      },
      {
        "chunk_id": 2013,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14506,
          14748
        ],
        "text": ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
      },
      {
        "chunk_id": 1970,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2717,
          2943
        ],
        "text": ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
      },
      {
        "chunk_id": 1963,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          494,
          836
        ],
        "text": ": x Free: Terrestrial, Cable, Satellite x Pay: Terrestrial, Cable, Satellite x Direct Satellite IP Distribution Systems Licensed Territory x Worldwide \u00a8 Other: _______________________________________________ License Term Perpetual, unlimited runs x Other: 2 years Commencing: November 15, 2012 Run Dates Within ConvergTV determined parameters"
      },
      {
        "chunk_id": 2018,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16298,
          16765
        ],
        "text": ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
      },
      {
        "chunk_id": 1981,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6228,
          6721
        ],
        "text": ".    (d) The Program materials delivered to ConvergTV shall be duplicate copies, and ConvergTV disclaims liability for any damage or loss to any original master delivered by Producer to ConvergTV.   3. Consideration. The Producer agrees and acknowledges that it will receive no upfront compensation for the rights it has granted herein and that ConvergTV has no obligation to Producer to exercise any of its rights under this Agreement. The revenue share for the Program is stated in Exhibit B"
      },
      {
        "chunk_id": 2012,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14210,
          14506
        ],
        "text": "13. Entire Agreement . This Agreement, which includes the Deal Terms and any and all exhibits, schedules or attachments to this Agreement, contains the entire agreement of the Parties, and supersedes any prior written or oral agreements between them concerning the subject matter contained herein"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; Does the licensee's affiliates have any licensing rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          3836,
          4188
        ],
        "answer": "Producer further grants to ConvergTV the right and license to Distribute the Program on any ConvergTV channel, and/or other distribution outlets, that exists today or that is created or developed in the future and this right includes the right to Distribute on any channels of a ConvergTV affiliate and/or other distribution outlets without limitation."
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "Does the licensee's affiliates have any licensing rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 11.36
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1982,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6721,
          6974
        ],
        "text": ". The Producer shall have thirty (30) days from the payment date to dispute the amount of any revenue share payout or any such claim or dispute is hereby waived by the Producer.   4. Program Exclusivity For The License Term Within The Licensed Territory"
      },
      {
        "chunk_id": 1973,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          3827,
          4187
        ],
        "text": ".    (b) Producer further grants to ConvergTV the right and license to Distribute the Program on any ConvergTV channel, and/or other distribution outlets, that exists today or that is created or developed in the future and this right includes the right to Distribute on any channels of a ConvergTV affiliate and/or other distribution outlets without limitation"
      },
      {
        "chunk_id": 1983,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          6975,
          7244
        ],
        "text": ". During the License Term (which is identified in the Deal Terms), Producer agrees that ConvergTV has the exclusive right to exercise the rights granted to it under this Agreement with respect to the Program, including those in Section 1, within the Licensed Territory."
      },
      {
        "chunk_id": 1992,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          8565,
          8836
        ],
        "text": ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder"
      },
      {
        "chunk_id": 1970,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2717,
          2943
        ],
        "text": ". The terms \"License Term\", \"Licensed Rights\", and \"Licensed Territory\" shall have the meaning specified in the Deal Terms above, which such Deal Terms are part of this Agreement and are hereby incorporated herein by reference"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      },
      {
        "chunk_id": 1974,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          4187,
          4416
        ],
        "text": ".    (c) Producer further grants to ConvergTV the right and license to Distribute and re-Distribute, including relicensing or sublicensing, the Program at such dates and times as are determined by ConvergTV in its sole discretion"
      },
      {
        "chunk_id": 1987,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          7436,
          7660
        ],
        "text": ": (A) has the right to enter into and perform this Agreement and to grant ConvergTV all the rights and licenses granted by it herein; and (B) either owns the Program or controls the exhibition and distribution rights thereto"
      },
      {
        "chunk_id": 1978,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          5127,
          5627
        ],
        "text": ".    (f) The grant of rights and license pursuant to this Section 1 shall include, but not be limited to, the right of ConvergTV to Distribute and re-Distribute all or any portions of the Program and Promotional Works, including excerpts therefrom, and any new and different versions of the Program, on simultaneous internet transmission or streaming, internet protocol television and any television networks and stations, and/or other distribution outlets, via domestic or foreign television signals"
      },
      {
        "chunk_id": 1971,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          2943,
          3425
        ],
        "text": ". As used in this Agreement and this license, the term \"Distribute\" includes, but is not limited to, any and all License Rights specified in the Deal Terms, all rights of distribution, the right to copy and reproduce the Program, the right to create derivative works of the Program for the purpose of creating branding elements and short form promotional materials (\"Promotional Works\"), the right to sell copies, the right to import and export the Program and the Promotional Works"
      }
    ]
  },
  {
    "query": "Consider the Content Distribution and License Agreement between ConvergTV, Inc. and Fulucai Productions Ltd.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17542,
          17731
        ],
        "answer": "Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties."
      }
    ],
    "file_set": [
      "FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "file_locator": "Content Distribution License Agreement ConvergTV, Inc. Fulucai Productions Ltd.",
        "similarity_score": 0.6785076856613159,
        "only_question": "What are the audit rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.95
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2023,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          17531,
          17931
        ],
        "text": "18. Audit. Each of the Parties may, at its own expense, audit the other Party's compliance with this Agreement, including but not limited to, auditing the other Party's representations and warranties.   19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall be deemed to be one and the same instrument"
      },
      {
        "chunk_id": 2003,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11694,
          11743
        ],
        "text": ": (i) any information contained in this Agreement"
      },
      {
        "chunk_id": 2018,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          16298,
          16765
        ],
        "text": ". Subject to the restrictions against assignment as herein contained, this Agreement shall be binding upon and inure to the benefit of the Parties, their predecessors, assigns, successors in interest, personal representatives, their past and present attorneys, principals, employees, independent contractors, officers, directors, shareholders, parents, issue, subsidiaries, agents, servants, estates, heirs, administrators, executors, conservators, trustees, legatees"
      },
      {
        "chunk_id": 2013,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          14506,
          14748
        ],
        "text": ". There are no representations, agreements, arrangements, or understandings, oral or written, between and among the Parties hereto, relating to the subject matter contained in this Agreement that are not fully expressed herein.   14.. Notices"
      },
      {
        "chunk_id": 1985,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          7307,
          7351
        ],
        "text": "5. Producer's Representations and Warranties"
      },
      {
        "chunk_id": 1992,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          8565,
          8836
        ],
        "text": ";    (d) there are no agreements, contracts, commitments or licenses, nor shall Producer enter into any agreements, contracts, commitments or grant any licenses, which would prevent the fulfillment of this Agreement or impair or conflict with the rights granted hereunder"
      },
      {
        "chunk_id": 2004,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11743,
          12241
        ],
        "text": "; or (ii) any non-public, confidential or proprietary information as it relates to ConvergTV with any third party, including but not limited to any individual, person, corporation, company, or distributor, except that Producer may disclose such information or materials, to the extent reasonably necessary, to its attorneys, auditors, consultants, shareholders, and other fiduciaries who are themselves bound by confidentiality obligations with regarding any such disclosed information or materials"
      },
      {
        "chunk_id": 1996,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          9658,
          10067
        ],
        "text": ".   6. Insurance. The Producer has no insurance requirement.   7. Indemnification. Producer shall indemnify, defend and hold harmless ConvergTV and its parents, subsidiaries, divisions, officers, directors, employees, attorneys and agents, and their respective successors or assigns, from all costs, expenses and damages arising from any breach or alleged breach of the warranties made by it in this Agreement"
      },
      {
        "chunk_id": 2000,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          11064,
          11477
        ],
        "text": ".    (b) If the Producer does not fulfill its obligation in Section 8(a) above, ConvergTV shall have the right, but not the obligation, to take such action as ConvergTV deems reasonable under the circumstances. For this purpose, Producer hereby appoints ConvergTV its attorney-in-fact to act in its name to prevent any unauthorized use, reproduction, exhibition, or exploitation of any Program or any part thereof"
      },
      {
        "chunk_id": 1987,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          7436,
          7660
        ],
        "text": ": (A) has the right to enter into and perform this Agreement and to grant ConvergTV all the rights and licenses granted by it herein; and (B) either owns the Program or controls the exhibition and distribution rights thereto"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17382,
          17622
        ],
        "answer": "The initial term of this Agreement commences as of the Effective Date and, unless terminated earlier pursuant to any express provision of this Agreement, shall continue until five (5) years following the Effective Date (the \"Initial Term\")."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9273,
        "readability": "expert",
        "readability_score": 12.82
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      },
      {
        "chunk_id": 3364,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          19404,
          19842
        ],
        "text": ".   6.3 Effect of Expiration or Termination. Upon any expiration or termination of this Agreement:   (a) All licenses granted under this Agreement shall also terminate, and Licensee shall immediately delete from its systems and servers all Licensed Content, Licensor's Marks and any other materials provided by Licensor. Upon Licensor's written request, Licensee shall promptly provide Licensor with written certification of such deletion"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 235,
        "filepath": "contractnli/GreenStorm%20NDCSC.txt",
        "span": [
          5087,
          5350
        ],
        "text": "This Agreement shall, by mutual consent of the Parties, remain in force and effect for a period of seven years from the date signed and executed by all parties, with the effective date being the date on which the final signature is affixed hereto.\n8. JURISDICTION"
      },
      {
        "chunk_id": 441,
        "filepath": "contractnli/ExcelerateStandardNDAFormat.txt",
        "span": [
          6723,
          7213
        ],
        "text": "b. Notwithstanding the termination of this agreement, the supplied data must be maintained and protected in accordance with its provisions for three (3) years following the termination of this agreement. At the conclusion of this agreement/contract for which data is exchanged, proprietary data shall be returned to the provider or destroyed with a certification to that effect provided to the other party, except the one (1) copy retained by legal counsel as provided in paragraph 8 above."
      },
      {
        "chunk_id": 1500,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          23473,
          23841
        ],
        "text": "MA shall return any and all full and/or partial copies of material related to the Technology, including demonstrations of the Technology, in MA's possession or under its control to Company within ten (10) days following the termination or cancellation date of this Agreement;\n\n10\n\nSource: CYBERGY HOLDINGS, INC., 10-Q, 5/20/2014\n\n\n\n\n\n(c)\n\n(d)\n\n(e)\n\n(f)\n\n(g)\n\n19.\n\n19.1"
      },
      {
        "chunk_id": 2626,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          59980,
          60443
        ],
        "text": "12.06 Continuing Rights and Obligations. Except as otherwise stated in this Agreement, the following Articles and Paragraphs will survive termination of this Agreement:\n\no Article 1 (Definitions);\n\no Article 4 (Disclosure, Confidentiality and Restricted Use);\n\no Article 6 (Procurement and Ownership of Program Results)\n\no Article 7 (License to Program Results), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17623,
          17946
        ],
        "answer": "Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term]."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9877,
        "readability": "expert",
        "readability_score": 12.82
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 3358,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17621,
          17964
        ],
        "text": ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
      },
      {
        "chunk_id": 1690,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          18413,
          18751
        ],
        "text": ": (i) in perpetuity with respect to Titles for which the licenses granted in Section 2(a) [License Grant] are perpetual; and (ii) for the duration of the applicable license term specified in Schedule A with respect to Titles for which the license term specified in Schedule A extends beyond the expiration or termination of this Agreement"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 1689,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          18234,
          18413
        ],
        "text": "(c) Sections 2(a) [License Grant], 2(b) [Sublicensing], 2(c) [Display of Titles], 2(d) [Removal of Titles], 3, and 11 shall survive the expiration or termination of this Agreement"
      },
      {
        "chunk_id": 235,
        "filepath": "contractnli/GreenStorm%20NDCSC.txt",
        "span": [
          5087,
          5350
        ],
        "text": "This Agreement shall, by mutual consent of the Parties, remain in force and effect for a period of seven years from the date signed and executed by all parties, with the effective date being the date on which the final signature is affixed hereto.\n8. JURISDICTION"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 723,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24985,
          25342
        ],
        "text": ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17623,
          17946
        ],
        "answer": "Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term]."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.8849,
        "readability": "expert",
        "readability_score": 13.51
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 3359,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17964,
          18434
        ],
        "text": ".   (a) Either party may terminate this Agreement, effective upon written notice to the other party, if the other partymaterially breaches this Agreement, and such breach is incapable of cure or, if capable of cure, (i) fails to commence a plan of action approved by Licensor to cure such breach within thirty (30) days, or (ii) fails to cure such breach within ninety (90) days after receiving written notice thereof, in either case after receiving notice of the breach"
      },
      {
        "chunk_id": 3360,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          18434,
          18616
        ],
        "text": ". Provided, however, that if the breach giving rise to the termination right under this Section 6.2is non-payment of License Fees or Royalties, the cure period shall be ten (10) days"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 1688,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          17969,
          18232
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the other party materially breaches this Agreement and fails to cure such breach within thirty (30) days after the date that it receives written notice of such breach from the non-breaching party."
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          36761,
          36944
        ],
        "answer": "This Agreement shall be governed by and construed in accordance with the internal laws of the State of Nevada without giving effect to any choice or conflict of law provision or rule."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9647,
        "readability": "expert",
        "readability_score": 12.82
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 10325,
        "filepath": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
        "span": [
          223687,
          224076
        ],
        "text": "; (b) Contracts pursuant to which the Company grants any Person any license, sublicense, consent, waiver, covenant not to sue or other right with respect to any Intellectual Property material to the business of the Company as of the date of this Agreement; (c) co-existence agreements and settlement agreements relating to any Owned Intellectual Property or Exclusive Intellectual Property"
      },
      {
        "chunk_id": 1710,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          24678,
          25166
        ],
        "text": "i. The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action on the part of Licensee and this Agreement constitutes a valid and legally binding agreement of Licensee enforceable against Licensee in accordance with its terms;\n\nii. It will use the Titles solely as permitted under this Agreement;\n\niii. It has the full right, capacity and authority to enter into this Agreement and to perform all of its obligations hereunder; and"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 7191,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          71685,
          72071
        ],
        "text": "(h)    To the Company\u2019s Knowledge, neither the execution, delivery, nor performance of this Agreement, nor the consummation of the Transactions, will impair the right of the Company and its Subsidiaries to use, develop, make, have made, offer for sale, sell, import, copy, modify, create derivative works of, perform, display, distribute, license or dispose of any Intellectual Property"
      },
      {
        "chunk_id": 11578,
        "filepath": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
        "span": [
          107222,
          107628
        ],
        "text": "; or (vii) each Contract pursuant to which any Acquired Company (A) is granting any license to Company Intellectual Property or (B) is granted any license to Intellectual Property of a third party which is incorporated into any product sold by the Acquired Companies and necessary for the operation of the businesses of each of the Acquired Companies as presently conducted, in each case, (A) and (B),   31"
      },
      {
        "chunk_id": 1836,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          22596,
          23029
        ],
        "text": ". Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          5472,
          6080
        ],
        "answer": "Subject to Licensee's on\u00adgoing compliance with Section 3.2 and all other terms and conditions of this Agreement, Licensor grants to Licensee an exclusive (save for rights reserved to Licensor hereunder), non-transferable (except as provided in Section 11.7) and non- sublicensable license, during the License Term, to reproduce, perform, display, transmit and distribute the Licensed Content on the Licensee Siteand Related Media intended solely for use by End Usersin the Territory within the scope set forth in Schedule 1 (License Scope), which is attached hereto and incorporated herein by this reference."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9941,
        "readability": "expert",
        "readability_score": 14.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1748,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          35344,
          35534
        ],
        "text": "13\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\n(c) Non-Exclusivity. Nothing in this Agreement limits or restricts Licensee from entering into any similar agreements with any third party."
      },
      {
        "chunk_id": 12682,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          135166,
          135611
        ],
        "text": ", exclusive or non-exclusive) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business and non-exclusive licenses granted or received in the Ordinary Course of Business consistent with past practice), or (B) is restricted in its rights, or permits other Persons, to use or register any material Intellectual Property Rights or Key Marks, including any license agreements, coexistence agreements"
      },
      {
        "chunk_id": 17004,
        "filepath": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
        "span": [
          167704,
          168170
        ],
        "text": ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP"
      },
      {
        "chunk_id": 285,
        "filepath": "contractnli/IPTK-CO-MutualNon-DisclosureAgreement.txt",
        "span": [
          9134,
          9351
        ],
        "text": ". This Agreement grants no rights of ownership, licenses, and/or any other intellectual property rights, nor does it create any agency, partnership, joint venture or any other relationship not expressly stated herein."
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          33871,
          34228
        ],
        "answer": "For purposes of the preceding sentence, and without limiting its generality, any merger, consolidation or reorganization involving Licensee (regardless of whether Licensee is a surviving or disappearing entity) will be deemed to be a transfer of rights, obligations or performance under this Agreement for which Licensor's prior written consent is required."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9875,
        "readability": "expert",
        "readability_score": 11.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 3415,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          33869,
          34344
        ],
        "text": ". For purposes of the preceding sentence, and without limiting its generality, any merger, consolidation or reorganization involving Licensee (regardless of whether Licensee is a surviving or disappearing entity) will be deemed to be a transfer of rights, obligations or performance under this Agreement for which Licensor's prior written consent is required. No delegation or other transfer will relieve Licensee of any of its obligations or performance under this Agreement"
      },
      {
        "chunk_id": 3364,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          19404,
          19842
        ],
        "text": ".   6.3 Effect of Expiration or Termination. Upon any expiration or termination of this Agreement:   (a) All licenses granted under this Agreement shall also terminate, and Licensee shall immediately delete from its systems and servers all Licensed Content, Licensor's Marks and any other materials provided by Licensor. Upon Licensor's written request, Licensee shall promptly provide Licensor with written certification of such deletion"
      },
      {
        "chunk_id": 3334,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          10431,
          10887
        ],
        "text": ". Neither this Agreement nor the licenses granted hereunder convey any ownership right in any of the Licensed Content, Licensor's Marks or other materials provided by or on behalf of Licensor under this Agreement. Except for the express licenses granted in this Agreement, all right, title and interest in and to the Licensed Content and Licensor's Marks are and will remain with Licensor and its licensors.   4. Licensee Obligations.   4.1 Content Display"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          33584,
          33870
        ],
        "answer": "Licensee shall not assign or otherwise transfer any of its rights, or delegate or otherwise transfer any of its obligations or performance, under this Agreement, in each case whether voluntarily, involuntarily, by operation of law or otherwise, without Licensor's prior written consent."
      },
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          34346,
          34488
        ],
        "answer": "Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.7267,
        "readability": "expert",
        "readability_score": 14.4
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3416,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          34344,
          34826
        ],
        "text": ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns."
      },
      {
        "chunk_id": 11185,
        "filepath": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
        "span": [
          212878,
          213298
        ],
        "text": ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 7941,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          285901,
          286263
        ],
        "text": "10.5    Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void"
      },
      {
        "chunk_id": 285,
        "filepath": "contractnli/IPTK-CO-MutualNon-DisclosureAgreement.txt",
        "span": [
          9134,
          9351
        ],
        "text": ". This Agreement grants no rights of ownership, licenses, and/or any other intellectual property rights, nor does it create any agency, partnership, joint venture or any other relationship not expressly stated herein."
      },
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 7191,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          71685,
          72071
        ],
        "text": "(h)    To the Company\u2019s Knowledge, neither the execution, delivery, nor performance of this Agreement, nor the consummation of the Transactions, will impair the right of the Company and its Subsidiaries to use, develop, make, have made, offer for sale, sell, import, copy, modify, create derivative works of, perform, display, distribute, license or dispose of any Intellectual Property"
      },
      {
        "chunk_id": 15315,
        "filepath": "maud/HMS Holdings Corp._Veritas Capital.txt",
        "span": [
          287013,
          287337
        ],
        "text": ".   (b)               Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto by operation of Law or otherwise without the prior written consent of the other parties. Any purported assignment in violation of this Section 10.06(b) shall be null and void"
      },
      {
        "chunk_id": 12142,
        "filepath": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
        "span": [
          268661,
          269145
        ],
        "text": "Section 9.10. Assignment. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties (whether by operation of law or otherwise) without the prior written consent of the other Party. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective permitted successors and assigns. Any purported assignment in violation of this Section 9"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          14071,
          14446
        ],
        "answer": "In addition to the License Fee payable in accordance with Section 5.1, Licensee shall pay a royalty (\"Royalty\") to Licensor according to the following schedule (\"Royalty Schedule\"):   Subscribers Royalty Payable as Percentage of Gross Revenue 0 - 5000 6.25% 5001 - 7500 6.75% 7501 - 10,000 7.00% 10,001 - 15,000 8.00% 15,001 - 20,000 8.50% 20,001 - 25,000 9.25% 25,001+ 9.75%"
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 15.44
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1697,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          20664,
          21062
        ],
        "text": "No royalty or fees of any kind shall be owed by Licensee under this Agreement. The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").\n\n11. Use of Licensor Marks."
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1674,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          14089,
          14263
        ],
        "text": ", payments and obligations arising out of the activities contemplated by this Agreement, and Licensee shall have no responsibility or liability for any such royalties or fees"
      },
      {
        "chunk_id": 1658,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          9839,
          10229
        ],
        "text": "(e) Profit Participation. For content listed in Schedule A6 of Schedule A (each a \"Project\"), Licensor will only grant Licensee certain profit participation rights, for certain durations, as detailed and set forth in Schedule A6 of Schedule A. Licensee will not have distribution rights or any other rights to the content in Schedule A6 of Schedule A under Section 2(a) [License Grant]- (d)"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          5472,
          6080
        ],
        "answer": "Subject to Licensee's on\u00adgoing compliance with Section 3.2 and all other terms and conditions of this Agreement, Licensor grants to Licensee an exclusive (save for rights reserved to Licensor hereunder), non-transferable (except as provided in Section 11.7) and non- sublicensable license, during the License Term, to reproduce, perform, display, transmit and distribute the Licensed Content on the Licensee Siteand Related Media intended solely for use by End Usersin the Territory within the scope set forth in Schedule 1 (License Scope), which is attached hereto and incorporated herein by this reference."
      },
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          9020,
          9719
        ],
        "answer": "Licensor grants to Licensee a limited, non-exclusive, non-transferable (except as provided in Section 11.7) and non-sublicensable royalty-free license during the Term to those of Licensor's Marks designated by Licensor from time to time to:   (i)display such Marks on the Licensee Site: (x) with the Licensed Content to provide source attribution; or (y) as links to the Licensed Content;   (ii)comply with its express obligations under this Agreement; and   (iii)advertise, market and promote the availability of the Licensed Content or the Licensee Site and identify the Licensor as a content provider;   provided, that all uses of Licensor's Marks shall require Licensor's prior written approval."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9445,
        "readability": "expert",
        "readability_score": 14.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 20713,
        "filepath": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
        "span": [
          111971,
          112406
        ],
        "text": "(vii)          is (A) a license agreement pursuant to which the Company or any Company Subsidiary is licensed by a third party to use any Intellectual Property or Intellectual Property Rights for which the Company or any Company Subsidiary is required to make annual payments in excess of $2,000,000 (other than any \u201ccommercially available off-the-shelf software package,\u201d or other software licensed pursuant to a software \u201cshrink wrap"
      },
      {
        "chunk_id": 19342,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          156389,
          156659
        ],
        "text": ", option to license, or any other similar rights with respect to any Company Product or any material Intellectual Property Rights, in each case, which payments are in an amount having an expected value in excess of $50,000,000 in the fiscal year ending December 31, 2020"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1251,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          36268,
          36763
        ],
        "text": ":   (i) It has the full right, power and authority to enter into this Agreement and to perform its obligations hereunder; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein; (iii) the Licensed Products, any element thereof, or any advertising, promotional or publicity materials supplied by Licensee or third parties hereunder will not contain any language or material which is obscene, libelous, slanderous or defamatory"
      },
      {
        "chunk_id": 10325,
        "filepath": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
        "span": [
          223687,
          224076
        ],
        "text": "; (b) Contracts pursuant to which the Company grants any Person any license, sublicense, consent, waiver, covenant not to sue or other right with respect to any Intellectual Property material to the business of the Company as of the date of this Agreement; (c) co-existence agreements and settlement agreements relating to any Owned Intellectual Property or Exclusive Intellectual Property"
      },
      {
        "chunk_id": 3008,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37034,
          37111
        ],
        "text": "4.1.2 Company License. Subject to the terms and conditions of this Agreement:"
      },
      {
        "chunk_id": 12682,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          135166,
          135611
        ],
        "text": ", exclusive or non-exclusive) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business and non-exclusive licenses granted or received in the Ordinary Course of Business consistent with past practice), or (B) is restricted in its rights, or permits other Persons, to use or register any material Intellectual Property Rights or Key Marks, including any license agreements, coexistence agreements"
      },
      {
        "chunk_id": 11578,
        "filepath": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
        "span": [
          107222,
          107628
        ],
        "text": "; or (vii) each Contract pursuant to which any Acquired Company (A) is granting any license to Company Intellectual Property or (B) is granted any license to Intellectual Property of a third party which is incorporated into any product sold by the Acquired Companies and necessary for the operation of the businesses of each of the Acquired Companies as presently conducted, in each case, (A) and (B),   31"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Are the licenses granted under this contract non-transferable?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          5472,
          6080
        ],
        "answer": "Subject to Licensee's on\u00adgoing compliance with Section 3.2 and all other terms and conditions of this Agreement, Licensor grants to Licensee an exclusive (save for rights reserved to Licensor hereunder), non-transferable (except as provided in Section 11.7) and non- sublicensable license, during the License Term, to reproduce, perform, display, transmit and distribute the Licensed Content on the Licensee Siteand Related Media intended solely for use by End Usersin the Territory within the scope set forth in Schedule 1 (License Scope), which is attached hereto and incorporated herein by this reference."
      },
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          9020,
          9719
        ],
        "answer": "Licensor grants to Licensee a limited, non-exclusive, non-transferable (except as provided in Section 11.7) and non-sublicensable royalty-free license during the Term to those of Licensor's Marks designated by Licensor from time to time to:   (i)display such Marks on the Licensee Site: (x) with the Licensed Content to provide source attribution; or (y) as links to the Licensed Content;   (ii)comply with its express obligations under this Agreement; and   (iii)advertise, market and promote the availability of the Licensed Content or the Licensee Site and identify the Licensor as a content provider;   provided, that all uses of Licensor's Marks shall require Licensor's prior written approval."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9935,
        "readability": "expert",
        "readability_score": 15.19
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 3416,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          34344,
          34826
        ],
        "text": ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns."
      },
      {
        "chunk_id": 3334,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          10431,
          10887
        ],
        "text": ". Neither this Agreement nor the licenses granted hereunder convey any ownership right in any of the Licensed Content, Licensor's Marks or other materials provided by or on behalf of Licensor under this Agreement. Except for the express licenses granted in this Agreement, all right, title and interest in and to the Licensed Content and Licensor's Marks are and will remain with Licensor and its licensors.   4. Licensee Obligations.   4.1 Content Display"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 3414,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          33582,
          33869
        ],
        "text": ". Licensee shall not assign or otherwise transfer any of its rights, or delegate or otherwise transfer any of its obligations or performance, under this Agreement, in each case whether voluntarily, involuntarily, by operation of law or otherwise, without Licensor's prior written consent"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16232,
          16745
        ],
        "answer": "Licensee shall make such books and records, and appropriate personnel, available during normal business hours for audit by Licensor or its authorized representative; provided that Licensor shall:   (a) provide Licensee with reasonable prior notice of any audit;   (b) undertake an audit no more than once per calendar year, unless a prior audit has disclosed a balance due; and   (c) conduct or cause to be conducted such audit in a manner designed to minimize disruption of Licensee's normal business operations."
      },
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16809,
          17036
        ],
        "answer": "Licensor will pay the cost of such audits unless an audit reveals a discrepancy in payment or reporting of five percent (5%) or more, in which case the Licensee shall reimburse the Licensor for the reasonable cost of the audit."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9477,
        "readability": "expert",
        "readability_score": 13.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 2663,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71595,
          71613
        ],
        "text": "18.02 Audit Rights"
      },
      {
        "chunk_id": 1288,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          47843,
          48251
        ],
        "text": ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
      },
      {
        "chunk_id": 3100,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62720,
          62988
        ],
        "text": "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
      },
      {
        "chunk_id": 3354,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16744,
          17215
        ],
        "text": ".   Licensor may take copies and abstracts of materials audited. Licensor will pay the cost of such audits unless an audit reveals a discrepancy in payment or reporting of five percent (5%) or more, in which case the Licensee shall reimburse the Licensor for the reasonable cost of the audit. Licensee shall immediately upon notice from Licensor pay Licensor the amount of any underpayment revealed by the audit, including interest calculated in accordance with Section 5"
      },
      {
        "chunk_id": 2292,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          23385,
          23765
        ],
        "text": ". Each Party shall permit an independent certified public accounting firm selected by the auditing Party and reasonably acceptable to the non-auditing Party, that has agreed to be bound by a confidentiality agreement reasonably acceptable to the Parties, to have access, during normal business hours and upon reasonable prior notice (not more often than once in any calendar year)"
      },
      {
        "chunk_id": 3089,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          59938,
          60146
        ],
        "text": "5.4 Audit Rights. The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3"
      },
      {
        "chunk_id": 1668,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          12221,
          12653
        ],
        "text": "vi. Licensee shall have equal rights and access to all financial statements, records and/or data received from any entity in connection with the Project. Licensor shall compile this information (including information regarding approved budgets) on a annual basis and provide to Licensee in summary form, the calculation of Profit Participation for all of the parties, which shall be accompanied by the parties' share thereof, if any"
      },
      {
        "chunk_id": 3353,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16426,
          16744
        ],
        "text": ":   (a) provide Licensee with reasonable prior notice of any audit;   (b) undertake an audit no more than once per calendar year, unless a prior audit has disclosed a balance due; and   (c) conduct or cause to be conducted such audit in a manner designed to minimize disruption of Licensee's normal business operations"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          25255,
          25454
        ],
        "answer": "The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.5999,
        "readability": "expert",
        "readability_score": 14.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 3382,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24562,
          24938
        ],
        "text": ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 3384,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24989,
          25476
        ],
        "text": "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality"
      },
      {
        "chunk_id": 5275,
        "filepath": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
        "span": [
          119818,
          120217
        ],
        "text": ". (e) Notwithstanding anything to the contrary in this Agreement, the representations and warranties contained in this Section 4.17, together with Section 4.10(a)(vi), are the only representations and warranties being made by the Company in this Agreement with respect to Intellectual Property rights or the violation of any Person\u2019s privacy or personal information. Section 4.18  Insurance Coverage"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between PSiTech Corporation and Empirical Ventures, Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24564,
          24938
        ],
        "answer": "NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      },
      {
        "file_path": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          25018,
          25236
        ],
        "answer": "EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM."
      }
    ],
    "file_set": [
      "GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement PSiTech Corporation Empirical Ventures, Inc.",
        "similarity_score": 0.5177726149559021,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.7121,
        "readability": "expert",
        "readability_score": 12.43
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3384,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24989,
          25476
        ],
        "text": "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality"
      },
      {
        "chunk_id": 3301,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          16,
          455
        ],
        "text": "PSiTECHCORPORATION   WEBSITE CONTENT LICENSE AGREEMENT     This Content License Agreement (\"Agreement\"), dated as of Feb 10, 2014 (the \"Effective Date\"), is by and between PSiTech Corporation, a BVI Corporation, with offices located at 303, 3rdFl, St. Georges Bldg, 2 Ice House St, Central, Hong Kong(\"Licensor\"), and Empirical Ventures, Inc., a Nevada corporation with offices located at 100, 40 Lake Bellevue Dr, Bellevue, WA(\"Licensee\")"
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 3382,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24562,
          24938
        ],
        "text": ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      },
      {
        "chunk_id": 905,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15833,
          16314
        ],
        "text": ".     (c) This Section shall survive the termination or expiration of this Agreement.     16. LIMITATION OF LIABILITY.   Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind. This Section shall survive the termination or expiration of this Agreement.     17. COPYRIGHT ROYALTY PAYMENTS"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          17465,
          17667
        ],
        "answer": "The Term of this Agreement (the \"Term\") shall commence on the Effective Date listed above and continue for twenty (20) years, unless sooner terminated as provided in Section 7(b) [Term and Termination]."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9892,
        "readability": "expert",
        "readability_score": 12.49
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 873,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          7692,
          7966
        ],
        "text": ", such continued distribution and exhibition shall be governed by the terms of this Agreement in effect at the time of expiry, except that each of Licensor and Rogers shall have the right, on sixty (60) days' prior written notice, to terminate this Agreement, as so extended"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          32754,
          32932
        ],
        "answer": "This Agreement shall be governed by and construed in all respects in accordance with the laws of the State of New York, without giving effect to any conflicts of laws principles."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9715,
        "readability": "expert",
        "readability_score": 12.49
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1967,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          1480,
          1845
        ],
        "text": "This CONTENT DISTRIBUTION AND LICENSE AGREEMENT (the \"Agreement\") is entered into as of November 15, 2012 (the \"Effective Date\") by and between, CONVERGTV, INC., a Delaware Corporation, (\"ConvergTV\"), whose principal place of business is located at 3201 Budinger Ave., St. Cloud, FL 34769, P.O. Box 540817, Merritt Island, Florida 32954, and Fulucai Productions Ltd"
      },
      {
        "chunk_id": 1962,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          0,
          494
        ],
        "text": "CONTENT DISTRIBUTION AND LICENSE AGREEMENT   Deal Terms   Licensed Program/ Film or Video Inevitable \"Licensed Rights\" to ConvergTV and ConvergTV Channels and/or Distribution Outlets x All, including but not limited to: xSimultaneous Internet Streaming x OTT Television x Internet Protocol Television x Radio, short wave, microwave, fiber optic x Alternative, secondary and specialty distribution x Stored as VOD, Content Distribution Networks/Company Servers x Full Television Broadcast Rights"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          16232,
          16833
        ],
        "answer": "If, during the Term, Licensor develops or obtains the rights to license any live action or animated feature-length motion picture (each an \"Additional Title\"), Licensor shall give Licensee the first right of negotiation for each Additional Title (i.e., the preferred vendor). Licensor will promptly provide written notice to Licensee in which Licensor lists each Additional Title. Should Licensee agree to be the vendor for an Additional Title, Licensor and Licensee will negotiate in good faith to mutually agree upon the pricing and terms for each Additional Title in an amendment to this Agreement."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.38
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 17004,
        "filepath": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
        "span": [
          167704,
          168170
        ],
        "text": ";   (iii)            each Contract that (A) grants any exclusive rights to any Third Party, including any exclusive license or supply or distribution agreement or other exclusive rights or which, pursuant to its terms, could have such effect after the Closing solely as a result of the consummation of the transactions contemplated hereby, (B) grants any rights of first refusal or rights of first negotiation with respect to any product, service or Company Owned IP"
      },
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 8565,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          128128,
          128305
        ],
        "text": ", right of first negotiation, option to purchase, option to license, or any other similar rights with respect to any Company Product or any material Intellectual Property Rights"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          7869,
          8207
        ],
        "answer": "Licensee shall have the right to assign or sublicense any or all of its rights granted under this Agreement, in whole or in part, to third parties exhibiting the Titles in the ordinary course of Licensee's business with prior written notice to Licensor and subject to the applicable limitations (if any) in Section 2(a)(i) [License Grant]"
      },
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          8209,
          8440
        ],
        "answer": "Except as otherwise specified in the previous sentence, Licensee may not sublicense any of its rights under Section 2(a) [License Grant] without Licensor's prior written consent, which shall not be unreasonably withheld or delayed."
      },
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          37152,
          37863
        ],
        "answer": "Neither party may assign its rights, duties or obligations under this Agreement to any third party in whole or in part, without the other party's prior written consent, except that (i) Licensee may assign its rights and obligations to this Agreement to any of its Affiliate or subsidiaries with the prior written consent of the Licensor, and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9874,
        "readability": "expert",
        "readability_score": 13.66
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 3416,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          34344,
          34826
        ],
        "text": ". Any purported assignment, delegation or transfer in violation of this Section 11.7 is void from the outset and shall be of no force or effect. Licensor may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensee's consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns."
      },
      {
        "chunk_id": 7941,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          285901,
          286263
        ],
        "text": "10.5    Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          9865,
          10082
        ],
        "answer": "For content listed in Schedule A6 of Schedule A (each a \"Project\"), Licensor will only grant Licensee certain profit participation rights, for certain durations, as detailed and set forth in Schedule A6 of Schedule A."
      },
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          20743,
          21034
        ],
        "answer": "The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\")."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 14.48
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1697,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          20664,
          21062
        ],
        "text": "No royalty or fees of any kind shall be owed by Licensee under this Agreement. The consideration for the licenses granted by Licensor to Licensee under this Agreement is the issuance of the IP Common Shares as defined in the Amended and Securities Purchase Agreement, dated as of December 21, 2015, by and among the Licensee and the Licensor (the \"Share Consideration\").\n\n11. Use of Licensor Marks."
      },
      {
        "chunk_id": 1674,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          14089,
          14263
        ],
        "text": ", payments and obligations arising out of the activities contemplated by this Agreement, and Licensee shall have no responsibility or liability for any such royalties or fees"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          12743,
          12966
        ],
        "answer": "Until one (1) year after the expiration of the Profit Participation of each Project, the books and records will be available for inspection by a certified accounting firm or CPA once per year upon reasonable advance notice."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9803,
        "readability": "expert",
        "readability_score": 13.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 2663,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71595,
          71613
        ],
        "text": "18.02 Audit Rights"
      },
      {
        "chunk_id": 3100,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62720,
          62988
        ],
        "text": "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          32282,
          32713
        ],
        "answer": "EXCEPT FOR THE ABOVE INDEMNIFICATION OBLIGATIONS AND FOR BREACHES OF SECTION 14, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES ARISING OUT OF THIS AGREEMENT (INCLUDING, BUT NOT LIMITED TO, LOSS OF PROFITS), WHETHER IN AN ACTION OR ARISING OUT OF BREACH OF CONTRACT, TORT OR ANY OTHER CAUSE OF ACTION EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.995,
        "readability": "expert",
        "readability_score": 13.39
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 3382,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24562,
          24938
        ],
        "text": ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      }
    ]
  },
  {
    "query": "Consider the Content License Agreement between Beijing Sun Seven Stars Culture Development Limited and You On Demand Holdings, Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          32282,
          32713
        ],
        "answer": "EXCEPT FOR THE ABOVE INDEMNIFICATION OBLIGATIONS AND FOR BREACHES OF SECTION 14, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES ARISING OUT OF THIS AGREEMENT (INCLUDING, BUT NOT LIMITED TO, LOSS OF PROFITS), WHETHER IN AN ACTION OR ARISING OUT OF BREACH OF CONTRACT, TORT OR ANY OTHER CAUSE OF ACTION EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      }
    ],
    "file_set": [
      "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Content License Agreement Beijing Sun Seven Stars Culture Development Limited Demand Holdings, Inc.",
        "similarity_score": 0.4318065941333771,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9943,
        "readability": "expert",
        "readability_score": 12.23
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1625,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          27,
          510
        ],
        "text": "THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of December 21, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\")."
      },
      {
        "chunk_id": 1624,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          0,
          25
        ],
        "text": "CONTENT LICENSE AGREEMENT"
      },
      {
        "chunk_id": 1763,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          40325,
          40823
        ],
        "text": "IN WITNESS WHEREOF and intending to be legally bound hereby, the parties have executed this Content License Agreement as of the date first set forth above.\n\nLICENSOR:\n\nBEIJING SUN SEVEN STARS CULTURE DEVELOPMENT LIMITED\n\nBy: /s/ Bruno Wu Name: Bruno Wu Title:Chairman & CEO\n\nLICENSEE:\n\nYOU ON DEMAND HOLDINGS, INC.\n\nBy: /s/ Shane McMahon Name: Shane McMahon Title:Chairman\n\n[SIGNATURE PAGE TO CONTENT LICENSE AGREEMENT]\n\nSource: IDEANOMICS, INC., 10-K, 3/30/2016\n\n\n\n\n\nSCHEDULE A\n\nTITLES\n\n[Attached]"
      },
      {
        "chunk_id": 905,
        "filepath": "cuad/EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.txt",
        "span": [
          15833,
          16314
        ],
        "text": ".     (c) This Section shall survive the termination or expiration of this Agreement.     16. LIMITATION OF LIABILITY.   Except with respect to any claim or liability arising from an infringement of any third party intellectual property right, in no event shall either party be liable for any special, indirect, consequential, punitive or incidental damages of any kind. This Section shall survive the termination or expiration of this Agreement.     17. COPYRIGHT ROYALTY PAYMENTS"
      },
      {
        "chunk_id": 3382,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24562,
          24938
        ],
        "text": ". NEITHER PARTY SHALL BE LIABLE UNDER OR IN CONNECTION WITH THIS AGREEMENT FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, LIQUIDATED, SPECIAL OR EXEMPLARY DAMAGES OR PENALTIES, INCLUDING WITHOUT LIMITATION, LOSSES OF BUSINESS, REVENUE OR ANTICIPATED PROFITS, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          1515,
          2043
        ],
        "answer": "The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd. and/or its Affiliates holds less than fifty percent (50%) of the voting control of DeltaThree's outstanding shares."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "What is the expiration date of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 955,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          1495,
          1926
        ],
        "text": "Section 1.01. Term. The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd"
      },
      {
        "chunk_id": 990,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          12514,
          12591
        ],
        "text": "4\n\ndate shall be no earlier than ten (10) days after the date of such notice."
      },
      {
        "chunk_id": 986,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          11445,
          11914
        ],
        "text": "Section 5.01. Payment Terms. Any amounts due hereunder shall be calculated and paid in U.S. dollars on a monthly basis within twenty-five (25) business days following the receipt of the reports detailed in Sections 3.06  [Reporting] and 4.02  [Reporting] hereof or any other invoices provided for herein. All payments shall be made via wire transfer in accordance with written instructions from the parties.\n\n                                   ARTICLE VI  [Termination]"
      },
      {
        "chunk_id": 989,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          12033,
          12473
        ],
        "text": ". In the event that either PrimeCall or DeltaThree materially breaches any of its duties or obligations hereunder, which breach shall not be cured within thirty (30) days after written notice is given to the breaching party specifying the breach, then either PrimeCall or DeltaThree, as the case may be, may, by giving written notice thereof to the other, terminate this Agreement as of a date specified in such notice of termination, which"
      },
      {
        "chunk_id": 1042,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          28781,
          28825
        ],
        "text": "10\n\nSource: DELTATHREE INC, S-1/A, 11/2/1999"
      },
      {
        "chunk_id": 999,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14511,
          14747
        ],
        "text": ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect"
      },
      {
        "chunk_id": 1004,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          15725,
          15768
        ],
        "text": "5\n\nSource: DELTATHREE INC, S-1/A, 11/2/1999"
      },
      {
        "chunk_id": 1001,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14785,
          14866
        ],
        "text": "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
      },
      {
        "chunk_id": 998,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14180,
          14511
        ],
        "text": ". In the event of the termination of this Agreement, all rights and obligations of PrimeCall and DeltaThree shall terminate as of the effective date of such termination, except that (i) such termination shall not constitute a waiver of any rights that either PrimeCall or DeltaThree may have by reason of a breach of this Agreement"
      },
      {
        "chunk_id": 991,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          12602,
          13010
        ],
        "text": "Section 6.02  [Termination for Bankruptcy]. Termination for Bankruptcy. In the event of the Bankruptcy (as hereinafter defined) of either PrimeCall or DeltaThree, then the non-bankrupt party may, by written notice thereof to the party in Bankruptcy, terminate this Agreement as of a date specified in such notice of termination, which date shall be no earlier than ten (10) days after the date of such notice"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          26053,
          26224
        ],
        "answer": "This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws principles thereof."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1018,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19876,
          20349
        ],
        "text": ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
      },
      {
        "chunk_id": 1027,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          23338,
          23678
        ],
        "text": "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged."
      },
      {
        "chunk_id": 1001,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14785,
          14866
        ],
        "text": "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
      },
      {
        "chunk_id": 999,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14511,
          14747
        ],
        "text": ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect"
      },
      {
        "chunk_id": 1035,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          26007,
          26287
        ],
        "text": "Section 9.11  [Governing Law]. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws principles thereof. For purposes of this\n\nSource: DELTATHREE INC, S-1/A, 11/2/1999"
      },
      {
        "chunk_id": 1029,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24056,
          24404
        ],
        "text": "Section 9.07  [Entire Agreement]. Entire Agreement. This Agreement and all other documents to be delivered in connection herewith set forth the entire agreement and understanding between the parties as to the subject matter hereof and merges and supersedes all prior discussions, agreements and understandings of every kind and nature between them."
      },
      {
        "chunk_id": 1031,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24882,
          25346
        ],
        "text": "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
      },
      {
        "chunk_id": 1026,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          22940,
          23327
        ],
        "text": "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
      },
      {
        "chunk_id": 986,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          11445,
          11914
        ],
        "text": "Section 5.01. Payment Terms. Any amounts due hereunder shall be calculated and paid in U.S. dollars on a monthly basis within twenty-five (25) business days following the receipt of the reports detailed in Sections 3.06  [Reporting] and 4.02  [Reporting] hereof or any other invoices provided for herein. All payments shall be made via wire transfer in accordance with written instructions from the parties.\n\n                                   ARTICLE VI  [Termination]"
      },
      {
        "chunk_id": 1021,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          20846,
          21317
        ],
        "text": ". All statements, certifications, indemnifications, representations and warranties made by the parties to this Agreement in this Agreement or in any certificate or list delivered pursuant hereto, and their respective obligations to be performed pursuant to the terms hereof and thereof, shall survive the Term notwithstanding (a) any examination or audit by or on behalf of any party hereto and (b) any notice of a breach or of a failure to perform not waived in writing."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          1515,
          2043
        ],
        "answer": "The term of this Agreement shall be effective as of the date first stated above and shall continue for a term of three (3) years, unless terminated earlier in accordance with the provisions of this Agreement (the \"Term\"); provided, however, that PrimeCall may elect to terminate this Agreement, upon thirty (30) days' written notice, at any time from and after the time that collectively RSL Communications, Ltd. and/or its Affiliates holds less than fifty percent (50%) of the voting control of DeltaThree's outstanding shares."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "What happens in the event of a change of control of one of the parties in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 8.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1018,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19876,
          20349
        ],
        "text": ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
      },
      {
        "chunk_id": 1027,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          23338,
          23678
        ],
        "text": "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged."
      },
      {
        "chunk_id": 1031,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24882,
          25346
        ],
        "text": "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
      },
      {
        "chunk_id": 1030,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24415,
          24871
        ],
        "text": "Section 9.08  [Severability]. Severability. If any provision of this Agreement or the application of any provision hereof to any person or circumstances is held invalid, the remainder of this Agreement and the application of such provision to other persons or circumstances shall not be affected unless the provision held invalid shall substantially impair the benefits of the remaining portions of this Agreement.\n\n                                       8"
      },
      {
        "chunk_id": 998,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14180,
          14511
        ],
        "text": ". In the event of the termination of this Agreement, all rights and obligations of PrimeCall and DeltaThree shall terminate as of the effective date of such termination, except that (i) such termination shall not constitute a waiver of any rights that either PrimeCall or DeltaThree may have by reason of a breach of this Agreement"
      },
      {
        "chunk_id": 999,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14511,
          14747
        ],
        "text": ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect"
      },
      {
        "chunk_id": 1029,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24056,
          24404
        ],
        "text": "Section 9.07  [Entire Agreement]. Entire Agreement. This Agreement and all other documents to be delivered in connection herewith set forth the entire agreement and understanding between the parties as to the subject matter hereof and merges and supersedes all prior discussions, agreements and understandings of every kind and nature between them."
      },
      {
        "chunk_id": 1026,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          22940,
          23327
        ],
        "text": "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
      },
      {
        "chunk_id": 1014,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19119,
          19558
        ],
        "text": "(and without limiting the availability of legal or equitable, including injunctive, remedies under any other provisions of this Agreement), each of PrimeCall and DeltaThree agrees that in the event of any such breach, the other party hereto shall be entitled to injunctive relief in addition to such other legal and equitable remedies that may be available. In addition, PrimeCall and DeltaThree each agree that the provisions of Section 8"
      },
      {
        "chunk_id": 992,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          13010,
          13109
        ],
        "text": ". For the purposes of this Agreement, \"Bankruptcy\" shall mean the happening of any of the following"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          25061,
          25157
        ],
        "answer": "This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall."
      },
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          25348,
          25490
        ],
        "answer": "Except as provided in the preceding sentence, this Agreement may not be assigned by PrimeCall without the prior written consent of DeltaThree."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "Is there an anti-assignment clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1026,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          22940,
          23327
        ],
        "text": "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
      },
      {
        "chunk_id": 1031,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24882,
          25346
        ],
        "text": "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
      },
      {
        "chunk_id": 1027,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          23338,
          23678
        ],
        "text": "Section 9.05  [No Modification Except in Writing]. No Modification Except in Writing. This Agreement shall not be changed, modified, or amended except by a writing signed by the party to be charged and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed by the party to be charged."
      },
      {
        "chunk_id": 1032,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          25346,
          25490
        ],
        "text": ". Except as provided in the preceding sentence, this Agreement may not be assigned by PrimeCall without the prior written consent of DeltaThree."
      },
      {
        "chunk_id": 1035,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          26007,
          26287
        ],
        "text": "Section 9.11  [Governing Law]. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws principles thereof. For purposes of this\n\nSource: DELTATHREE INC, S-1/A, 11/2/1999"
      },
      {
        "chunk_id": 1018,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19876,
          20349
        ],
        "text": ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
      },
      {
        "chunk_id": 1039,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          27498,
          27872
        ],
        "text": "Section 9.12  [Captions]. Captions. The captions appearing in this Agreement are inserted only as a matter of convenience and for reference and in no way define, limit or describe the scope and intent of this Agreement or any of the provisions hereof.\n\n         Section 9.13  [Third Parties]. Third Parties. There are no intended third party beneficiaries to this Agreement."
      },
      {
        "chunk_id": 1036,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          26293,
          26516
        ],
        "text": "Agreement, each party hereby irrevocably submits to the nonexclusive jurisdiction of the courts of the State of New York, sitting in New York County, and the courts of the United States for the Southern District of New York"
      },
      {
        "chunk_id": 963,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          3982,
          4224
        ],
        "text": ". Except as set forth herein, neither party shall use the other party's proprietary marks without the prior, express, written consent of the other party. All rights to either party's proprietary marks shall remain with the owner of the marks."
      },
      {
        "chunk_id": 1040,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          27883,
          28250
        ],
        "text": "Section 9.14  [Counterparts]. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original.\n\n                                       9\n\n         IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.\n\n                                RSL COM PRIMECALL, INC."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          3574,
          3840
        ],
        "answer": "Throughout the Term of this Agreement, the parties hereby agree to grant to each other a limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "What licenses are granted under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 962,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          3524,
          3982
        ],
        "text": "Section 2.03  [Limited License]. Limited License. Throughout the Term of this Agreement, the parties hereby agree to grant to each other a limited license to use each other's proprietary marks solely in connection with the sale, distribution, marketing and promotion of each party's calling cards by the other party. Both parties hereto shall exercise such license in compliance with the quality and other standards established by the party owning such marks"
      },
      {
        "chunk_id": 1031,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24882,
          25346
        ],
        "text": "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
      },
      {
        "chunk_id": 1018,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19876,
          20349
        ],
        "text": ". Each party will, at any time and from time to time after the date hereof, upon the request of the other, do, execute, acknowledge and deliver, or shall cause to be done, executed, acknowledged and delivered, all such other instruments as may be reasonably required in connection with the performance of this Agreement and each shall take all such further actions as may be reasonably required to carry out or further effect the transactions contemplated by this Agreement"
      },
      {
        "chunk_id": 1001,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14785,
          14866
        ],
        "text": "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
      },
      {
        "chunk_id": 963,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          3982,
          4224
        ],
        "text": ". Except as set forth herein, neither party shall use the other party's proprietary marks without the prior, express, written consent of the other party. All rights to either party's proprietary marks shall remain with the owner of the marks."
      },
      {
        "chunk_id": 1010,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          17593,
          18088
        ],
        "text": "; provided, however, that the foregoing limitations and restrictions shall not apply to information that (i) is or becomes generally available to the public other than as a result of a disclosure by the directors, officers, shareholders, partners, affiliates, employees, agents or advisors of PrimeCall or DeltaThree, as the case may be, or (ii) is or becomes available to PrimeCall or DeltaThree on a non-confidential basis from a source other than the other party hereto or any of its advisors"
      },
      {
        "chunk_id": 1026,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          22940,
          23327
        ],
        "text": "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
      },
      {
        "chunk_id": 1032,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          25346,
          25490
        ],
        "text": ". Except as provided in the preceding sentence, this Agreement may not be assigned by PrimeCall without the prior written consent of DeltaThree."
      },
      {
        "chunk_id": 1034,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          25567,
          25996
        ],
        "text": ". Except to the extent required by law, all publicity related to the transactions contemplated hereby shall be subject to the mutual approval of the parties hereto and, except as otherwise may be required by law, no public announcement of any of the transactions contemplated hereby will be made by either party hereto without the prior written consent of the other party hereto, which consent shall not be unreasonably withheld."
      },
      {
        "chunk_id": 953,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          988,
          1440
        ],
        "text": "WHEREAS, PrimeCall has agreed to provide to DeltaThree certain services in connection with the Calling Card and DeltaThree has agreed to provide certain services in connection with the development of an on-line business to PrimeCall.\n\n         NOW, THEREFORE, in consideration of the foregoing premises and of the mutual covenants hereinafter contained, the parties hereto hereby agree as follows:\n\n                                    ARTICLE I  [Term]"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Services Agreement between RSL COM PrimeCall, Inc. and deltathree.com, Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          15192,
          15684
        ],
        "answer": "IN NO EVENT SHALL PRIMECALL BE LIABLE TO DELTATHREE FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT DELTATHREE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF PRIMECALL FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, DELTATHREE'S DIRECT DAMAGES."
      },
      {
        "file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          16101,
          16592
        ],
        "answer": "IN NO EVENT SHALL DELTATHREE BE LIABLE TO PRIMECALL FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT PRIMECALL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF DELTATHREE FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, PRIMECALL'S DIRECT DAMAGES."
      }
    ],
    "file_set": [
      "DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "file_locator": "Co-Branding Services Agreement RSL COM PrimeCall, Inc. deltathree.com, Inc.",
        "similarity_score": 0.6111589670181274,
        "only_question": "Is there a cap on liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1001,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14785,
          14866
        ],
        "text": "ARTICLE VII  [Limited Warranty]\n\n                                Limited Warranty"
      },
      {
        "chunk_id": 1006,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          16099,
          16592
        ],
        "text": ". IN NO EVENT SHALL DELTATHREE BE LIABLE TO PRIMECALL FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT PRIMECALL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF DELTATHREE FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, PRIMECALL'S DIRECT DAMAGES."
      },
      {
        "chunk_id": 1003,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          15190,
          15684
        ],
        "text": ". IN NO EVENT SHALL PRIMECALL BE LIABLE TO DELTATHREE FOR ANY SPECIAL, INCIDENTIAL OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, LOSS OF PROFITS, REVENUES OR DATA WHETHER BASED ON BREACH OF CONTRACT, TORT OR OTHERWISE, WHETHER OR NOT DELTATHREE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE LIABILITY OF PRIMECALL FOR DAMAGES OR ALLEGED DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND WILL NOT EXCEED, DELTATHREE'S DIRECT DAMAGES."
      },
      {
        "chunk_id": 999,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14511,
          14747
        ],
        "text": ", (ii) such termination shall not constitute a waiver of any right to receive payments that are due and owing pursuant to this Agreement and (iii) the provisions of Article VII  [Limited Warranty] shall continue in full force and effect"
      },
      {
        "chunk_id": 1014,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          19119,
          19558
        ],
        "text": "(and without limiting the availability of legal or equitable, including injunctive, remedies under any other provisions of this Agreement), each of PrimeCall and DeltaThree agrees that in the event of any such breach, the other party hereto shall be entitled to injunctive relief in addition to such other legal and equitable remedies that may be available. In addition, PrimeCall and DeltaThree each agree that the provisions of Section 8"
      },
      {
        "chunk_id": 1013,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          18760,
          19117
        ],
        "text": "Section 8.02  [Confidentiality]. Equitable Remedies PrimeCall and DeltaThree each specifically recognize that any breach of Section 8.01  [Confidentiality] will cause irreparable injury to the other party hereto and that actual damages may be difficult to ascertain, and in any event, may be inadequate. Accordingly\n\n                                       6"
      },
      {
        "chunk_id": 1026,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          22940,
          23327
        ],
        "text": "Section 9.04  [Independent Contractors]. Independent Contractors. At all times the parties hereto shall be considered independent contractors and this Agreement shall not create any agency, partnership or employment relationship between the parties. Except as specifically set forth herein, neither party shall have the right to act for or on behalf of or in the name of the other party."
      },
      {
        "chunk_id": 1005,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          15783,
          16099
        ],
        "text": "Section 7.02  [Disclaimer of General Warranty by DeltaThree]. Disclaimer of General Warranty by DeltaThree. DELTATHREE MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, CONCERNING THE SERVICES PROVIDED HEREUNDER, INCLUDING ANY IMPLIED WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE, MERCHANTABILITY OR OTHERWISE"
      },
      {
        "chunk_id": 1002,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          14877,
          15190
        ],
        "text": "Section 7.01  [Disclaimer of General Warranty by PrimeCall]. Disclaimer of General Warranty by PrimeCall. PRIMECALL MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, CONCERNING THE SERVICES PROVIDED HEREUNDER, INCLUDING ANY IMPLIED WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE, MERCHANTABILITY OR OTHERWISE"
      },
      {
        "chunk_id": 1031,
        "filepath": "cuad/DeltathreeInc_19991102_S-1A_EX-10.19_6227850_EX-10.19_Co-Branding Agreement_ Service Agreement.txt",
        "span": [
          24882,
          25346
        ],
        "text": "Section 9.09  [Assignment]. Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned by DeltaThree without the prior written consent of PrimeCall. PrimeCall may assign this Agreement to any affiliate of PrimeCall or in connection with a merger or consolidation of PrimeCall or a sale of all or substantially all of PrimeCall's business"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24987,
          25249
        ],
        "answer": "This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "What is the renewal term for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 723,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24985,
          25342
        ],
        "text": ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
      },
      {
        "chunk_id": 722,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24690,
          24985
        ],
        "text": "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      },
      {
        "chunk_id": 799,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45024,
          45429
        ],
        "text": "15.4 Notice. Any notice under this Agreement will be in writing and delivered by personal delivery, express courier, confirmed facsimile, confirmed e-mail or certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, one (1) day after deposit with express courier, upon confirmation of receipt of facsimile or e-mail or five (5) days after deposit in the mail"
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      },
      {
        "chunk_id": 691,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14736,
          15105
        ],
        "text": ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      },
      {
        "chunk_id": 673,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          9784,
          9991
        ],
        "text": ".com agrees that if eDiets elects to extend the Agreement the monthly fee due and payable during the Make Good Period will be recalculated and reduced to reflect the changes in the revised delivery schedule."
      },
      {
        "chunk_id": 670,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          8830,
          8959
        ],
        "text": "; 12,000,000 per year) each quarter following the Launch Date, within sixty (60) days of the end of the applicable quarter, Women"
      },
      {
        "chunk_id": 729,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          27277,
          27534
        ],
        "text": "(g) within sixty (60) days after such Termination Date, Women.com shall make-good to eDiets any and all payments made to Women.com under this Agreement for advertising inventory not yet delivered or run, provided that eDiets has paid for such inventory; and"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24987,
          25249
        ],
        "answer": "This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "What is the notice period required to terminate the renewal?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 723,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24985,
          25342
        ],
        "text": ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
      },
      {
        "chunk_id": 722,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24690,
          24985
        ],
        "text": "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")"
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      },
      {
        "chunk_id": 799,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45024,
          45429
        ],
        "text": "15.4 Notice. Any notice under this Agreement will be in writing and delivered by personal delivery, express courier, confirmed facsimile, confirmed e-mail or certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, one (1) day after deposit with express courier, upon confirmation of receipt of facsimile or e-mail or five (5) days after deposit in the mail"
      },
      {
        "chunk_id": 729,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          27277,
          27534
        ],
        "text": "(g) within sixty (60) days after such Termination Date, Women.com shall make-good to eDiets any and all payments made to Women.com under this Agreement for advertising inventory not yet delivered or run, provided that eDiets has paid for such inventory; and"
      },
      {
        "chunk_id": 725,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25837,
          26129
        ],
        "text": "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      },
      {
        "chunk_id": 750,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          32337,
          32705
        ],
        "text": "11.6 Within fifteen (15) days of receipt by Receiving Party of a written request from the Disclosing Party for the return of Confidential Information, all Disclosing Party's Confidential Information and all copies thereof in Receiving Party's possession or control shall be returned to Disclosing Party or destroyed by Receiving Party at Disclosing Party's instruction"
      },
      {
        "chunk_id": 691,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14736,
          15105
        ],
        "text": ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      },
      {
        "chunk_id": 727,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26537,
          26767
        ],
        "text": "(d) within sixty (60) days after such Termination Date, Women.com shall remove and cease to use all eDiets Content provided or made available for use or display on the Gateway Page pursuant to or in connection with this Agreement;"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          44612,
          45013
        ],
        "answer": "This Agreement shall be interpreted and enforced in accordance with the laws of the State of California as applied to agreements made, entered into and performed entirely in California by California residents, notwithstanding the actual residence of the parties, without giving effect to any choice of laws of California that would require the application of the laws of a state other than California."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 755,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33818,
          34272
        ],
        "text": "by such party of its obligations and duties hereunder, do not and will not violate any agreement to which such party is a party or by which it is bound, (c) when executed and delivered by such party, this Agreement will constitute the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms and (d) such party will perform its obligations hereunder in compliance with applicable law and regulations."
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 754,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33493,
          33816
        ],
        "text": "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10"
      },
      {
        "chunk_id": 793,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43615,
          43737
        ],
        "text": ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 801,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45589,
          45856
        ],
        "text": "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
      },
      {
        "chunk_id": 798,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          44592,
          45013
        ],
        "text": "15.3 Governing Law. This Agreement shall be interpreted and enforced in accordance with the laws of the State of California as applied to agreements made, entered into and performed entirely in California by California residents, notwithstanding the actual residence of the parties, without giving effect to any choice of laws of California that would require the application of the laws of a state other than California."
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      },
      {
        "chunk_id": 766,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37556,
          37581
        ],
        "text": "13.      INDEMNIFICATION."
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any exceptions to competitive restrictions in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          11916,
          12336
        ],
        "answer": "Notwithstanding the foregoing, Women.com shall be entitled to (aa) provide mini and micro web sites and Women.com promotions and sponsorships to Jenny Craig; (bb) sell, display, or distribute advertisements, including banner advertisements, newsletter placements, internet radio, commerce placements and market research, or otherwise promote Competitive Companies on pages other than the Gateway Page of the Diet Center."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Are there any exceptions to competitive restrictions in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 677,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          10870,
          10891
        ],
        "text": "5.       EXCLUSIVITY."
      },
      {
        "chunk_id": 679,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          11339,
          11650
        ],
        "text": ".com will not enter into a relationship with a Competitive Company that involves any of the following; (i) custom developed mini or micro web sites; (ii) content integration; (iii) discounts offered only to Women.com members on the Member Central page of the Women.com Sites; (iv) editorial endorsement (such as"
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 801,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45589,
          45856
        ],
        "text": "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 743,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          30903,
          31379
        ],
        "text": ".4 Each party agrees (a) that it will disclose such Confidential Information only to its employees, agents and contractors with a need to know such Confidential Information and who have obligations of confidentiality not to use such Confidential Information for any purpose except as expressly permitted hereunder, (b) that it will not disclose to any third party or use any Confidential Information disclosed to it by the other except as expressly permitted in this Agreement"
      },
      {
        "chunk_id": 753,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33277,
          33482
        ],
        "text": "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY."
      },
      {
        "chunk_id": 691,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14736,
          15105
        ],
        "text": ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      },
      {
        "chunk_id": 789,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42424,
          42621
        ],
        "text": ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          12707,
          13543
        ],
        "answer": "During the Term, Women.com agrees to give eDiets the right of first refusal to participate in all diet and diet-counseling related promotion opportunities created or otherwise made available by Women.com on channels or sub-channels created after the Effective Date of this Agreement, including sponsorships, anchor placements and any other content integration opportunities (\"Diet Promos\"). If Women.com proposes to create and make available Diet Promos after the Effective Date, it shall give eDiets written notice of its intention, describing the terms and conditions of participation in the Diet Promos. eDiets shall have fifteen (15) days from the giving of such notice to agree to participate in the applicable Diet Promo upon the terms and conditions specified in the notice by giving written notice of its agreement to Women.com."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          51944,
          52140
        ],
        "answer": "eDiets.com will have the first right to substitute any of the following content features for any of the eight (8) content features selected above once inventory on such features becomes available."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Does this contract include any right of first refusal, right of first offer, or right of first negotiation?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 8.04
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 801,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45589,
          45856
        ],
        "text": "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
      },
      {
        "chunk_id": 722,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24690,
          24985
        ],
        "text": "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")"
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 754,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33493,
          33816
        ],
        "text": "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10"
      },
      {
        "chunk_id": 753,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33277,
          33482
        ],
        "text": "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY."
      },
      {
        "chunk_id": 769,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          38182,
          38443
        ],
        "text": ", \"Indemnifiable Sums\") that the other party may incur as a result of third party claims arising from circumstances that constitute a breach or alleged breach of such party's warranties set forth in Section 12 or otherwise explicitly set forth in this Agreement"
      },
      {
        "chunk_id": 743,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          30903,
          31379
        ],
        "text": ".4 Each party agrees (a) that it will disclose such Confidential Information only to its employees, agents and contractors with a need to know such Confidential Information and who have obligations of confidentiality not to use such Confidential Information for any purpose except as expressly permitted hereunder, (b) that it will not disclose to any third party or use any Confidential Information disclosed to it by the other except as expressly permitted in this Agreement"
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43739,
          44244
        ],
        "answer": "For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger, consolidation or sale of assets the holders of such party's voting securities prior thereto hold at least fifty percent (50%) of the total voting power represented by the voting securities of the surviving or successor corporation after such transaction."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "What happens in the event of a change of control of one of the parties in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 8.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 794,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43737,
          43988
        ],
        "text": ". For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger"
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 792,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43157,
          43615
        ],
        "text": "controlled by, under common control with, or controls a party. For purposes hereof, the terms \"control\", \"controlled by\" or \"under common control with\" refer to the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity, whether through the ownership of voting securities, by contract or otherwise. Any attempt to assign this Agreement other than as permitted above will be null and void"
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      },
      {
        "chunk_id": 754,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33493,
          33816
        ],
        "text": "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10"
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 725,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25837,
          26129
        ],
        "text": "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
      },
      {
        "chunk_id": 793,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43615,
          43737
        ],
        "text": ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are there any price restrictions or controls specified in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14703,
          15105
        ],
        "answer": "Following the Initial Term, Women.com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Are there any price restrictions or controls specified in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 753,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33277,
          33482
        ],
        "text": "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY."
      },
      {
        "chunk_id": 769,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          38182,
          38443
        ],
        "text": ", \"Indemnifiable Sums\") that the other party may incur as a result of third party claims arising from circumstances that constitute a breach or alleged breach of such party's warranties set forth in Section 12 or otherwise explicitly set forth in this Agreement"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 823,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          54371,
          54570
        ],
        "text": "eDiets shall offer in any membership offer provided pursuant to this Agreement a minimum discount of 20% on the fair market value of any products or services.\n\nPlacement within Women.com Newsletters:"
      },
      {
        "chunk_id": 691,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14736,
          15105
        ],
        "text": ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 801,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45589,
          45856
        ],
        "text": "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
      },
      {
        "chunk_id": 690,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14260,
          14736
        ],
        "text": "6.1 Payment Schedule. In consideration of Women.com's developing, maintaining and promoting the Diet Center pursuant to this Agreement, beginning on the tenth (10th) day after the execution of this Agreement and thereafter on the last day of each month during the Term of this Agreement, eDiets shall pay to Women.com a monthly fee in the amount set forth on Exhibit C unless adjusted as set forth in Section 3.1  [Advertising and Promotion]. Following the Initial Term, Women"
      },
      {
        "chunk_id": 837,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          59080,
          59572
        ],
        "text": "Pricing/Delivery: PRICING AS PART OF THIS PACKAGE ONLY Flight:                             2 Year Deal Net Advertising CPM:                $37.00 (Just Co-Branded Banners) Overall Net CPM                     $28.57 (With all other elements) Total Net Cost:                     $2,000,000 (Per Year)/$4,000,000 (Two Years) Total Guaranteed Impressions:       70,000,000 (Per Year)/140,000,000 (TwoYears)\n\nYEAR 1\n\n10 days after Effective Date-Production                                 $250,000"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          8397,
          9546
        ],
        "answer": "If Women.com does not deliver at least 80% of the Quarterly Impression Guarantee for Advertsing Promotions as set forth on Exhibit B (11,250,000 per quarter; 45,000,000 per year); 80% of the Quarterly Impression Guarantee for the Diet Center Logo as set forth on Exhibit B (3,250,000 per quarter; 13,000,000 per year); and 80% of the Quarterly Impression Guarantee for Other Campaigns as set forth on Exhibit B (3,000,000 per quarter; 12,000,000 per year) each quarter following the Launch Date, within sixty (60) days of the end of the applicable quarter, Women.com shall deliver an amount equal to the under-delivery within the same campaign elements, including newsletters, promotions, exclusive sponsorships, targeted rotations, ROS, channel and sub-channel center logo placements, or mutually agreed upon comparable elements. If Women.com does not deliver the shortfall within sixty (60) days of the end of the applicable quarter, eDiets may terminate this Agreement in its entirety immediately or authorize Women.com to deliver the shortfall within an extended number of days to be mutually agreed upon by the parties (the \"Make Good Period\")."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          54959,
          55581
        ],
        "answer": "During the Term, eDiets.com will be guaranteed 12 million circulation per year from and after the Effective Date via newsletters, including but not limited to:      >>  Fashion & Beauty Newsletter: 300,000 subscribers per month      >>  Food News: 180,000 subscribers per month      >>  Prevention: 1,600,000 subscribers per month      >>  Internet Scopes:  2,400,000 subscribers per month      >>  Sex & Romance: 120,000 subscribers per month      >>  What's New: 1,100,000 subscribers per month      >>  Women.com Member Newsletter: 1,700,000 subscribers per month\n\nGuaranteed Circulation Per Year:            12,000,000"
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          60777,
          60914
        ],
        "answer": "Notwithstanding the foregoing, Women.com does guarantee a minimum of 13,000,000 impressions promoting eDiets per year on the Diet Center."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Is there a minimum commitment required under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.1
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 801,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45589,
          45856
        ],
        "text": "15.5 No Agency. The parties are independent contractors and will have no power or authority to assume or create any obligation or responsibility on behalf of each other. This Agreement will not be construed to create or imply any partnership, agency or joint venture."
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 722,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24690,
          24985
        ],
        "text": "10.1 Initial Term. This Agreement will become effective as of the Effective Date and, unless sooner terminated pursuant to Sections 3.1  [Advertising and Promotion] or 10.2  [Termination for Breach], shall remain effective for two (2) years from and after the Effective Date (the \"Initial Term\")"
      },
      {
        "chunk_id": 793,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43615,
          43737
        ],
        "text": ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 765,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37368,
          37554
        ],
        "text": ". To the extent that a party may not, as a matter of applicable law, disclaim any implied warranty, the scope and duration of such warranty shall be the minimum permitted under such law."
      },
      {
        "chunk_id": 724,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25353,
          25826
        ],
        "text": "10.2 Termination for Breach. In the event of a material breach of this Agreement by either party, the non-breaching party may terminate this Agreement if such breach is not cured within thirty (30) days from receipt of written notice of such breach sent to the address of the breaching party as specified herein. Such termination shall be in addition to any and all other actions or remedies the parties may seek at law or equity with respect to a breach of this Agreement."
      },
      {
        "chunk_id": 753,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33277,
          33482
        ],
        "text": "11.8 The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and will not be disclosed without the written consent of the other party.\n\n12.      WARRANTY."
      },
      {
        "chunk_id": 691,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          14736,
          15105
        ],
        "text": ".com shall have the right, upon no fewer than sixty (60) days prior written notice to eDiets, to increase the amount of the Payment Schedule; provided, that (i) Women.com may not increase the Payment Schedule more than once in any period of twelve (12) consecutive months; and (ii) such increase may not exceed twenty percent (20%) of the then current Payment Schedule."
      },
      {
        "chunk_id": 799,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          45024,
          45429
        ],
        "text": "15.4 Notice. Any notice under this Agreement will be in writing and delivered by personal delivery, express courier, confirmed facsimile, confirmed e-mail or certified or registered mail, return receipt requested, and will be deemed given upon personal delivery, one (1) day after deposit with express courier, upon confirmation of receipt of facsimile or e-mail or five (5) days after deposit in the mail"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          4360,
          5041
        ],
        "answer": "eDiets hereby grants to Women.com, subject to the terms and conditions of this Agreement, a non-exclusive, nontransferable, worldwide, royalty-free license to use, copy, reproduce and display the editorial content and other data, branding and other identification provided by eDiets to Women.com in connection with this Agreement (the \"eDiets Content\") on the Women.com Sites: (i) for publication in the Diet Center and elsewhere throughout the Women.com Sites; (ii) for the promotion of eDiets and the Diet Center on the Women.com Sites and in collateral advertising materials; and (iii) for such other purposes as are consistent with or otherwise authorized under this Agreement."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          19748,
          20096
        ],
        "answer": "Women.com hereby grants eDiets a non-exclusive, non-transferable, royalty-free worldwide right and license without the right to sublicense to use the Women.com Marks during the Term solely in connection with (i) the fulfillment of eDiets' obligations under this Agreement, and (ii) in advertising and marketing collateral related to this Agreement."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          21364,
          21713
        ],
        "answer": "eDiets hereby grants Women.com a non-exclusive, non-transferable, royalty-free worldwide right and license without the right to sublicense to use the eDiets Marks during the Term solely in connection with (i) the fulfillment of Women.com's obligations under this Agreement, and (ii) in advertising and marketing collateral related to this Agreement."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "What licenses are granted under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 707,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          19368,
          19716
        ],
        "text": "8.5 Tools. To the extent either party, directly or indirectly, utilizes any software, HTML and/or Java scripts, proprietary tools and/or methodologies (collectively the \"Tools\") in performing under this Agreement, such party and its licensors retain all right, title and interest in and to any such Tools.\n\n9.       TRADEMARK OWNERSHIP AND LICENSE."
      },
      {
        "chunk_id": 725,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25837,
          26129
        ],
        "text": "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 759,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          35325,
          35803
        ],
        "text": "For the purposes of this Agreement, \"Affiliate\" shall mean another entity that controls, is controlled by or is under common control with such party; provided, however, that such entity is not a human being. For purposes of this definition, the terms \"controls,\" \"is controlled by,\" or \"is under common control with,\" refer to the power to direct the policies and day-to-day operations of an entity, whether by virtue of ownership of a voting securities, contract, or otherwise."
      },
      {
        "chunk_id": 743,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          30903,
          31379
        ],
        "text": ".4 Each party agrees (a) that it will disclose such Confidential Information only to its employees, agents and contractors with a need to know such Confidential Information and who have obligations of confidentiality not to use such Confidential Information for any purpose except as expressly permitted hereunder, (b) that it will not disclose to any third party or use any Confidential Information disclosed to it by the other except as expressly permitted in this Agreement"
      },
      {
        "chunk_id": 784,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41259,
          41560
        ],
        "text": ": (a) use of old, superseded content or Marks if such infringement would have been avoided by the use of the current version of such content or replacement Marks made available by the indemnifying party to the other party; (b) use of content or Marks not in accordance with the terms of this Agreement"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 717,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          22900,
          23181
        ],
        "text": "9.3 Usage. All uses by one party of the other party's Marks shall be in accordance with such quality control standards as the licensing party may promulgate from time to time and each party agrees to refrain from all uses of the other party's Marks to which the other party objects"
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Are the licenses granted under this contract non-transferable?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          4360,
          5041
        ],
        "answer": "eDiets hereby grants to Women.com, subject to the terms and conditions of this Agreement, a non-exclusive, nontransferable, worldwide, royalty-free license to use, copy, reproduce and display the editorial content and other data, branding and other identification provided by eDiets to Women.com in connection with this Agreement (the \"eDiets Content\") on the Women.com Sites: (i) for publication in the Diet Center and elsewhere throughout the Women.com Sites; (ii) for the promotion of eDiets and the Diet Center on the Women.com Sites and in collateral advertising materials; and (iii) for such other purposes as are consistent with or otherwise authorized under this Agreement."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          19748,
          20095
        ],
        "answer": "Women.com hereby grants eDiets a non-exclusive, non-transferable, royalty-free worldwide right and license without the right to sublicense to use the Women.com Marks during the Term solely in connection with (i) the fulfillment of eDiets' obligations under this Agreement, and (ii) in advertising and marketing collateral related to this Agreement"
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          21364,
          21713
        ],
        "answer": "eDiets hereby grants Women.com a non-exclusive, non-transferable, royalty-free worldwide right and license without the right to sublicense to use the eDiets Marks during the Term solely in connection with (i) the fulfillment of Women.com's obligations under this Agreement, and (ii) in advertising and marketing collateral related to this Agreement."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Are the licenses granted under this contract non-transferable?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 13.9
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 790,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42623,
          43112
        ],
        "text": "15.      GENERAL.\n\n         15.1 Assignment. Neither party may assign this Agreement, in whole or in part, without the other party's written consent (which will not be unreasonably delayed or withheld), except that no such consent will be required in connection with an assignment or transfer of this Agreement to (a) a party's successor in connection with a Change in Control of such party, provided that such successor is not a competitor of the other party, or (b) to any entity that is"
      },
      {
        "chunk_id": 725,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          25837,
          26129
        ],
        "text": "10.3 Effect of Termination. Upon the termination, expiration or earlier termination of this Agreement in accordance with its terms (the \"Termination Date\"):\n\n              (a) the rights and licenses granted by each party to the other pursuant to this Agreement shall automatically terminate;"
      },
      {
        "chunk_id": 696,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          16427,
          16916
        ],
        "text": "8.       OWNERSHIP.\n\n         8.1 eDiets Content. Nothing in this Agreement shall effect a transfer of ownership in the eDiets Content from eDiets to Women.com, and eDiets shall retain all rights of copyright, trademark or other intellectual property rights in such eDiets Content that it possessed prior to providing such eDiets Content to Women.com, subject only to the licenses expressly granted by eDiets to Women.com by this Agreement. eDiets retains all rights with respect to eDiets"
      },
      {
        "chunk_id": 707,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          19368,
          19716
        ],
        "text": "8.5 Tools. To the extent either party, directly or indirectly, utilizes any software, HTML and/or Java scripts, proprietary tools and/or methodologies (collectively the \"Tools\") in performing under this Agreement, such party and its licensors retain all right, title and interest in and to any such Tools.\n\n9.       TRADEMARK OWNERSHIP AND LICENSE."
      },
      {
        "chunk_id": 726,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          26145,
          26521
        ],
        "text": "(b) where applicable, each party shall return to the other party, within thirty (30) days from such Termination Date, all intellectual property, technology or other property in its possession used in connection with this Agreement that is proprietary to the other party;\n\n              (c) Confidential Information shall be returned in accordance with the terms of Section 11;"
      },
      {
        "chunk_id": 720,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          23975,
          24340
        ],
        "text": "9.4 Non-Alteration. In any identification of either party pursuant to this Agreement, one party shall not alter or otherwise impair the branding or other identification of the other party, nor alter or remove any copyright,\n\nSource: EDIETS COM INC, 10QSB, 10/30/2000\n\n\n\n\n\ntrademark or other protective notices of such other\n\n                                       7"
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 794,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43737,
          43988
        ],
        "text": ". For purposes of this Agreement, \"Change in Control\" means a merger or consolidation of the party with, or any sale of all or substantially all of the assets of such party to, any other person, corporation or entity, unless as a result of such merger"
      },
      {
        "chunk_id": 702,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          18240,
          18341
        ],
        "text": ".com or its third party licensors and eDiets acquires no right, title or interest therein or thereto."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41949,
          42621
        ],
        "answer": "EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Is there uncapped liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 787,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41915,
          41947
        ],
        "text": "14.      LIMITATION OF LIABILITY"
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 789,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42424,
          42621
        ],
        "text": ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
      },
      {
        "chunk_id": 767,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37592,
          37705
        ],
        "text": "13.1 Breach of Warranty. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets and Women"
      },
      {
        "chunk_id": 782,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          40965,
          41073
        ],
        "text": "13.4 Limitations on Indemnification. Notwithstanding the terms of Sections 13.1  [Breach of Warranty] and 13"
      },
      {
        "chunk_id": 774,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          39100,
          39456
        ],
        "text": "(b) eDiets Liability. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets agrees to indemnify, defend and forever hold harmless the Women.com Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the eDiets Sites, other than Women"
      },
      {
        "chunk_id": 772,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          38507,
          38910
        ],
        "text": "(a) Women.com Liability. Subject to Section 13.3  [Indemnification Requirements and Procedures], Women.com agrees to indemnify, defend and forever hold harmless the eDiets Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the Women.com Sites, other than eDiets Content; (b) the operation of the Women"
      },
      {
        "chunk_id": 766,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37556,
          37581
        ],
        "text": "13.      INDEMNIFICATION."
      },
      {
        "chunk_id": 783,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41073,
          41259
        ],
        "text": ".2  [Products, Services and Content], an indemnifying party shall have no liability for, nor shall it indemnify, defend or hold any Indemnitee harmless from or against any claim based on"
      },
      {
        "chunk_id": 763,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36697,
          36887
        ],
        "text": "12.4 Sole Remedy. Each party agrees that the sole and exclusive remedy for a breach of the warranties set forth in this Section 12 shall be the indemnification set forth in Section 13 below."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36715,
          36887
        ],
        "answer": "Each party agrees that the sole and exclusive remedy for a breach of the warranties set forth in this Section 12 shall be the indemnification set forth in Section 13 below."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41949,
          42425
        ],
        "answer": "EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Is there a cap on liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 787,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41915,
          41947
        ],
        "text": "14.      LIMITATION OF LIABILITY"
      },
      {
        "chunk_id": 789,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42424,
          42621
        ],
        "text": ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 782,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          40965,
          41073
        ],
        "text": "13.4 Limitations on Indemnification. Notwithstanding the terms of Sections 13.1  [Breach of Warranty] and 13"
      },
      {
        "chunk_id": 767,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37592,
          37705
        ],
        "text": "13.1 Breach of Warranty. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets and Women"
      },
      {
        "chunk_id": 772,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          38507,
          38910
        ],
        "text": "(a) Women.com Liability. Subject to Section 13.3  [Indemnification Requirements and Procedures], Women.com agrees to indemnify, defend and forever hold harmless the eDiets Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the Women.com Sites, other than eDiets Content; (b) the operation of the Women"
      },
      {
        "chunk_id": 774,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          39100,
          39456
        ],
        "text": "(b) eDiets Liability. Subject to Section 13.3  [Indemnification Requirements and Procedures], eDiets agrees to indemnify, defend and forever hold harmless the Women.com Indemnitees from and against all Indemnifiable Sums arising out of third party claims to the extent such claims are based upon: (a) content published on the eDiets Sites, other than Women"
      },
      {
        "chunk_id": 783,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41073,
          41259
        ],
        "text": ".2  [Products, Services and Content], an indemnifying party shall have no liability for, nor shall it indemnify, defend or hold any Indemnitee harmless from or against any claim based on"
      },
      {
        "chunk_id": 764,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          36898,
          37368
        ],
        "text": "12.5 EXCEPT AS SPECIFIED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL IMPLIED OR STATUTORY WARRANTIES, INCLUDING ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR USE OR PURPOSE REGARDING SUCH SUBJECT MATTER. NEITHER PARTY WARRANTS THAT ITS WEB SITE(S) OR THE CENTER WILL FUNCTION WITHOUT INTERRUPTION OR THAT THEY ARE ERROR FREE"
      },
      {
        "chunk_id": 766,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37556,
          37581
        ],
        "text": "13.      INDEMNIFICATION."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Women.com Networks, Inc. and eDiets.com, Inc. for the Establishment of a Diet Center; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          17023,
          17250
        ],
        "answer": "Women.com acknowledges that eDiets owns all right, title and interest in and to the eDiets Content, and Women.com shall not now or in the future contest the validity of the eDiets' ownership rights in and to the eDiets Content."
      },
      {
        "file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          23667,
          23964
        ],
        "answer": "At no time during the term of the Agreement or thereafter shall eDiets attack, challenge or file any application with respect to any Women.com Mark. At no time during the term of the Agreement or thereafter shall Women.com attack, challenge or file any application with respect to any eDiets Mark."
      }
    ],
    "file_set": [
      "EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Women.com Networks, Inc. eDiets.com, Inc. Establishment Diet Center",
        "similarity_score": 0.5564807653427124,
        "only_question": "Is there a covenant not to sue included in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 9.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 780,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          40598,
          40907
        ],
        "text": ". Each party, as Indemnitee, may participate, at its own cost, in the defense of any indemnifiable claim with counsel of its own choosing. Each party agrees not to settle any indemnifiable claim without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed."
      },
      {
        "chunk_id": 788,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          41947,
          42424
        ],
        "text": ". EXCEPT FOR BREACHES OF SECTION 11 OR BREACHES OF ANY LICENSE GRANT SET FORTH IN THIS AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF, KNEW, OR SHOULD HAVE KNOWN OF, THE POSSIBILITY OF SUCH DAMAGE AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY"
      },
      {
        "chunk_id": 766,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37556,
          37581
        ],
        "text": "13.      INDEMNIFICATION."
      },
      {
        "chunk_id": 793,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          43615,
          43737
        ],
        "text": ". This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 789,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          42424,
          42621
        ],
        "text": ". THE LIMITATIONS ON LIABILITY FOR DAMAGES SET FORTH IN THIS AGREEMENT SHALL BE INAPPLICABLE TO EACH PARTY'S CONTRACTUAL OBLIGATION TO INDEMNIFY THE OTHER PARTY AS SET FORTH IN SECTIONS 2.6 AND 13."
      },
      {
        "chunk_id": 803,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          46215,
          46628
        ],
        "text": "15.7 Severability. In the event that any of the provisions of this Agreement are held to be unenforceable, the remaining portions of the Agreement will remain in full force and effect.\n\n         15.8 Entire Agreement. This Agreement is the complete and exclusive agreement between the parties with respect to the subject matter hereof, superseding that certain Letter of\n\n                                       14"
      },
      {
        "chunk_id": 768,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          37705,
          38182
        ],
        "text": ".com each agree to indemnify, defend and forever hold the other party, its present and former Affiliates, officers, members, stockholders, directors, employees, and agents, and successors and assigns (collectively, the \"Indemnitees\") harmless from and against any and all losses, liabilities, claims, costs, damages, fees and expenses (including, without limitation, fines, forfeitures, reasonable attorneys' fees, disbursements and administrative or court costs) (collectively"
      },
      {
        "chunk_id": 797,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          44255,
          44581
        ],
        "text": "15.2 Jurisdiction and Venue. The parties agree that all lawsuits arising out of or related to this Agreement shall be brought in the state or federal courts located in the state of California, San Francisco County, and each party hereby referred consents to the exclusive personal jurisdiction of such courts for such purpose."
      },
      {
        "chunk_id": 754,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          33493,
          33816
        ],
        "text": "12.1 General. Each party represents and warrants to the other that: (a) such party has the full corporate right, power, and authority to enter into this Agreement and perform the acts required of it hereunder, (b) the execution of this Agreement by such party, and the performance\n\n                                       10"
      },
      {
        "chunk_id": 782,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          40965,
          41073
        ],
        "text": "13.4 Limitations on Indemnification. Notwithstanding the terms of Sections 13.1  [Breach of Warranty] and 13"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          19511,
          19640
        ],
        "answer": "This agreement shall commence as of date first above written, and          shall Continue through December 31, 2004 (\"the Term\")."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9968,
        "readability": "expert",
        "readability_score": 13.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2825,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15963,
          16455
        ],
        "text": "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          26467,
          26816
        ],
        "answer": "This Agreement has been entered into in the State of                   Tennessee, and the validity, interpretation and legal effect                   of this Agreement will be governed by the laws of the State of                   Tennessee applicable to contracts entered into and performed                   entirely within the State of Tennessee."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9963,
        "readability": "expert",
        "readability_score": 13.08
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 643,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          0,
          65
        ],
        "text": "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a most favored nation clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          11474,
          11682
        ],
        "answer": "If for any reason, Integrity and TL are subject to lower \"free                   goods\" limits by any third party license, the foregoing shall                   be adjusted to comply with any such license(s)."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9966,
        "readability": "expert",
        "readability_score": 13.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 4160,
        "filepath": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
        "span": [
          78874,
          79343
        ],
        "text": ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area"
      },
      {
        "chunk_id": 17005,
        "filepath": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
        "span": [
          168170,
          168537
        ],
        "text": ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole"
      },
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 19336,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          154395,
          154893
        ],
        "text": ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through third parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
      },
      {
        "chunk_id": 8559,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          126124,
          126622
        ],
        "text": ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through Third Parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          5158,
          5500
        ],
        "answer": "TL will hold exclusive worldwide                   rights to promote and sell the product through the following                   distribution channels: Outgoing telemarketing, General Market                   retail, and General Market catalogs, and exclusive rights                   within the United States for Television Direct response."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          6086,
          6457
        ],
        "answer": "Integrity will hold exclusive                   worldwide rights to promote and sell the product to/through                   the following distribution channels: Christian retail (CBA or                   Christian Booksellers Association markets), direct mail                   (including continuity sales, church sales, digital and                   e-commerce sales.)"
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9994,
        "readability": "expert",
        "readability_score": 14.0
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2825,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15963,
          16455
        ],
        "text": "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
      },
      {
        "chunk_id": 643,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          0,
          65
        ],
        "text": "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          12272,
          12788
        ],
        "answer": "On sales of recorded products pursuant to this Agreement (less                   any returns) Integrity will pay to TL royalties in the amount                   of [**]/1/ ($[**]/1/) for each and every unit of the product                   sold by Integrity in the United States pursuant to this                   Agreement, and [**]/1/ the foregoing rate or [**]/1/ percent                   ([**]/1/%) of Integrity's net receipts, whichever is less, on                   subject products outside the United States."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          13043,
          13589
        ],
        "answer": "On sales of printed products (song books) pursuant to this                   Agreement (less any returns) Integrity will pay to TL                   royalties in the amount of [**]/1/ ($[**]/1/) for each and                   every unit of the product sold by Integrity in the United                   States pursuant to this Agreement, and [**]/1/ the foregoing                   rate or [**]/1/ percent ([**]/1/%) of Integrity's net                   receipts, whichever is less, on subject products outside the                   United States."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          14031,
          14273
        ],
        "answer": "On sales of products pursuant to this          Agreement (less any returns) TL will pay to Integrity royalties in the          amount of [**]/1/ ($[**]/1/) for each and every unit of the product          sold by it pursuant to this Agreement."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 15.05
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2811,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          12264,
          12722
        ],
        "text": ".       On sales of recorded products pursuant to this Agreement (less                   any returns) Integrity will pay to TL royalties in the amount                   of [**]/1/ ($[**]/1/) for each and every unit of the product                   sold by Integrity in the United States pursuant to this                   Agreement, and [**]/1/ the foregoing rate or [**]/1/ percent                   ([**]/1/%) of Integrity's net receipts, whichever is less"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          10306,
          10671
        ],
        "answer": "In consideration of the above pricing, TL guarantees to                   purchase from Integrity a minimum of ten thousand (10,000)                   units of each recorded Product during the first thirty-two                   (32) months of release. TL's initial order for each recorded                   Product shall be a minimum of five thousand (5,000) units."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9991,
        "readability": "expert",
        "readability_score": 13.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 643,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          0,
          65
        ],
        "text": "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract include any volume restrictions?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          10851,
          11455
        ],
        "answer": "TL may purchase from Integrity limited quantities of the                   Product for its promotional use, at the Manufacturing cost set                   forth in paragraph 3(a) above, provided the quantity of such                   purchases does not exceed seven percent (7%) of the total                   royalty bearing units of such Product title purchased by TL,                   TL warrants that any units so purchased, whether or not                   labeled \"promotional only\" or cut-out, will be given away for                   purposes of promotion of the Products, and will not be sold."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 14.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2815,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          13035,
          13523
        ],
        "text": ".       On sales of printed products (song books) pursuant to this                   Agreement (less any returns) Integrity will pay to TL                   royalties in the amount of [**]/1/ ($[**]/1/) for each and                   every unit of the product sold by Integrity in the United                   States pursuant to this Agreement, and [**]/1/ the foregoing                   rate or [**]/1/ percent ([**]/1/%) of Integrity's net                   receipts, whichever is less"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Does this contract provide for joint intellectual property ownership?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          19158,
          19372
        ],
        "answer": "The parties hereby agree that the                   copyright in the Product sound recording compilation will be                   jointly registered by Integrity in the names of Integrity                   and TL."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          19407,
          19494
        ],
        "answer": "TL will trademark the series name in joint                   names of TL and Integrity."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 15.05
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2825,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15963,
          16455
        ],
        "text": "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          5158,
          5500
        ],
        "answer": "TL will hold exclusive worldwide                   rights to promote and sell the product through the following                   distribution channels: Outgoing telemarketing, General Market                   retail, and General Market catalogs, and exclusive rights                   within the United States for Television Direct response."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15994,
          16456
        ],
        "answer": "Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          17679,
          18134
        ],
        "answer": "TL hereby grants to Integrity the right to use                   its \"TL Music\" name and logo (\"the TL Trademarks\") in                   connection with the products produced during the Term of this                   Agreement for as long as the parties continue to sell and                   distribute such products at no additional cost to Integrity,                   and in accordance with the terms and conditions contained                   herein."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9982,
        "readability": "expert",
        "readability_score": 14.0
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2825,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15963,
          16455
        ],
        "text": "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          14909,
          15257
        ],
        "answer": "Either party, at its sole expense, upon at least          thirty (30) days written notice (and not more than once in respect of          any accounting period) will have the right to inspect the other party's          books regarding the obligations hereunder for a period of two (2) years          from the date on which any statement is rendered."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9963,
        "readability": "expert",
        "readability_score": 13.66
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 2825,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          15963,
          16455
        ],
        "text": "a.       Integrity Trademarks. Integrity hereby grants to TL the right                   to use its \"Integrity Music\" name and logo (\"the Integrity                   Trademarks') in connection with the products produced during                   the Term of this Agreement for as long as the parties continue                   to sell and distribute such products at no additional cost to                   TL, and in accordance with the terms and conditions contained                   herein"
      }
    ]
  },
  {
    "query": "Consider the Product Development and Co-Branding Agreement between Integrity Incorporated and Time Life, Inc. for 'Songs 4 Worship' Series; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          16951,
          17214
        ],
        "answer": "TL recognizes Integrity's title                   to the Integrity Trademarks and will not at any time do or                   suffer to be done any act or thing which will in any way                   impair Integrity's rights in and to the Integrity Trademarks."
      },
      {
        "file_path": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          18629,
          18871
        ],
        "answer": "Integrity recognizes TL's title to the                   TL Trademarks and will not at any time do or suffer to be done                   any act or thing which will in any way impair TL's rights in                   and to the TL Trademarks."
      }
    ],
    "file_set": [
      "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Product Development Co-Branding Agreement Integrity Incorporated Time Life, Inc. 'Songs 4 Worship' Series",
        "similarity_score": 0.45198339223861694,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9989,
        "readability": "expert",
        "readability_score": 13.33
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2772,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          973,
          1089
        ],
        "text": "3\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\""
      },
      {
        "chunk_id": 2769,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          0,
          414
        ],
        "text": "1                                                                    EXHIBIT 10.17\n\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\n\n                         \"SONGS 4 WORSHIP SERIES\"\n\n                      EXCLUDING CONFIDENTIAL PORTIONS\n\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\n\n2\n\n                    INDEX TO THE CONFIDENTIAL PORTIONS"
      },
      {
        "chunk_id": 643,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          0,
          65
        ],
        "text": "EXHIBIT 10.4\n\n                              CO-BRANDING AGREEMENT"
      },
      {
        "chunk_id": 2785,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          4725,
          5117
        ],
        "text": "e.       Shared expenses. The parties agree to share equally in costs                   of additional products created (excluding the Product, and                   song books, which such song books shall be created at                   Integrity's sole discretion and expense), by mutual agreement                   under the \"Songs 4 Worship\" branding.\n\n2.       Marketing and Distribution."
      },
      {
        "chunk_id": 2773,
        "filepath": "cuad/IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.txt",
        "span": [
          1097,
          1447
        ],
        "text": "This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\")"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2710,
          2924
        ],
        "answer": "This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What is the expiration date of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 1146,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          5215,
          5544
        ],
        "text": ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1140,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3120,
          3218
        ],
        "text": ". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\""
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1419,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          85593,
          86060
        ],
        "text": "Section (3)   Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666"
      },
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1278,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          44980,
          45380
        ],
        "text": ". Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein"
      },
      {
        "chunk_id": 1420,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          86060,
          86267
        ],
        "text": ".66 payment due on the following dates: July 23, 2020; October 1, 2020; February 1, 2021 Nine   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2021; October 1, 2021; February 1, 2022"
      },
      {
        "chunk_id": 1216,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26688,
          26983
        ],
        "text": ".   (viii) MusclePharm's obligations for the payment of a Royalty and the Guaranteed Minimum Royalty (as defined below) shall survive expiration or termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3226,
          4397
        ],
        "answer": "In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4404,
          5540
        ],
        "answer": "In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term\") on the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What is the renewal term for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1146,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          5215,
          5544
        ],
        "text": ".0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.   2"
      },
      {
        "chunk_id": 1419,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          85593,
          86060
        ],
        "text": "Section (3)   Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666"
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1144,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4396,
          4744
        ],
        "text": ".   (c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term\") on the same terms and conditions for the initial Term except that"
      },
      {
        "chunk_id": 1140,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3120,
          3218
        ],
        "text": ". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\""
      },
      {
        "chunk_id": 1141,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3218,
          3583
        ],
        "text": ".   (b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          72138,
          72371
        ],
        "answer": "This Agreement has been executed and delivered in Los Angeles County in the State of California, and its interpretation, validity and performance shall be construed and enforced in accordance with the laws of the State of California."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1266,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41221,
          41284
        ],
        "text": ".   (b) This Agreement may be terminated by the AS Parties only"
      },
      {
        "chunk_id": 1281,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45959,
          46104
        ],
        "text": ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1274,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          43598,
          44091
        ],
        "text": ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party"
      },
      {
        "chunk_id": 1311,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          54615,
          55049
        ],
        "text": "(b) MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any exceptions to competitive restrictions in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          67052,
          67713
        ],
        "answer": "Notwithstanding the foregoing, the following will not be a breach of this Agreement: (i) Endorser's performance of services or appearing in the news or informational portion of any radio, TV or film or entertainment program regardless of products or services therein or sponsorship thereof; (ii) Endorser's participation in movies or TV programs as well as merchandising, commercial tie-ins and/or product placements utilizing Endorser, or (iii) Endorser's performance of services, appearance or use of his name, likeness in connection with charitable events, sports events, organizations, regardless of usage of products or services and/or sponsorship thereof."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68305,
          68819
        ],
        "answer": "Notwithstanding the foregoing or anything else contained herein, this Agreement shall not prevent or shall in any manner restrict Endorser from advertising, marketing and or endorsing products (or other companies which manufacture such products) which incidentally contain dietary supplements (including without limitation protein, vitamins, minerals, amino acids, herbs, legal performance enhancing substances) provided the primary purpose of such product or company is not to sell or market a dietary supplement."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Are there any exceptions to competitive restrictions in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1296,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          50526,
          50853
        ],
        "text": "; it being understood that the parties may mutually decide not to deploy the full Marketing Budget in any Contract Year if in the good faith determination by the parties that the deployment of the full Marketing Budget is unnecessary to achieve its projected revenue targets in connection with the sale of the Licensed Products"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1357,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68169,
          68297
        ],
        "text": ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm"
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1194,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          20101,
          20348
        ],
        "text": ". Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).   (d) Discretion to Utilize"
      },
      {
        "chunk_id": 1155,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          7302,
          7538
        ],
        "text": ", it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1206,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          23737,
          24096
        ],
        "text": ", transportation costs and commissions not deductible in the calculation of Royalty) and less any bona fide returns (net of all returns actually made or allowed as supported by credit memoranda actually issued to the customers not to exceed 5% in any reporting cycle), the aggregate of which discounts and allowances shall not exceed 5% in any reporting cycle"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a non-compete clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          67720,
          68298
        ],
        "answer": "Endorser shall not use or provide endorsements or testimonials for products that compete with MusclePharm Products or the Licensed Products. Any failure of Endorser to disclose such conflicting interests, or any breach of this Section, shall be deemed a material breach of the Agreement. Endorser's duty not to compete with the business of MusclePharm shall continue for a period of one year following the expiration or termination of this Agreement. Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Is there a non-compete clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1357,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68169,
          68297
        ],
        "text": ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1325,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          59513,
          59744
        ],
        "text": "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1342,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          63652,
          63885
        ],
        "text": ". MusclePharm shall not pay any contributions to Social Security, unemployment insurance, federal or state withholding taxes, nor provide any other contributions or benefits that might be expected in an employer-employee relationship"
      },
      {
        "chunk_id": 1334,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          61548,
          61761
        ],
        "text": ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1280,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45496,
          45959
        ],
        "text": ". In the event of a termination by MusclePharm pursuant to paragraph 9(a)(i)-(ii), Musclepharm shall not be required to pay Endorser any further compensation except for Royalties earned up until such termination date, and provided, however, that if Musclepharm terminates this Agreement because of death, disability, physical injury, or other incapacity of Endorser, if Endorser has performed all services required by this Agreement for a particular Contract Year"
      },
      {
        "chunk_id": 1318,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          56895,
          57299
        ],
        "text": "(ii)  MusclePharm and the manufacturers will only employ persons whose presence is voluntary. MusclePharm and the manufacturers will not use any forced or involuntary labor.   (iii) MusclePharm and the manufacturers will treat each employee with dignity and respect, and will not use corporal punishment, threats of violence, abuse, or other forms of physical, sexual, psychological, or verbal harassment"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          66703,
          67049
        ],
        "answer": "During the term of this Agreement, or any extensions of this Agreement, Endorser and the Lender hereby agree and warrant that it will not enter into any other endorsement agreement for the use of Endorser's name, image and/or likeness for advertising, marketing and/or endorsement of any other dietary supplements during the Term of this Agreemen"
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Does this contract include an exclusivity agreement?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 13.01
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1199,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          21550,
          22042
        ],
        "text": ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1325,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          59513,
          59744
        ],
        "text": "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1282,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          46104,
          46393
        ],
        "text": ". Notwithstanding anything contained herein, irrespective of the expiratation or termination of this Agreement, the AS Parties shall always be entitled to retain and shall never be obligated to return any monies paid and/or stock issued to Lender and/or Endorser pursuant to this Agreement"
      },
      {
        "chunk_id": 1352,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          66663,
          67050
        ],
        "text": "16. Exclusivity; Non-Competition:   (a) During the term of this Agreement, or any extensions of this Agreement, Endorser and the Lender hereby agree and warrant that it will not enter into any other endorsement agreement for the use of Endorser's name, image and/or likeness for advertising, marketing and/or endorsement of any other dietary supplements during the Term of this Agreement"
      },
      {
        "chunk_id": 1266,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41221,
          41284
        ],
        "text": ".   (b) This Agreement may be terminated by the AS Parties only"
      },
      {
        "chunk_id": 1334,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          61548,
          61761
        ],
        "text": ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          6804,
          7539
        ],
        "answer": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Does this contract include any right of first refusal, right of first offer, or right of first negotiation?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 8.04
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1223,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28486,
          28830
        ],
        "text": ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1266,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41221,
          41284
        ],
        "text": ".   (b) This Agreement may be terminated by the AS Parties only"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69144,
          69360
        ],
        "answer": "Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69480,
          69921
        ],
        "answer": "Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What happens in the event of a change of control of one of the parties in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 8.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1274,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          43598,
          44091
        ],
        "text": ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party"
      },
      {
        "chunk_id": 1266,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41221,
          41284
        ],
        "text": ".   (b) This Agreement may be terminated by the AS Parties only"
      },
      {
        "chunk_id": 1365,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          70396,
          70545
        ],
        "text": "19. Modification of Agreement:   The parties may modify this Agreement hereto only by a written supplemental agreement executed by both parties.   20"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1378,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74209,
          74375
        ],
        "text": ". Binding Effect:   This Agreement when signed by the parties shall be binding upon the parties, and their respective heirs, successors or legal representatives.   24"
      },
      {
        "chunk_id": 1332,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          61101,
          61151
        ],
        "text": ", become and remain the property of the AS Parties"
      },
      {
        "chunk_id": 1280,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45496,
          45959
        ],
        "text": ". In the event of a termination by MusclePharm pursuant to paragraph 9(a)(i)-(ii), Musclepharm shall not be required to pay Endorser any further compensation except for Royalties earned up until such termination date, and provided, however, that if Musclepharm terminates this Agreement because of death, disability, physical injury, or other incapacity of Endorser, if Endorser has performed all services required by this Agreement for a particular Contract Year"
      },
      {
        "chunk_id": 1223,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28486,
          28830
        ],
        "text": ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          40897,
          41222
        ],
        "answer": "This Agreement may also be terminated by MusclePharm, upon fifteen days prior written notice, if death, or physical disability, physical injury, or other incapacity lasting more than eight (8) weeks, causes Endorser to be unable to perform a material amount of the personal or consulting services described in this Agreement."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68858,
          69479
        ],
        "answer": "The license granted by this Agreement is personal to MusclePharm. Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties. Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Is there an anti-assignment clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1194,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          20101,
          20348
        ],
        "text": ". Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).   (d) Discretion to Utilize"
      },
      {
        "chunk_id": 1266,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41221,
          41284
        ],
        "text": ".   (b) This Agreement may be terminated by the AS Parties only"
      },
      {
        "chunk_id": 1282,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          46104,
          46393
        ],
        "text": ". Notwithstanding anything contained herein, irrespective of the expiratation or termination of this Agreement, the AS Parties shall always be entitled to retain and shall never be obligated to return any monies paid and/or stock issued to Lender and/or Endorser pursuant to this Agreement"
      },
      {
        "chunk_id": 1231,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          30758,
          31016
        ],
        "text": ".   (c) In connection with the issuance of the Compensation Shares, but without limitation of Section 8(a) or the other terms and conditions in this Agreement, Lender hereby makes the following representations to MusclePharm regarding the Compensation Shares"
      },
      {
        "chunk_id": 1353,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          67050,
          67135
        ],
        "text": ". Notwithstanding the foregoing, the following will not be a breach of this Agreement"
      },
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1357,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68169,
          68297
        ],
        "text": ". Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          10550,
          11016
        ],
        "answer": "In the event that Endorser shall agree to produce the Training Video (such decision shall be made by the Endorser exercisable in his sole discretion) and Products (other than the Licensed Products) are featured and sold in connection with such Training Video then Endorser shall receive ten percent (10%) of Net Sales (as defined below) from the sale of any Products other than the Licensed Products featured and sold directly in conjunction with the Training Video."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          15128,
          15312
        ],
        "answer": "In the event that MusclePharm shall sell any Promotional Products above its cost then Endorser shall be entitled to receive 10% of Net Sales from the sale of such Promotional Products."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          23047,
          23503
        ],
        "answer": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Does this contract include any revenue or profit-sharing arrangements?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 14.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1204,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          23012,
          23502
        ],
        "text": "7. Compensation:   (a) Cash:   (i) During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1220,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          27676,
          27820
        ],
        "text": ",000 shares of MusclePharm's restricted stock (the \"Compensation Shares\"), for services performed and to be performed pursuant to this Agreement"
      },
      {
        "chunk_id": 1244,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          34851,
          35344
        ],
        "text": ".   (vii) The offer to issue the Compensation Shares as compensation to Lender was directly communicated to Lender or its business or financial advisors by such a manner that it or such advisors were able to ask questions of and receive answers from MusclePharm or a person acting on its behalf concerning this Agreement. At no time was Lender presented with or solicited by or through any leaflet, public promotional meeting, television advertisement, or any other form of general advertising"
      },
      {
        "chunk_id": 1223,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28486,
          28830
        ],
        "text": ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
      },
      {
        "chunk_id": 1222,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28064,
          28486
        ],
        "text": "; provided, that, the Lender shall be entitled, without the prior consent of MusclePharm, to transfer the Compensation Shares at any time to affiliates and family members so long as such transfers are in compliance with state and federal securities laws and such transferees agree to be bound by foregoing transfer restrictions for the six (6) month period following the date hereof with respect to the Compensation Shares"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          16019,
          16313
        ],
        "answer": "Endorser shall also supply MusclePharm with at least fifty (50) signed items for each Contract Year, on the Licensed Products or on other items to be mutually agreed upon by the parties hereto, to be used by MusclePharm in connection with the promotion of the Products and/or Licensed Products."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26987,
          27235
        ],
        "answer": "Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84373,
          84825
        ],
        "answer": "Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84895,
          85537
        ],
        "answer": "Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2017; October 1, 2017; February 1, 2018 Six   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2018; October 1, 2018; February 1, 2019"
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          85607,
          86267
        ],
        "answer": "Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2020; October 1, 2020; February 1, 2021 Nine   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2021; October 1, 2021; February 1, 2022"
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Is there a minimum commitment required under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.1
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1296,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          50526,
          50853
        ],
        "text": "; it being understood that the parties may mutually decide not to deploy the full Marketing Budget in any Contract Year if in the good faith determination by the parties that the deployment of the full Marketing Budget is unnecessary to achieve its projected revenue targets in connection with the sale of the Licensed Products"
      },
      {
        "chunk_id": 1281,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45959,
          46104
        ],
        "text": ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1419,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          85593,
          86060
        ],
        "text": "Section (3)   Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1350,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          66507,
          66607
        ],
        "text": ". No settlement will be entered into by the AS Parties without MusclePharm's prior written approval."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Does this contract include any volume restrictions?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          6804,
          7539
        ],
        "answer": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Does this contract include any volume restrictions?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 13.01
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1414,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84345,
          84825
        ],
        "text": "Exhibit \"C\"   Section (1)   Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016"
      },
      {
        "chunk_id": 1199,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          21550,
          22042
        ],
        "text": ":   Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written consent, such consent not to be unreasonably withheld or delayed"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1217,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26983,
          27239
        ],
        "text": ".   Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.   8"
      },
      {
        "chunk_id": 1349,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          66066,
          66507
        ],
        "text": "; (ii) any material inaccuracy or misrepresentation by MusclePharm in this Agreement; (iii) any advertisement and/or promotion of MusclePharm, its Products, or Licensed Products, including but not limited to any use of the materials produced pursuant to this Agreement, as well as MusclePharm's advertising/promotion campaign described above in this Agreement and/or (iv) any breach of this Agreement and/or in connection with this Agreement"
      },
      {
        "chunk_id": 1416,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          84881,
          85333
        ],
        "text": "Section (2)   Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333"
      },
      {
        "chunk_id": 1267,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41284,
          41775
        ],
        "text": ":   (i) In the event MusclePharm shall default under any indebtedness or financial obligations owed by MusclePharm in an amount in excess of $1,000,000 including, without limitation, any failure to pay principal or interest thereon, and such event of default or condition shall continue after any applicable grace period specified in such agreement or instrument, and the effect of such event or condition results in an actual acceleration of the maturity of such indebtedness or obligations"
      },
      {
        "chunk_id": 1216,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26688,
          26983
        ],
        "text": ".   (viii) MusclePharm's obligations for the payment of a Royalty and the Guaranteed Minimum Royalty (as defined below) shall survive expiration or termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1256,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          38134,
          38486
        ],
        "text": ", require any consent under, or give to others any rights of termination, amendment or acceleration of, or result in the creation of any encumbrance on any of its assets pursuant to, any note, bond, mortgage or indenture, contract, agreement, lease, license, permit or franchise to which it is a party or by which any of its assets is bound or affected"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; How is intellectual property ownership assigned in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          60425,
          60626
        ],
        "answer": "MusclePharm agrees that any copyrights in works created based upon the Trademarks and/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)"
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          60628,
          61762
        ],
        "answer": "MusclePharm irrevocably and unconditionally transfers and assigns to the AS Parties in perpetuity and throughout the universe any and all of MusclePharm's right, title, and interest, if any (including, without limitation, the rights generally known as 'moral rights') in and to all works, including any packaging, advertising and promotional materials, and other materials based upon the Trademarks and/or Name and Appearance Rights, all of which shall, upon their creation, become and remain the property of the AS Parties. All such works based upon the Trademarks and/or Name and Appearance Rights shall be prepared by an employee-for- hire of MusclePharm (under MusclePharms's sole supervision, responsibility, and monetary obligation) or as a work-for-hire by a third party who assigns to the AS Parties in writing and in perpetuity throughout the universe all right, title, and interest in the same provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "How is intellectual property ownership assigned in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 12.86
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1334,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          61548,
          61761
        ],
        "text": ", nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1330,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          60417,
          60626
        ],
        "text": ".   (e) MusclePharm agrees that any copyrights in works created based upon the Trademarks and/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)"
      },
      {
        "chunk_id": 1325,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          59513,
          59744
        ],
        "text": "; provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement"
      },
      {
        "chunk_id": 1223,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28486,
          28830
        ],
        "text": ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
      },
      {
        "chunk_id": 1362,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69478,
          69920
        ],
        "text": ". Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction"
      },
      {
        "chunk_id": 1331,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          60626,
          61101
        ],
        "text": ". MusclePharm irrevocably and unconditionally transfers and assigns to the AS Parties in perpetuity and throughout the universe any and all of MusclePharm's right, title, and interest, if any (including, without limitation, the rights generally known as 'moral rights') in and to all works, including any packaging, advertising and promotional materials, and other materials based upon the Trademarks and/or Name and Appearance Rights, all of which shall, upon their creation"
      },
      {
        "chunk_id": 1323,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          58879,
          59216
        ],
        "text": ". Ownership and Registration of Trademarks and Name and Appearance Rights:   (a) During the Term and after expiration or termination of this Agreement, MusclePharm shall not contest or otherwise challenge or attack the AS Parties' rights in the Trademarks or Name and Appearance Rights or the validity of the license being granted herein"
      },
      {
        "chunk_id": 1209,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          24641,
          25001
        ],
        "text": ".   (iii) If MusclePharm sells any Licensed Products to any party affiliated with MusclePharm, or in any way directly or indirectly related to or under the common control with MusclePharm, at a price less than the regular price charged to other parties, the Royalty payable to Lender shall be computed on the basis of the regular price charged to other parties"
      },
      {
        "chunk_id": 1204,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          23012,
          23502
        ],
        "text": "7. Compensation:   (a) Cash:   (i) During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          5859,
          6160
        ],
        "answer": "Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of MusclePharm, its Products, and the Licensed Products."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          12869,
          13839
        ],
        "answer": "Endorser agrees that during the Term MusclePharm shall have the right to use, worldwide, Endorser's Name and Appearance Rights (as specified in Section 6) to advertise MusclePharm and its Products and Licensed Products in print media, and in all other forms of media (other than telephone marketing or texting campaigns) including, but not limited to, point of sale material, premiums and novelties, direct marketing material, and radio, television, electronic, and computer media (including but not limited to MusclePharm's Internet and social media websites). Print media will also include promotional items on which Endorser's approved picture; approved likeness, or facsimile signature may appear. Endorser will have the right to approve, in writing via his representative's office, all advertising materials which utilize Endorser's Name and Appearance Rights, but Endorser will not unreasonably withhold approval and will promptly respond to all approval requests."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          14814,
          14926
        ],
        "answer": "During the Term, MusclePharm shall have the right to create and distribute the Promotional Products world- wide."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          17765,
          18948
        ],
        "answer": "As provided below, during the Term, the AS Parties grant to MusclePharm the right to use the Trademarks as defined in this Agreement and the Name and Appearance Rights, which shall include Endorser's name, approved photograph, approved picture (including, without limitation, any copyrighted pictures and video images of the Endorser owned by the Endorser which Endorser agrees to make available for use hereunder), approved appearance, or approved likeness, including video and other recordings of Endorser's appearance, along with the right to use Endorser's voice, including audio or other recordings of Endorser's voice, Endorser's signature, personal or professional background and experience, reputation, approved quotations and approved endorsements, or approved paraphrases of Endorser's approved quotations and endorsements, including approved touch-ups, approved simulations or approved compositions of any of the above whether generated by computer or by any other means, for the period of time and for the purposes set forth in this Agreement. MusclePharm acknowledges that the use of some works may require that MusclePharm obtain a copyright license from third parties."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          18973,
          19622
        ],
        "answer": "During the Term of this Agreement, the AS Parties grant to MusclePharm and consent to MusclePharm's commercial use of the Name and Appearance Rights to advertise, promote, endorse and publicize Products, Licensed Products, and MusclePharm's business, worldwide in any media selected by MusclePharm (excluding telephone or texting campaigns), including but not limited to print, radio, television, electronic, wireless or internet, pursuant to the terms and conditions set forth herein. MusclePharm acknowledges that any use on products requires approval and that use of the Name and Appearance Rights on products is limited to the Licensed Products."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          19698,
          20320
        ],
        "answer": "Endorser also grants to MusclePharm and consents to MusclePharm's editorial use world-wide of Endorser's Name and Appearance in MusclePharm published materials approved by Endorser. For purposes of this Agreement, MusclePharm's editorial use of Endorser's Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm's business, its Products or Licensed Products. Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any)."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          20785,
          21131
        ],
        "answer": "MusclePharm shall have the rights to use Endorser's Name and Appearance Rights and the Right to Publicize Endorser's Name and Appearance, as provided in this Agreement, unless Endorser and MusclePharm enter into a separate written agreement in which MusclePharm waives or releases some or all of the rights Endorser has granted in this Agreement."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What licenses are granted under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1251,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          36268,
          36763
        ],
        "text": ":   (i) It has the full right, power and authority to enter into this Agreement and to perform its obligations hereunder; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein; (iii) the Licensed Products, any element thereof, or any advertising, promotional or publicity materials supplied by Licensee or third parties hereunder will not contain any language or material which is obscene, libelous, slanderous or defamatory"
      },
      {
        "chunk_id": 1360,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          68818,
          69142
        ],
        "text": ".   17. [RESERVED.]   18. Assignment:   The license granted by this Agreement is personal to MusclePharm. Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties"
      },
      {
        "chunk_id": 1211,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          25444,
          25940
        ],
        "text": ". Each such royalty payment shall include an itemized statement showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized statement shall be certified by a duly authorized officer of MusclePharm"
      },
      {
        "chunk_id": 1295,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          50171,
          50526
        ],
        "text": ". MusclePharm shall use its commercially reasonable efforts to market and distribute the Licensed Products, and MusclePharm shall allocate between $3,000,000 and $5,000,000 in the First Contract Year and $5,000,000 in each subsequent Contract Year (including any renewal terms if any) toward the marketing of the Licensed Products (the \"Marketing Budget\")"
      },
      {
        "chunk_id": 1384,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          75819,
          76080
        ],
        "text": ".   (b) MusclePharm represents, warrants and covenants that (i) it has the full right, power and authority to enter into this Agreement; (ii) it has acquired all rights necessary to perform this Agreement and exploit the Licensed Products as contemplated herein"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1207,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          24096,
          24448
        ],
        "text": ". No other costs incurred in the manufacturing, selling, advertising, and distribution of the Licensed Products shall be deducted nor shall any deduction be allowed for any uncollectible accounts, allowances or bad debt.   (ii) A Royalty obligation shall accrue upon the sale of the Licensed Products regardless of the time of collection by MusclePharm"
      },
      {
        "chunk_id": 1338,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          62922,
          63010
        ],
        "text": ", registration, license recordal, and other requirements of any applicable jurisdictions"
      },
      {
        "chunk_id": 1252,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          36763,
          36962
        ],
        "text": "; and (iv) the use of the Licensed Product and the Lender's Name and Appearance rights as contemplated herein will not violate or infringe the copyright, trademark, or other rights of any third party"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          14287,
          14785
        ],
        "answer": "During the Term, the right to use Endorser's Name and Appearance Rights granted to MusclePharm in this Section shall extend for six (6) months beyond the expiration of this Agreement (the \"Use-up Period\"). MusclePharm shall create no new advertising during the Use-up Period using Endorser's Name and Appearance, but shall have the right to use during the Use-up Period Endorser's Name and Appearance in advertisements and promotional materials created before the expiration date of this Agreement."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          23047,
          23503
        ],
        "answer": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          26699,
          26984
        ],
        "answer": "MusclePharm's obligations for the payment of a Royalty and the Guaranteed Minimum Royalty (as defined below) shall survive expiration or termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          44982,
          45381
        ],
        "answer": "Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          48945,
          49157
        ],
        "answer": "MusclePharm agrees to preserve and keep accessible and available to the AS Parties all relevant books and records for a period of at least three (3) years following the expiration or termination of the Agreement."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Are there any services to be provided after the termination of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.14
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1276,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          44482,
          44641
        ],
        "text": ": Upon expiration or termination of the Agreement for pursuant to Section 9 herein, Endorser shall have no further obligation to render any services whatsoever"
      },
      {
        "chunk_id": 1280,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45496,
          45959
        ],
        "text": ". In the event of a termination by MusclePharm pursuant to paragraph 9(a)(i)-(ii), Musclepharm shall not be required to pay Endorser any further compensation except for Royalties earned up until such termination date, and provided, however, that if Musclepharm terminates this Agreement because of death, disability, physical injury, or other incapacity of Endorser, if Endorser has performed all services required by this Agreement for a particular Contract Year"
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1281,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45959,
          46104
        ],
        "text": ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
      },
      {
        "chunk_id": 1279,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45380,
          45496
        ],
        "text": ". MusclePharm shall not be liable to pay any compensation for services performed after the expiration or termination"
      },
      {
        "chunk_id": 1282,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          46104,
          46393
        ],
        "text": ". Notwithstanding anything contained herein, irrespective of the expiratation or termination of this Agreement, the AS Parties shall always be entitled to retain and shall never be obligated to return any monies paid and/or stock issued to Lender and/or Endorser pursuant to this Agreement"
      },
      {
        "chunk_id": 1274,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          43598,
          44091
        ],
        "text": ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party"
      },
      {
        "chunk_id": 1143,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4062,
          4396
        ],
        "text": ".0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019"
      },
      {
        "chunk_id": 1265,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          40887,
          41221
        ],
        "text": ".   (iii) This Agreement may also be terminated by MusclePharm, upon fifteen days prior written notice, if death, or physical disability, physical injury, or other incapacity lasting more than eight (8) weeks, causes Endorser to be unable to perform a material amount of the personal or consulting services described in this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          33253,
          33456
        ],
        "answer": "Lender understands that all books, records, and documents of MusclePharm relating to it have been and remain available for inspection by him or his business and financial advisors upon reasonable notice."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          47865,
          48251
        ],
        "answer": "The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          48712,
          48938
        ],
        "answer": "In the event a shortfall in the amount of five percent (5%) or more is discovered, MusclePharm shall reimburse the AS Parties for the cost of the audit including any reasonable attorney's fees incurred in connection therewith."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          54619,
          55190
        ],
        "answer": "MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense, randomly test the formulas of the Licensed Products for quality control purposes, although the AS Parties will have no obligation to do so."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What are the audit rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.95
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1288,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          47843,
          48251
        ],
        "text": ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
      },
      {
        "chunk_id": 1390,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          77099,
          77488
        ],
        "text": ". Each party shall be entitled to share such confidential information received by such party only with such party's representatives, legal and accounting advisors who shall agree to be bound by the confidentiality obligations set forth in this Section 26. During the term of this Agreement and for three (3) years thereafter, each party shall hold in strict confidence all such information"
      },
      {
        "chunk_id": 1311,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          54615,
          55049
        ],
        "text": "(b) MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense"
      },
      {
        "chunk_id": 1290,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          48704,
          49162
        ],
        "text": ".   (c) In the event a shortfall in the amount of five percent (5%) or more is discovered, MusclePharm shall reimburse the AS Parties for the cost of the audit including any reasonable attorney's fees incurred in connection therewith.   (d) MusclePharm agrees to preserve and keep accessible and available to the AS Parties all relevant books and records for a period of at least three (3) years following the expiration or termination of the Agreement.   12"
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1223,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          28486,
          28830
        ],
        "text": ". MusclePharm agrees that (i) with respect to the Compensation Shares, Lender shall be entitled to all rights and benefits under the registration rights agreement, dated as of March 28, 2013 (the \"Registration Rights Agreement\"), by and among MusclePharm and the investors party thereto as if it were an investor party thereto, mutatis mutandis"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1289,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          48251,
          48704
        ],
        "text": ". The AS Parties shall have reasonable access thereto for such purposes and shall be permitted to be able to make copies thereof and extracts therefrom.   (b) MusclePharm shall keep complete and accurate books of account for the preceding three years from the date of termination and expiration. In the event that any shortfalls, inconsistencies or mistakes are discovered, they shall immediately be rectified by MusclePharm at its sole cost and expense"
      },
      {
        "chunk_id": 1230,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          30280,
          30758
        ],
        "text": "; provided, however, that nothing herein shall preclude MusclePharm from utilizing a different method of calculating the fair market value of the Compensation Shares for financial accounting purposes if MusclePharm's Chief Financial Officer, audit committee and independent auditors shall determine in good faith that such alternative calculation of the fair market value of the Compensation Shares is required under generally accepted accounting principles in the United States"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          64976,
          65156
        ],
        "answer": "In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement."
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          75729,
          75820
        ],
        "answer": "IN NO EVENT SHALL THE AS PARTIES BE LIABLE FOR SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Is there a cap on liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1346,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          64974,
          65177
        ],
        "text": ". In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.   (b) By MusclePharm"
      },
      {
        "chunk_id": 1348,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          65584,
          66066
        ],
        "text": "; both those incurred in connection with the defense or prosecution of the indemnifiable claim and those incurred in connection with the enforcement of this provision), caused by, arising out of, or in any way connected with (i) any injury, death, or other harm or claim connected with, or claimed defect in, Products or Licensed Products provided, manufactured, produced, marketed, promoted, sold, and/or distributed by MusclePharm (including any party affiliated with MusclePharm)"
      },
      {
        "chunk_id": 1398,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          79386,
          79878
        ],
        "text": ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies."
      },
      {
        "chunk_id": 1279,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45380,
          45496
        ],
        "text": ". MusclePharm shall not be liable to pay any compensation for services performed after the expiration or termination"
      },
      {
        "chunk_id": 1393,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          77803,
          78278
        ],
        "text": ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability"
      },
      {
        "chunk_id": 1267,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          41284,
          41775
        ],
        "text": ":   (i) In the event MusclePharm shall default under any indebtedness or financial obligations owed by MusclePharm in an amount in excess of $1,000,000 including, without limitation, any failure to pay principal or interest thereon, and such event of default or condition shall continue after any applicable grace period specified in such agreement or instrument, and the effect of such event or condition results in an actual acceleration of the maturity of such indebtedness or obligations"
      },
      {
        "chunk_id": 1341,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          63384,
          63652
        ],
        "text": "14. Independent Contractor:   It is expressly agreed that Endorser is acting as an independent contractor in performing his services hereunder. MusclePharm shall carry no worker's compensation insurance or any health, accident or disability insurance to cover Endorser"
      },
      {
        "chunk_id": 1394,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78278,
          78536
        ],
        "text": ", in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1395,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78536,
          78856
        ],
        "text": ". Without limiting the generality of the foregoing, such policy shall provide protection against any and all claims, demands, and causes of action arising out of any defects or failure to perform, alleged or otherwise, of the Products and Licensed Products or any material used in connection therewith or any use thereof"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; What are the insurance requirements under this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          77807,
          78536
        ],
        "answer": "MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability, in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds"
      },
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78538,
          79878
        ],
        "answer": "Without limiting the generality of the foregoing, such policy shall provide protection against any and all claims, demands, and causes of action arising out of any defects or failure to perform, alleged or otherwise, of the Products and Licensed Products or any material used in connection therewith or any use thereof. The policy shall provide for ten (10) days notice to the AS Parties from the insurer by Registered or Certified Mail, return receipt requested, in the event of any modification, cancellation, or termination thereof. MusclePharm agrees to furnish the AS Parties a certificate of insurance evidencing same within thirty (30) days after execution of this Agreement and, in no event, shall MusclePharm manufacture, distribute, advertise, or sell the Licensed Products prior to receipt by the AS Parties of such evidence of insurance. MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "What are the insurance requirements under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.95
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1393,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          77803,
          78278
        ],
        "text": ":   MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability"
      },
      {
        "chunk_id": 1398,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          79386,
          79878
        ],
        "text": ". MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser. MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies."
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1392,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          77792,
          77803
        ],
        "text": ". Insurance"
      },
      {
        "chunk_id": 1396,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78856,
          79072
        ],
        "text": ". The policy shall provide for ten (10) days notice to the AS Parties from the insurer by Registered or Certified Mail, return receipt requested, in the event of any modification, cancellation, or termination thereof"
      },
      {
        "chunk_id": 1394,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78278,
          78536
        ],
        "text": ", in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds"
      },
      {
        "chunk_id": 1341,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          63384,
          63652
        ],
        "text": "14. Independent Contractor:   It is expressly agreed that Endorser is acting as an independent contractor in performing his services hereunder. MusclePharm shall carry no worker's compensation insurance or any health, accident or disability insurance to cover Endorser"
      },
      {
        "chunk_id": 1348,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          65584,
          66066
        ],
        "text": "; both those incurred in connection with the defense or prosecution of the indemnifiable claim and those incurred in connection with the enforcement of this provision), caused by, arising out of, or in any way connected with (i) any injury, death, or other harm or claim connected with, or claimed defect in, Products or Licensed Products provided, manufactured, produced, marketed, promoted, sold, and/or distributed by MusclePharm (including any party affiliated with MusclePharm)"
      },
      {
        "chunk_id": 1395,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          78536,
          78856
        ],
        "text": ". Without limiting the generality of the foregoing, such policy shall provide protection against any and all claims, demands, and causes of action arising out of any defects or failure to perform, alleged or otherwise, of the Products and Licensed Products or any material used in connection therewith or any use thereof"
      },
      {
        "chunk_id": 1346,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          64974,
          65177
        ],
        "text": ". In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.   (b) By MusclePharm"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding and Endorsement Licensing Agreement between MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, and Fitness Publications, Inc.; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          58960,
          59217
        ],
        "answer": "During the Term and after expiration or termination of this Agreement, MusclePharm shall not contest or otherwise challenge or attack the AS Parties' rights in the Trademarks or Name and Appearance Rights or the validity of the license being granted herein."
      }
    ],
    "file_set": [
      "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Endorsement Licensing Agreement MusclePharm Corporation, Arnold Schwarzenegger, Marine MP, LLC, Fitness Publications, Inc.",
        "similarity_score": 0.6481006741523743,
        "only_question": "Is there a covenant not to sue included in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 9.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 1353,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          67050,
          67135
        ],
        "text": ". Notwithstanding the foregoing, the following will not be a breach of this Agreement"
      },
      {
        "chunk_id": 1361,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          69142,
          69478
        ],
        "text": ". Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party. Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void"
      },
      {
        "chunk_id": 1350,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          66507,
          66607
        ],
        "text": ". No settlement will be entered into by the AS Parties without MusclePharm's prior written approval."
      },
      {
        "chunk_id": 1255,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          37651,
          38134
        ],
        "text": ".   (iv) Neither the execution, delivery nor performance by it of this Agreement does or will (a) violate, conflict with or result in the breach of any provision of its organizational documents, (b) conflict with or violate any law or governmental authorization applicable to it or any of its assets or its business, or (c) conflict with, result in any breach of, constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under"
      },
      {
        "chunk_id": 1374,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          73374,
          73550
        ],
        "text": ". Nothing in this agreement clause shall preclude parties from seeking provisional or injunctive relief remedies in aid of arbitration from a court of appropriate jurisdiction."
      },
      {
        "chunk_id": 1282,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          46104,
          46393
        ],
        "text": ". Notwithstanding anything contained herein, irrespective of the expiratation or termination of this Agreement, the AS Parties shall always be entitled to retain and shall never be obligated to return any monies paid and/or stock issued to Lender and/or Endorser pursuant to this Agreement"
      },
      {
        "chunk_id": 1347,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          65177,
          65584
        ],
        "text": ". MusclePharm agrees to protect, indemnify, save, defend, and hold harmless the AS Parties, their related companies, affiliates, and partners, and each of their assigns, agents, representatives, officers, directors, shareholders, and employees from and against any and all expenses, damages, liabilities, claims, suits, actions, judgments, costs and expenses whatsoever (including reasonable attorney's fees"
      },
      {
        "chunk_id": 1281,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          45959,
          46104
        ],
        "text": ", then MusclePharm shall continue to be obligated to compensate Lender with the full compensation amount of this Agreement for such Contract Year"
      },
      {
        "chunk_id": 1274,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          43598,
          44091
        ],
        "text": ".   (v)  In the event Musclepharm is in material breach or default of this Agreement, the AS Parties may give written notice to Musclepharm of intent to terminate, and such notice shall set forth in reasonable detail the facts, circumstances or events causing the alleged breach or default (\"MusclePharm Events of Default\"). Musclepharm shall have thirty (30) days' notice in which to cure the MusclePharm Events of Default to the reasonable and objective satisfaction of the terminating party"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63762,
          63972
        ],
        "answer": "The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What is the expiration date of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3107,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63752,
          63971
        ],
        "text": "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")"
      },
      {
        "chunk_id": 3108,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63971,
          64323
        ],
        "text": ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      },
      {
        "chunk_id": 3293,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          110053,
          110313
        ],
        "text": ". Except as specifically stated herein, each capitalized term used in this Statement shall have the same meaning as is assigned to it in the Agreement. The effective date (\"Effective Date\") of this Statement is  ,  , 200 .   2. General Description of Services:"
      },
      {
        "chunk_id": 3080,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          56876,
          57186
        ],
        "text": ". Provided that the respective Parties utilize their best efforts to provide such payments together with the respective Statements, no Party shall be deemed in breach hereof for delivering late payment until the date which is sixty (60) days following the last day of the respective applicable calendar quarter"
      },
      {
        "chunk_id": 3167,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          78066,
          78379
        ],
        "text": "8.3.1.3 the Party who delivers the Type One Notice gives notice to the other Parties of its intention to exercise its right to end the Non-Competition Period within 30 days of the expiry of the Type One Cure Period.; or   8.3.2 within thirty (30) days of the end of the Type Two Cure Period (defined below) where:"
      },
      {
        "chunk_id": 3124,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67697,
          67905
        ],
        "text": ".2); (ii) return such materials directly to the other Parties, or delete and overwrite any electronically stored copies of such materials within thirty (30) days from the date of termination of this Agreement"
      },
      {
        "chunk_id": 3166,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          77836,
          78064
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n8.3.1.2 the circumstances under Section 8.3.1.1(B) have not been cured by the end of the full calendar month following the delivery of the Type One Notice (\"Type One Cure Period\"); and"
      },
      {
        "chunk_id": 3228,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91320,
          91549
        ],
        "text": ". THE PARTIES ACKNOWLEDGE AND AGREE THAT NOTHING IN THIS SECTION 12.2 SHALL LIMIT A PARTY'S OBLIGATION TO PAY ANY AMOUNTS DUE AND OWING TO THE OTHER PARTY UNDER SECTION 5 ON OR BEFORE ANY DATE OF EXPIRATION OR TERMINATION HEREOF."
      },
      {
        "chunk_id": 3288,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          108219,
          108715
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\nIN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.   SKYPE COMMUNICATIONS, S.A.\n\nBy:     Its:  Chief Executive Officer\n\nSKYPE TECHNOLOGIES , S.A.\n\nBy:     Its:  Chief Executive Officer\n\nTOM ONLINE (BVI) LIMITED\n\nBy:     Its:  Chief Executive Officer\n\nTOM ONLINE INC.\n\nBy:     Its:  Chief Executive Officer\n\nTEL-ONLINE LIMITED\n\nBy:     Its:  Director   29\n\nSource: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\nEXHIBIT A"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63973,
          64323
        ],
        "answer": "This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What is the renewal term for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3108,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63971,
          64323
        ],
        "text": ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      },
      {
        "chunk_id": 3107,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63752,
          63971
        ],
        "text": "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")"
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3167,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          78066,
          78379
        ],
        "text": "8.3.1.3 the Party who delivers the Type One Notice gives notice to the other Parties of its intention to exercise its right to end the Non-Competition Period within 30 days of the expiry of the Type One Cure Period.; or   8.3.2 within thirty (30) days of the end of the Type Two Cure Period (defined below) where:"
      },
      {
        "chunk_id": 3129,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          68870,
          69327
        ],
        "text": ".4 The Parties agree that notwithstanding any termination or expiration of this Agreement, the rights and licenses granted to any Company- Skype Branded Customers prior to termination or expiration of this Agreement pursuant to any EULA shall continue during the 24 months after such termination or expiration for the sole purpose of permitting such users to continue to access and utilize the Company-Skype Branded Application and the Company-Skype Toolbar"
      },
      {
        "chunk_id": 2979,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          28590,
          28980
        ],
        "text": "2.3.2. Notwithstanding anything herein to the contrary, the Parties agree that they shall in the first quarter of each calendar year and the third quarter of each calendar year reach an agreement on the respective semi-annual promotional plan prepared by the Company, or by Online BVI for and on behalf of the Company, in each case in consultation with Skype (\"Semi-Annual Promotions Plan\")"
      },
      {
        "chunk_id": 3293,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          110053,
          110313
        ],
        "text": ". Except as specifically stated herein, each capitalized term used in this Statement shall have the same meaning as is assigned to it in the Agreement. The effective date (\"Effective Date\") of this Statement is  ,  , 200 .   2. General Description of Services:"
      },
      {
        "chunk_id": 2998,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          34516,
          34648
        ],
        "text": ", Online BVI or Skype may thereafter terminate this Agreement by delivery to the other parties 30 days written notice of termination"
      },
      {
        "chunk_id": 3106,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63727,
          63750
        ],
        "text": "6. TERM AND TERMINATION"
      },
      {
        "chunk_id": 3124,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67697,
          67905
        ],
        "text": ".2); (ii) return such materials directly to the other Parties, or delete and overwrite any electronically stored copies of such materials within thirty (30) days from the date of termination of this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63973,
          64323
        ],
        "answer": "This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What is the notice period required to terminate the renewal?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3108,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63971,
          64323
        ],
        "text": ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3107,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63752,
          63971
        ],
        "text": "6.1 Term. The term of this Agreement shall continue for a period of five years following the initial date of execution of the Memorandum, unless terminated earlier pursuant to Section 6.2 or Section 2.8 (\"Initial Term\")"
      },
      {
        "chunk_id": 3167,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          78066,
          78379
        ],
        "text": "8.3.1.3 the Party who delivers the Type One Notice gives notice to the other Parties of its intention to exercise its right to end the Non-Competition Period within 30 days of the expiry of the Type One Cure Period.; or   8.3.2 within thirty (30) days of the end of the Type Two Cure Period (defined below) where:"
      },
      {
        "chunk_id": 2998,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          34516,
          34648
        ],
        "text": ", Online BVI or Skype may thereafter terminate this Agreement by delivery to the other parties 30 days written notice of termination"
      },
      {
        "chunk_id": 3183,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          81334,
          81833
        ],
        "text": ", the Affected Period in respect of such Regulatory Event shall be deemed to have ended at the end of the third month following the delivery of notice of such Regulatory Event by the applicable Party and the applicable Party shall not be entitled to deliver another notice for such Regulatory Event which was so deemed to have ended) and any period between the end of the previous Quarter and/or Consecutive Quarters (as the case may be) and the start of the Affected Period shall be disregarded for"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 3124,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67697,
          67905
        ],
        "text": ".2); (ii) return such materials directly to the other Parties, or delete and overwrite any electronically stored copies of such materials within thirty (30) days from the date of termination of this Agreement"
      },
      {
        "chunk_id": 3129,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          68870,
          69327
        ],
        "text": ".4 The Parties agree that notwithstanding any termination or expiration of this Agreement, the rights and licenses granted to any Company- Skype Branded Customers prior to termination or expiration of this Agreement pursuant to any EULA shall continue during the 24 months after such termination or expiration for the sole purpose of permitting such users to continue to access and utilize the Company-Skype Branded Application and the Company-Skype Toolbar"
      },
      {
        "chunk_id": 3119,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          66922,
          67168
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          98605,
          98750
        ],
        "answer": "This Agreement will be governed by and construed in accordance with the laws of England and Wales, without regard to conflict of laws principles."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3227,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91132,
          91320
        ],
        "text": "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
      },
      {
        "chunk_id": 3265,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101860,
          102352
        ],
        "text": ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be"
      },
      {
        "chunk_id": 3133,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69791,
          70090
        ],
        "text": "7.1 Mutual Representations and Warranties. Each of the parties to this Agreement warrant and represent that it has the full right and power to enter into this Agreement and that no contractual right of any third party will be violated, breached or negatively impacted by entering into this Agreement"
      },
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 3110,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          64350,
          64590
        ],
        "text": ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
      },
      {
        "chunk_id": 3196,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          84353,
          84812
        ],
        "text": "and the Affected Party provides written notice to the breaching party detailing the Breach and requiring the breaching party to cure the Breach within thirty (30) days of the date of the notice, the Affected Party shall not be obligated to perform the relevant obligation or undertaking affected by the Breach so long as such Breach continues uncured where such non-performance or non-compliance would be deemed a material breach of this Agreement or the Deed"
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3264,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101621,
          101860
        ],
        "text": ". Each party acknowledges that in entering into this Agreement, it does not rely on, has not relied on, and shall have no remedy in respect of, any statement, representation, warranty or other provision (in any case whether oral or written"
      },
      {
        "chunk_id": 3272,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          103210,
          103641
        ],
        "text": ". All legal notices required or permitted hereunder shall be given in writing addressed to the respective parties to this Agreement as set forth below and shall either be (i) personally delivered, (ii) transmitted by postage prepaid certified mail, return receipt requested, or (iii) transmitted by nationally recognized private express courier, and shall be deemed to have been given on the date of receipt if delivered personally"
      },
      {
        "chunk_id": 3251,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97531,
          97577
        ],
        "text": ", or (iv) immediately terminate this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a most favored nation clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          31067,
          31879
        ],
        "answer": "The Company will, and Online BVI will cause the Company to, use its commercially reasonable efforts to make available and promote the Online Group's existing payment processing and customer billing and payment gateway methods for the purchase of Skype premium features by Company-Skype Branded Customers, including, without limitation, prepaid card distribution networks, vouchers and mobile payment methods, provided, that all payment processing and customer billing and payment gateway charges for such payment methods are on terms that are as or more favourable than the most favourable pricing and terms for such services otherwise provided at the applicable time by any member of the Online Group, and provided further that such pricing and terms have first been mutually approved in writing by the Parties."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Is there a most favored nation clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3158,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          75323,
          75646
        ],
        "text": "., with HGC), or (b) to any agreement now existing or hereafter entered into with an entity that operates in multiple international markets, which may include the PRC, so long as such agreement applies to multiple territories, which may include the PRC in addition to other territories, and does not, directly or indirectly"
      },
      {
        "chunk_id": 3247,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          96028,
          96371
        ],
        "text": ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement."
      },
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3110,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          64350,
          64590
        ],
        "text": ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
      },
      {
        "chunk_id": 3256,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          98749,
          99156
        ],
        "text": ". Subject to the parties' rights to seek injunctive relief or other right in equity by any court of competent jurisdiction, the parties to this Agreement expressly understand and agree that any dispute arising under this Agreement will be brought exclusively in the courts located in England and Wales and the parties to this Agreement hereby consent to the exclusive personal jurisdiction and venue therein"
      },
      {
        "chunk_id": 3143,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71590,
          71986
        ],
        "text": ".1 Each Party agrees that, for a period of five years (\"Non-Competition Period\") from the Effective Date (\"End Date\"), no Party, nor any of their respective Affiliates, will enter into an agreement with any third party, or otherwise carry on any business, directly or indirectly, which is focused on, and targets, primarily Consumers within the PRC, and (i) in the case of Skype and Skype Holding"
      },
      {
        "chunk_id": 3264,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101621,
          101860
        ],
        "text": ". Each party acknowledges that in entering into this Agreement, it does not rely on, has not relied on, and shall have no remedy in respect of, any statement, representation, warranty or other provision (in any case whether oral or written"
      },
      {
        "chunk_id": 3122,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67614,
          67693
        ],
        "text": ", Intellectual Property deemed to be owned by the other Parties under Section 4"
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any exceptions to competitive restrictions in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          74776,
          76567
        ],
        "answer": "In the case of Skype and its Affiliates, the foregoing restrictions shall not apply:\n\n8.2.1 (a) (i) for the avoidance of doubt, to the operations of Skype as existing now or hereafter undertaken with respect to any non co- branded version of the Skype Software distributed by Skype except where those operations provide for distribution in the PRC of the Skype Software in simplified Chinese by a Primarily PRC Based Service Provider, or (ii) the operations of Skype customers and Affiliates under any agreement existing as of the date hereof (e.g., with HGC), or (b) to any agreement now existing or hereafter entered into with an entity that operates in multiple international markets, which may include the PRC, so long as such agreement applies to multiple territories, which may include the PRC in addition to other territories, and does not, directly or indirectly, allow or provide for distribution in the PRC of the Skype Software in simplified Chinese by a Primarily PRC Based Service Provider (other than any service provider formed for the sole purpose of performing such agreement and not operating in the PRC prior to the date of such agreement), or (c) to any (i) Affiliate Program or (ii) any agreement or activity under the Affiliate Program by or with any third party, except in the case where the Affiliate Program, directly or indirectly, allows or provides for distribution in the PRC of the Skype Software in simplified Chinese by a Primarily PRC Based Service Provider (other than any service provider formed for the sole purpose of performing such agreement and not operating in the PRC prior to the date of such agreement); or\n\n8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Are there any exceptions to competitive restrictions in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3162,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          76428,
          76907
        ],
        "text": "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:"
      },
      {
        "chunk_id": 3141,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71545,
          71585
        ],
        "text": "8. NON-COMPETITION\n\n8.1 Non-Competition."
      },
      {
        "chunk_id": 3227,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91132,
          91320
        ],
        "text": "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
      },
      {
        "chunk_id": 3247,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          96028,
          96371
        ],
        "text": ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement."
      },
      {
        "chunk_id": 3221,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89493,
          89902
        ],
        "text": ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW"
      },
      {
        "chunk_id": 3226,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90815,
          91132
        ],
        "text": ", SHALL NOT INCLUDE COMPENSATION, REIMBURSEMENT OR DAMAGES ON ACCOUNT OF THE LOSS OF PRESENT OR PROSPECTIVE PROFITS, EXPENDITURES, DATA, OPPORTUNITY, ANTICIPATED SAVINGS, INVESTMENTS OR COMMITMENTS, WHETHER MADE IN ESTABLISHMENT, DEVELOPMENT OR MAINTENANCE OF REPUTATION OR GOODWILL OR FOR ANY OTHER REASON WHATSOEVER"
      },
      {
        "chunk_id": 3143,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71590,
          71986
        ],
        "text": ".1 Each Party agrees that, for a period of five years (\"Non-Competition Period\") from the Effective Date (\"End Date\"), no Party, nor any of their respective Affiliates, will enter into an agreement with any third party, or otherwise carry on any business, directly or indirectly, which is focused on, and targets, primarily Consumers within the PRC, and (i) in the case of Skype and Skype Holding"
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      },
      {
        "chunk_id": 3022,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40849,
          41004
        ],
        "text": "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a non-compete clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71593,
          72923
        ],
        "answer": "Each Party agrees that, for a period of five years (\"Non-Competition Period\") from the Effective Date (\"End Date\"), no Party, nor any of their respective Affiliates, will enter into an agreement with any third party, or otherwise carry on any business, directly or indirectly, which is focused on, and targets, primarily Consumers within the PRC, and (i) in the case of Skype and Skype Holding, which provides for a co-branded Internet-based application in simplified Chinese similar in functionality and features as the Company-Skype Branded Application (as may be updated or upgraded from time to time) (and for the avoidance of doubt, a co-branded Internet-based application in simplified Chinese shall be similar in functionality and features as the Company-Skype Branded Application only in the event such application is a customized co-branded version of the Skype Software having one or more functionality or features contained in the Company-Skype Branded Application), or provides for distribution in the PRC of the Skype Software in simplified Chinese by a Primarily PRC Based Service Provider; and (ii) in the case of Online BVI, Tom Holding and the Company, which provides for any voice over internet protocol and/or instant messaging products or services that compete or are likely to compete with the Skype Software."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          72931,
          74187
        ],
        "answer": "Each Party agrees that, from the Effective Date and through the three (3) month period (\"Enterprise Non-Competition Period\") immediately following the date (\"Enterprise Launch Date\") that Skype launches an enterprise version of the Skype Software primarily targeted for non-Consumer customers (\"Enterprise Skype Software\"), no Party, nor any of their respective Subsidiaries, will (i) discuss, negotiate or enter into (whether verbal or in writing) with any third Person or other third party (\"Other Party\") any understanding, arrangement, or memorandum of understanding, letter of intent, agreement or any other documents (whether or not legally binding); and/or (ii) voluntarily accept or solicit any offer made by any Other Party in respect of or in relation to, (a) in the case of Skype, an enterprise co-branded Internet-based application in simplified Chinese that is focused on, and targeted primarily at, non-Consumers within the PRC, and that is substantially similar in functionality and features as the Enterprise Skype Software, and (b) in the case of Online BVI, Tom Holding and the Company, any voice over internet protocol and/or instant messaging products or services that compete or are likely to compete with the Enterprise Skype Software"
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          76612,
          76907
        ],
        "answer": "Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:"
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Is there a non-compete clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3162,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          76428,
          76907
        ],
        "text": "8.2.2 with respect to the provisions of Section 8.1.2, during any period following the expiration of the Enterprise Non-Competition Period.\n\n8.3 Termination of Non-Competition Period. Notwithstanding any portion of the foregoing to the contrary, the Non-Competition Period shall terminate prior to the End Date, and for the avoidance of doubt, no party shall be obligated to comply with the restrictions set out in Section 8.1 after the termination of the Non-Competition Period:"
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      },
      {
        "chunk_id": 3153,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          74187,
          74605
        ],
        "text": ". During the Enterprise Non-Competition Period, the Parties agree to use their commercially reasonable efforts to discuss mutually agreeable terms pursuant to which the Company would, and Online BVI would cause the Company to, promote, market and distribute in the PRC an enterprise co-branded Internet-based application in simplified Chinese that is focused on, and targeted primarily at, non-Consumers within the PRC"
      },
      {
        "chunk_id": 3221,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89493,
          89902
        ],
        "text": ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW"
      },
      {
        "chunk_id": 3143,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71590,
          71986
        ],
        "text": ".1 Each Party agrees that, for a period of five years (\"Non-Competition Period\") from the Effective Date (\"End Date\"), no Party, nor any of their respective Affiliates, will enter into an agreement with any third party, or otherwise carry on any business, directly or indirectly, which is focused on, and targets, primarily Consumers within the PRC, and (i) in the case of Skype and Skype Holding"
      },
      {
        "chunk_id": 3149,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          72928,
          73323
        ],
        "text": ".2 Each Party agrees that, from the Effective Date and through the three (3) month period (\"Enterprise Non-Competition Period\") immediately following the date (\"Enterprise Launch Date\") that Skype launches an enterprise version of the Skype Software primarily targeted for non-Consumer customers (\"Enterprise Skype Software\"), no Party, nor any of their respective Subsidiaries, will (i) discuss"
      },
      {
        "chunk_id": 2955,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          21150,
          21313
        ],
        "text": ". If any provision of a Statement of Work conflicts with any of the terms and conditions of this Agreement, the provisions of this Agreement shall take precedence."
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3141,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71545,
          71585
        ],
        "text": "8. NON-COMPETITION\n\n8.1 Non-Competition."
      },
      {
        "chunk_id": 3251,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97531,
          97577
        ],
        "text": ", or (iv) immediately terminate this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102769,
          103196
        ],
        "answer": "Notwithstanding the foregoing, Skype or Skype Holding may assign this Agreement to a third party without such consent in the event of a merger, reorganization or sale of all or substantially all of Skype's or Skype Holding's assets or voting securities, provided that written notice of such assignment is delivered to Online BVI and the Company and the assignee assumes all the responsibilities and obligations provided herein."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What happens in the event of a change of control of one of the parties in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 8.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3110,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          64350,
          64590
        ],
        "text": ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
      },
      {
        "chunk_id": 3196,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          84353,
          84812
        ],
        "text": "and the Affected Party provides written notice to the breaching party detailing the Breach and requiring the breaching party to cure the Breach within thirty (30) days of the date of the notice, the Affected Party shall not be obligated to perform the relevant obligation or undertaking affected by the Breach so long as such Breach continues uncured where such non-performance or non-compliance would be deemed a material breach of this Agreement or the Deed"
      },
      {
        "chunk_id": 3274,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          103732,
          104049
        ],
        "text": ". A party to this Agreement may change its address for purposes hereof by written notice to the other in accordance with the provisions of this Section 14.5. The addresses for the parties to this Agreement are as set forth in the preamble hereof, with attention in each case to the respective Chief Executive Officer."
      },
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 3260,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          100498,
          100767
        ],
        "text": ", provided that until each of the other parties receive such notification, the party or parties not having received such notification shall be entitled to treat the agent named above (or its said successor) as the agent of such party for the purposes of this Section 14"
      },
      {
        "chunk_id": 3119,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          66922,
          67168
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:"
      },
      {
        "chunk_id": 3270,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102767,
          103196
        ],
        "text": ". Notwithstanding the foregoing, Skype or Skype Holding may assign this Agreement to a third party without such consent in the event of a merger, reorganization or sale of all or substantially all of Skype's or Skype Holding's assets or voting securities, provided that written notice of such assignment is delivered to Online BVI and the Company and the assignee assumes all the responsibilities and obligations provided herein."
      },
      {
        "chunk_id": 3108,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63971,
          64323
        ],
        "text": ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      },
      {
        "chunk_id": 3254,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          98255,
          98583
        ],
        "text": "14.1 Effect of Termination of Deed; References to Company. In the event that, while this Agreement remains in effect, (i) the Deed is terminated pursuant to the terms thereof, or (ii) the Company is being or has been wound up, liquidated or dissolved, Online BVI shall assume the rights and obligations of the Company hereunder."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          36649,
          37032
        ],
        "answer": "Notwithstanding the foregoing, upon the prior written approval of Online BVI, which approval may be withheld in its sole discretion, the Company shall be permitted to sublicense its rights hereunder to a wholly-owned Subsidiary of the Company or a majority-owned Subsidiary of Tom Holding, for the same purpose and under the same terms and conditions as the license set forth herein."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102526,
          102768
        ],
        "answer": "This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Is there an anti-assignment clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 3227,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91132,
          91320
        ],
        "text": "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      },
      {
        "chunk_id": 3265,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101860,
          102352
        ],
        "text": ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be"
      },
      {
        "chunk_id": 3228,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91320,
          91549
        ],
        "text": ". THE PARTIES ACKNOWLEDGE AND AGREE THAT NOTHING IN THIS SECTION 12.2 SHALL LIMIT A PARTY'S OBLIGATION TO PAY ANY AMOUNTS DUE AND OWING TO THE OTHER PARTY UNDER SECTION 5 ON OR BEFORE ANY DATE OF EXPIRATION OR TERMINATION HEREOF."
      },
      {
        "chunk_id": 3251,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97531,
          97577
        ],
        "text": ", or (iv) immediately terminate this Agreement"
      },
      {
        "chunk_id": 3247,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          96028,
          96371
        ],
        "text": ". Subject to any other provisions of this Agreement, the guarantees are in addition to and without prejudice to and not in substitution for any rights or security which parties may now or hereafter have or hold for the performance and observance of the obligations, commitments, undertakings and warranties of the parties under this Agreement."
      },
      {
        "chunk_id": 2955,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          21150,
          21313
        ],
        "text": ". If any provision of a Statement of Work conflicts with any of the terms and conditions of this Agreement, the provisions of this Agreement shall take precedence."
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3264,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101621,
          101860
        ],
        "text": ". Each party acknowledges that in entering into this Agreement, it does not rely on, has not relied on, and shall have no remedy in respect of, any statement, representation, warranty or other provision (in any case whether oral or written"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          52314,
          52530
        ],
        "answer": "In consideration of the licenses and other agreements set forth herein, Skype shall be entitled to receive 50% of all Adjusted Net Revenue, and the Company shall be entitled to receive 50% of all Adjusted Net Revenue"
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          52532,
          53473
        ],
        "answer": "Notwithstanding the foregoing, Online BVI shall be entitled to receive 50% of all Adjusted Net Revenue, in lieu of the Company's right to be paid hereunder, in the event that (A) this Agreement remains in effect, (B) Online BVI assumes the obligations of the Company hereunder, and (C) (i) the Deed is terminated pursuant to the terms thereof, or (ii)) the Company is being or has been wound up, liquidated or dissolved. Unless otherwise mutually agreed by the Parties in writing, the Company and Online BVI shall provide for, or make available, the payment methods, fraud prevention mechanisms, and other services related to the receipt of payments in connection with SkypeOut, SkypeIn or Skype Plus services provided through the Company-Skype Branded Application or Company-Skype Branded Web Site (\"Payment Services\"), in each case as shall be previously approved in writing by Skype, which approval may be withheld in its sole discretion."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          56461,
          56877
        ],
        "answer": "The respective Parties shall use their best efforts to accompany each respective Statement with payment, to Skype, if provided by the Company or Online BVI (or their associated third parties set forth above), or to the Company (or Online BVI, as applicable), if provided by Skype (or its associated third parties set forth above), as applicable, of 50% of the Adjusted Net Revenue shown on the respective Statements."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Does this contract include any revenue or profit-sharing arrangements?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 14.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3103,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63487,
          63559
        ],
        "text": ", the determination of the amounts of Gross Revenue under this Agreement"
      },
      {
        "chunk_id": 3066,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          52530,
          52951
        ],
        "text": ". Notwithstanding the foregoing, Online BVI shall be entitled to receive 50% of all Adjusted Net Revenue, in lieu of the Company's right to be paid hereunder, in the event that (A) this Agreement remains in effect, (B) Online BVI assumes the obligations of the Company hereunder, and (C) (i) the Deed is terminated pursuant to the terms thereof, or (ii)) the Company is being or has been wound up, liquidated or dissolved"
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3019,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40308,
          40808
        ],
        "text": ", agree that \"Gross Revenue\" to the extent generated by that unaffiliated third party distributor or reseller will arise on the date payment with respect to that revenue is due from the unaffiliated third party distributor or reseller to the Company as opposed to the date upon which the applicable revenue is actually collected by the third party distributor or reseller and the operation of the provisions of Section 5 in respect of the revenue due from that unaffiliated third party distributor or"
      },
      {
        "chunk_id": 3065,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          52293,
          52530
        ],
        "text": "5.2 Revenue Sharing. In consideration of the licenses and other agreements set forth herein, Skype shall be entitled to receive 50% of all Adjusted Net Revenue, and the Company shall be entitled to receive 50% of all Adjusted Net Revenue"
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      },
      {
        "chunk_id": 3076,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          55282,
          55664
        ],
        "text": ", any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of Tom Holding), licensee, distributor or reseller thereof, during the preceding calendar quarter and on a cumulative basis, (ii) the Direct Expenses incurred thereby, during the preceding calendar quarter and on a cumulative basis, and (iii) the calculation of Adjusted Net Revenue"
      },
      {
        "chunk_id": 3079,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          56459,
          56876
        ],
        "text": ". The respective Parties shall use their best efforts to accompany each respective Statement with payment, to Skype, if provided by the Company or Online BVI (or their associated third parties set forth above), or to the Company (or Online BVI, as applicable), if provided by Skype (or its associated third parties set forth above), as applicable, of 50% of the Adjusted Net Revenue shown on the respective Statements"
      },
      {
        "chunk_id": 2907,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          10804,
          10842
        ],
        "text": ", shall be deducted from Gross Revenue"
      },
      {
        "chunk_id": 3139,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          71366,
          71542
        ],
        "text": ", the future features or functionality of the Company-Skype Branded Application, Company-Skype Toolbar or the aggregate revenues to be received by the parties to this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; How is intellectual property ownership assigned in this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          43705,
          44178
        ],
        "answer": "The Company and Online BVI each assign to Skype, with full title guarantee, all copyrights, patents, trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the foregoing translations as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45634,
          45973
        ],
        "answer": "The right, title and interest in and to the Company-Skype Branded Content shall be owned by Skype to the extent made up of the Skype Rights which have been integrated into the Company-Skype Branded Content, and by the Online Group to the extent made up of the Group Rights which have been integrated into the Company-Skype Branded Content."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          46233,
          47687
        ],
        "answer": "if such rights comprise (i) intellectual property that constitutes predominantly communication software or related communication hardware or other technology, including without limitation, any upgrades and Improvements thereof, or (ii) any \"user\" names, and other \"user profile\" information included within the Company-Skype Branded Application (i.e., dates of birth, addresses, languages spoken, etc.), of Company-Skype Branded Customers collected as part of the registration process for the Company-Skype Branded Application (it being understood that Skype will make such user information available to Online BVI and the Company for use consistent with the applicable privacy policies and the EULA) and any database incorporating the same, then such rights shall be owned exclusively by Skype and neither Online BVI nor the Company will grant, nor claim for itself or its affiliated entities, independent contractors, or employees, either expressly or impliedly, any rights, title, interest, or licenses to such rights and each assigns to Skype, with full title guarantee, all copyrights, patents, trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the same as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          47749,
          48598
        ],
        "answer": "if such rights comprise any data specifically provided to the Group by Customers during the billing process (\"Billing Data\"), then such rights shall be owned exclusively by the Online Group and neither Skype nor the Company will grant, nor claim for itself or its affiliated entities, independent contractors, or employees, either expressly or impliedly, any rights, title, interest, or licenses to such rights and each assigns to Online BVI, with full title guarantee, all copyrights, patents, trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the same as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "How is intellectual property ownership assigned in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 12.86
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 3122,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67614,
          67693
        ],
        "text": ", Intellectual Property deemed to be owned by the other Parties under Section 4"
      },
      {
        "chunk_id": 3037,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          44745,
          44803
        ],
        "text": "4.2.3 Improvements; Jointly Created Intellectual Property."
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3250,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97051,
          97531
        ],
        "text": ".2(i), resulting from any party's respective use of the other party's Intellectual Property, then the Indemnifying Party may at its own election (and at its own expense) (i) replace substantially equivalent Intellectual Property for the infringing item, (ii) modify or fix the infringing item so that it no longer infringes but remains functionally equivalent, (iii) obtain for the benefit of the other party the right to continue using such item in accordance with this Agreement"
      },
      {
        "chunk_id": 3213,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          87874,
          88289
        ],
        "text": "11.3 The Receiving Party agrees (i) not to alter or remove any identification of any copyright, trade mark or other proprietary rights notice which indicates the ownership of any part of the Confidential Information, and (ii) to notify the Disclosing Party of the circumstances surrounding any possession, use or knowledge of the Confidential Information by any Person other than those authorized by this Agreement."
      },
      {
        "chunk_id": 3257,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          99156,
          99642
        ],
        "text": ". The foregoing shall not preclude the parties to this Agreement from seeking injunctive relief permitted hereunder in courts with such jurisdiction as may be needed to grant injunctive relief for protection of that party's intellectual property rights. Each of the parties to this Agreement hereby irrevocably appoints the following persons as its agent to receive and acknowledge on its behalf service of any writ, summons, order, judgment or other notice of legal process in England:"
      },
      {
        "chunk_id": 3050,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          48242,
          48597
        ],
        "text": ", trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the same as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof"
      },
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 2916,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          12969,
          13377
        ],
        "text": ".27 \"Online BVI Intellectual Property\" means all Online BVI Brand Features, the Online BVI Web Site, the Company-Skype Branded Web Site (exclusive of any Skype Intellectual Property contained therein), the Online Group's software and Code, databases of the Online Group, including, without limitation, customer information databases and account information related to Customers (other than, and not including"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does this contract provide for joint intellectual property ownership?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          48611,
          49530
        ],
        "answer": "if such rights comprise (i) analysis prepared for or on behalf of the Parties as participants in the Company-Skype Branded Application, or (ii) any intellectual property right co-developed by the Parties, or (iii) of any Support Information, or (iv) any data as specifically provided to Skype or the Online Group by Company-Skype Branded Customers (\"Joint Data\"), other than that set forth in Sections 4.2.3.2.1 and 4.2.3.2.2 above and other than any Group Rights or Skype Rights, then such rights shall be jointly owned by the Parties, and may be exploited by any Party in accordance with this Agreement, and outside of this Agreement to the extent such exploitation would not, (x) in the case of Online BVI, violate or infringe upon the Skype Rights, (y) in the case of Skype, violate or infringe upon the Group Rights, or (z) in the case of the Company, violate or infringe upon the Group Rights or the Skype Rights."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Does this contract provide for joint intellectual property ownership?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 14.61
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 3037,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          44745,
          44803
        ],
        "text": "4.2.3 Improvements; Jointly Created Intellectual Property."
      },
      {
        "chunk_id": 3122,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67614,
          67693
        ],
        "text": ", Intellectual Property deemed to be owned by the other Parties under Section 4"
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3281,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          105592,
          106007
        ],
        "text": "14.9 Independent Contractors. The parties to this Agreement acknowledge and agree that they are dealing with each other hereunder as independent contractors. Nothing contained in this Agreement shall be interpreted as constituting any party the joint venturer, employee or partner of the other party or as conferring upon any party the power of authority to bind another party in any transaction with third parties."
      },
      {
        "chunk_id": 3022,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40849,
          41004
        ],
        "text": "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
      },
      {
        "chunk_id": 3257,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          99156,
          99642
        ],
        "text": ". The foregoing shall not preclude the parties to this Agreement from seeking injunctive relief permitted hereunder in courts with such jurisdiction as may be needed to grant injunctive relief for protection of that party's intellectual property rights. Each of the parties to this Agreement hereby irrevocably appoints the following persons as its agent to receive and acknowledge on its behalf service of any writ, summons, order, judgment or other notice of legal process in England:"
      },
      {
        "chunk_id": 3201,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          85202,
          85637
        ],
        "text": ".1 Each party to this Agreement acknowledges and agrees that by reason of its relationship to the other parties to this Agreement it will have access to and acquire knowledge from, material, data, systems and other information concerning the operation, business, financial affairs, products, customers and intellectual property of the other parties to this Agreement that may not be accessible or known to the general public, including"
      },
      {
        "chunk_id": 3252,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97577,
          97800
        ],
        "text": ". THE FOREGOING PROVISIONS OF THIS SECTION 13.5 STATE THE ENTIRE LIABILITY AND THE EXCLUSIVE REMEDY OF THE PARTIES TO THIS AGREEMENT WITH RESPECT TO INFRINGEMENT OR ALLEGED INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS.   25"
      },
      {
        "chunk_id": 3250,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97051,
          97531
        ],
        "text": ".2(i), resulting from any party's respective use of the other party's Intellectual Property, then the Indemnifying Party may at its own election (and at its own expense) (i) replace substantially equivalent Intellectual Property for the infringing item, (ii) modify or fix the infringing item so that it no longer infringes but remains functionally equivalent, (iii) obtain for the benefit of the other party the right to continue using such item in accordance with this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          35994,
          36648
        ],
        "answer": "Subject to the terms and conditions of this Agreement, Online BVI hereby grants to Skype and the Company a limited, non-exclusive, non-sublicensable (except as set forth herein), non-transferable, non-assignable (except as provided in Section 14.4), royalty- free (but subject to the provisions of Section 5), license during the Term to use, market, provide access to, promote, reproduce and display the Online BVI Intellectual Property solely as incorporated in, and for the development of and for transmission pursuant to this Agreement of the Company-Skype Branded Application, the Company-Skype Branded Content and the Company-Skype Branded Web Site."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37121,
          39367
        ],
        "answer": "Skype hereby grants to Online BVI and the Company a limited, non-exclusive, non-sublicensable (except as set forth herein), non-transferable, non-assignable (except as provided in Section 14.4), royalty-free (but subject to the provisions of Section 5), license during the Term to use, market, provide access to, promote, reproduce and display the Skype Intellectual Property solely (i) as incorporated in the Company-Skype Branded Application and/or the Company-Skype Toolbar, and (ii) as incorporated in, for the development of, and for transmission pursuant to this Agreement of, the Company-Skype Branded Content and the Company-Skype Branded Web Site, in each case for the sole purposes (unless otherwise mutually agreed by the Parties) of promoting and distributing, pursuant to this Agreement, the Company-Skype Branded Application, the Company-Skype Toolbar, the Company-Skype Branded Content and the Company-Skype Branded Web Site in the Territory; (a) provided, that it is understood that the Company-Skype Branded Customers will have the right under the EULA to use the Company- Skype Branded Application and the Company-Skype Toolbar and will have the right to access the Company-Skype Branded Content, the Company-Skype Branded Web Site and the Online BVI Web Site through the Internet and to otherwise receive support from the Company anywhere in the world, and that the Company shall be permitted to provide access to and reproduce and display the Skype Intellectual Property through the Internet anywhere in the world, and (b) provided further, that Online BVI and the Company shall ensure that no Company-Skype Branded Customer (or potential Company-Skype Branded Customer) shall be permitted to access, using the Company-Skype Branded Application or the Company-Skype Toolbar or through the Company-Skype Branded Web Site, any Skype premium features requiring payment by the Company-Skype Branded Customer (or potential Company-Skype Branded Customer), including, but not limited to, SkypeIn, SkypeOut, or Skype Plus, unless such Company-Skype Branded Customer (or potential Company-Skype Branded Customer) uses the payment methods made available by the Company pursuant to Section 2.5 for the purchase of such premium features."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What licenses are granted under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3004,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          35918,
          35971
        ],
        "text": "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses."
      },
      {
        "chunk_id": 3008,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37034,
          37111
        ],
        "text": "4.1.2 Company License. Subject to the terms and conditions of this Agreement:"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3022,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40849,
          41004
        ],
        "text": "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
      },
      {
        "chunk_id": 3010,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37311,
          37776
        ],
        "text": ".4), royalty-free (but subject to the provisions of Section 5), license during the Term to use, market, provide access to, promote, reproduce and display the Skype Intellectual Property solely (i) as incorporated in the Company-Skype Branded Application and/or the Company-Skype Toolbar, and (ii) as incorporated in, for the development of, and for transmission pursuant to this Agreement of, the Company-Skype Branded Content and the Company-Skype Branded Web Site"
      },
      {
        "chunk_id": 3006,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          36239,
          36647
        ],
        "text": ".4), royalty- free (but subject to the provisions of Section 5), license during the Term to use, market, provide access to, promote, reproduce and display the Online BVI Intellectual Property solely as incorporated in, and for the development of and for transmission pursuant to this Agreement of the Company-Skype Branded Application, the Company-Skype Branded Content and the Company-Skype Branded Web Site"
      },
      {
        "chunk_id": 3009,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37113,
          37311
        ],
        "text": "4.1.2.1 Skype hereby grants to Online BVI and the Company a limited, non-exclusive, non-sublicensable (except as set forth herein), non-transferable, non-assignable (except as provided in Section 14"
      },
      {
        "chunk_id": 3050,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          48242,
          48597
        ],
        "text": ", trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the same as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof"
      },
      {
        "chunk_id": 3225,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90344,
          90815
        ],
        "text": ".1 TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensor's affiliates have any licensing rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          24600,
          25332
        ],
        "answer": "Skype further agrees that in the event that, prior to such time as the Company-Skype Branded Application is updated or upgraded to include the Mobile Technology, Skype or any of its Affiliates makes available to Skype users a new software product which allows access to services available through the Skype Software but on or through mobile communication devices (but in any event excluding Skype Zones), it will license that software product to the Company and Online BVI on the terms and conditions set forth in this Agreement with respect to the Skype Software and the Company-Skype Branded Application customized therefrom, and references to the Skype Software in this Agreement shall be deemed to include such software product."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Does the licensor's affiliates have any licensing rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 11.36
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 2883,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          3861,
          4097
        ],
        "text": "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital."
      },
      {
        "chunk_id": 3008,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37034,
          37111
        ],
        "text": "4.1.2 Company License. Subject to the terms and conditions of this Agreement:"
      },
      {
        "chunk_id": 3004,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          35918,
          35971
        ],
        "text": "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses."
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 2887,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          5012,
          5157
        ],
        "text": ", provided that, in each case, the arrangement with the Third Party Affiliate Partner applies to multiple territories (which may include the PRC)"
      },
      {
        "chunk_id": 3007,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          36647,
          37032
        ],
        "text": ". Notwithstanding the foregoing, upon the prior written approval of Online BVI, which approval may be withheld in its sole discretion, the Company shall be permitted to sublicense its rights hereunder to a wholly-owned Subsidiary of the Company or a majority-owned Subsidiary of Tom Holding, for the same purpose and under the same terms and conditions as the license set forth herein."
      },
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 3022,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40849,
          41004
        ],
        "text": "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
      },
      {
        "chunk_id": 3193,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          83336,
          83823
        ],
        "text": "9.2 The parties to this Agreement agree that, during the Term and prior to the obtaining by the Group of the Operating Licenses, the Online Group will act as agent for the Group in carrying out such distribution of the Company-Skype Branded Application or other activities as are restricted under PRC laws and regulations to holders of the relevant licenses which activities are represented by the Online Group to be permitted under the licenses held by the Online Group.\n\n10. DEPENDENCY"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Does the licensee's affiliates have any licensing rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          36649,
          37032
        ],
        "answer": "Notwithstanding the foregoing, upon the prior written approval of Online BVI, which approval may be withheld in its sole discretion, the Company shall be permitted to sublicense its rights hereunder to a wholly-owned Subsidiary of the Company or a majority-owned Subsidiary of Tom Holding, for the same purpose and under the same terms and conditions as the license set forth herein."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          39426,
          39846
        ],
        "answer": "Notwithstanding the foregoing, upon the prior written approval of Skype, which approval may be withheld in its sole discretion, the Company shall be permitted to sublicense its rights hereunder to a wholly-owned Subsidiary, a majority-owned Subsidiary of Tom Holding, or to an unaffiliated third party distributor or reseller, for the same purpose and under the same terms and conditions as the license set forth herein."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Does the licensee's affiliates have any licensing rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 11.36
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 2883,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          3861,
          4097
        ],
        "text": "1.2 \"Affiliate\" means in relation to any Person, any Subsidiary or Holding Company, and any company in which such Person or any such Holding Company holds or Controls directly or indirectly not less than 30% of the issued share capital."
      },
      {
        "chunk_id": 2887,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          5012,
          5157
        ],
        "text": ", provided that, in each case, the arrangement with the Third Party Affiliate Partner applies to multiple territories (which may include the PRC)"
      },
      {
        "chunk_id": 3008,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          37034,
          37111
        ],
        "text": "4.1.2 Company License. Subject to the terms and conditions of this Agreement:"
      },
      {
        "chunk_id": 3004,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          35918,
          35971
        ],
        "text": "4. PROPRIETARY RIGHTS & LICENSE GRANTS\n\n4.1 Licenses."
      },
      {
        "chunk_id": 3028,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          42286,
          42692
        ],
        "text": "4.1.4 Reservation of Rights. Each Party does not grant, and hereby expressly reserves unto itself, all rights not granted in this Agreement. Nothing in this Agreement shall be construed to prevent either party from using or from granting any other licenses and rights to other Persons to use the Intellectual Property licensed under this Section 4 in any manner whatsoever in the Territory.\n\n4.2 Ownership."
      },
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 3007,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          36647,
          37032
        ],
        "text": ". Notwithstanding the foregoing, upon the prior written approval of Online BVI, which approval may be withheld in its sole discretion, the Company shall be permitted to sublicense its rights hereunder to a wholly-owned Subsidiary of the Company or a majority-owned Subsidiary of Tom Holding, for the same purpose and under the same terms and conditions as the license set forth herein."
      },
      {
        "chunk_id": 3022,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          40849,
          41004
        ],
        "text": "4.1.3 Restrictions. Each Party may only use the Intellectual Property of the other Party as expressly set forth in the licenses provided in this Section 4."
      },
      {
        "chunk_id": 3102,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62991,
          63487
        ],
        "text": ".5 Notwithstanding any other provision in this Agreement, in the event of a discrepancy between the records of any Party with that of a third party billing agent that is not an Affiliate of such Party (including, without limitation, records of telecommunications network operators), in the absence of manifest error, the revenue statement or other records provided by such third party billing agent shall prevail and be conclusive for the purposes of this Agreement, including, without limitation"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          59956,
          60676
        ],
        "answer": "The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3.2, and (ii) supporting, verifying and necessary to demonstrate the calculation and collection of fees and/or revenue, as well as any deductions thereto, and payments made hereunder, including, without limitation, budgets, purchase orders, expense records, invoices, correspondence, banking and financial and other records pertaining to the determination of Gross Revenue, Direct Expenses and Adjusted Net Revenue, during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          67176,
          68379
        ],
        "answer": "Each Party shall (i) immediately stop displaying, featuring, linking or in any other manner using the Company-Skype Branded Application (provided in the case of Skype, other than the Skype Software in the Company-Skype Branded Application), Company-Skype Toolbar, Company-Skype Branded Web Site, Company-Skype Branded Content, any co-branded materials or any other Intellectual Property of the other Parties (including, without limitation, Intellectual Property deemed to be owned by the other Parties under Section 4.2.3.2); (ii) return such materials directly to the other Parties, or delete and overwrite any electronically stored copies of such materials within thirty (30) days from the date of termination of this Agreement; (iii) within such thirty (30) day period, deliver to the other Parties a certificate duly executed by its authorised officer certifying its compliance with the foregoing, and (iv) provide the other Parties with such information and access to data and databases as may be necessary to permit such other Parties to fulfil any contractual obligations by them to users of the Company-Skype Branded Application undertaken by such other Parties prior to the time of termination."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          68873,
          69558
        ],
        "answer": "The Parties agree that notwithstanding any termination or expiration of this Agreement, the rights and licenses granted to any Company- Skype Branded Customers prior to termination or expiration of this Agreement pursuant to any EULA shall continue during the 24 months after such termination or expiration for the sole purpose of permitting such users to continue to access and utilize the Company-Skype Branded Application and the Company-Skype Toolbar, and so long as any Gross Revenue is received with respect to the Company-Skype Branded Application and/or the Company-Skype Toolbar, the provisions of Section 5 shall continue to be applicable after any termination or expiration."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Are there any services to be provided after the termination of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.14
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3119,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          66922,
          67168
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n6.3 Duties Upon Termination. Subject to Section 6.5 and to the extent required for the Parties to give effect to Section 6.4, upon termination or expiration of this Agreement, the following shall occur:"
      },
      {
        "chunk_id": 3091,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60559,
          60675
        ],
        "text": ", during the term of this Agreement and for a period of two (2) years following the expiration or termination hereof"
      },
      {
        "chunk_id": 3132,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          69560,
          69789
        ],
        "text": "6.5 Except as otherwise set forth in Section 4.2.3.2.3 and this Section 6, upon termination or expiration of this Agreement all rights and licenses granted hereunder shall immediately terminate.\n\n7. REPRESENTATIONS AND WARRANTIES"
      },
      {
        "chunk_id": 3287,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          107724,
          108217
        ],
        "text": "14.15 Survival. Sections 1, 4.2 (but not 4.2.3.2.4), 5.4, 6.3, 6.4, 6.5, 7, 11, 12, 13, and 14 and the obligation to pay any amount accrued but not yet paid shall survive termination or expiration of this Agreement.\n\n14.16 The parties agree that the provisions of this Agreement are personal to them and are not intended to confer any rights of enforcement on any third party. The Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement or to any of its provisions.   28"
      },
      {
        "chunk_id": 2999,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          34648,
          34803
        ],
        "text": ". Upon any such termination, the Parties will comply with the other provisions surviving termination hereunder, including, without limitation, Section 6.3."
      },
      {
        "chunk_id": 3110,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          64350,
          64590
        ],
        "text": ". Any party to this Agreement shall have the right to terminate this Agreement during the Term by giving notice to another party to this Agreement or to any party that is not an Affiliate of the terminating party (collectively, \"Defaulter\")"
      },
      {
        "chunk_id": 3106,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63727,
          63750
        ],
        "text": "6. TERM AND TERMINATION"
      },
      {
        "chunk_id": 3251,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97531,
          97577
        ],
        "text": ", or (iv) immediately terminate this Agreement"
      },
      {
        "chunk_id": 2998,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          34516,
          34648
        ],
        "text": ", Online BVI or Skype may thereafter terminate this Agreement by delivery to the other parties 30 days written notice of termination"
      },
      {
        "chunk_id": 3108,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          63971,
          64323
        ],
        "text": ". This Agreement shall automatically continue following the Initial Term, for an additional period of three (3) years, unless a party to this Agreement provides written notice of termination to the other parties at least sixty (60) days prior to the expiration of the Initial Term or this Agreement (\"Extended Term\" and, with the Initial Term, \"Term\")."
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60677,
          61429
        ],
        "answer": "Not more than once per calendar quarter, each Party or its independent auditor (who shall be a certified public accountant) shall have the right, on not less than fifteen (15) calendar days prior notice and not during the first twenty (20) days after the close of any fiscal quarter of the other Parties, or within sixty (60) day of the close of such Parties' respective fiscal years, to audit the books of account and records of any and all such Parties. Such audit shall be conducted at the premises where the audited Party maintains consolidated books of account; provided however, that the auditing Party may conduct all or any part of such audit at any of the audited Party's premises where any relevant books of account and/or records are located"
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          61431,
          61579
        ],
        "answer": "During such audits, the auditing Party shall have the right to take extracts and/or make copies of the audited Party's records as it deems necessary"
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          61581,
          62101
        ],
        "answer": "Such audits shall be at the auditing Party's cost, except that, subject to Section 5.5, if an audit by an independent accounting firm establishes a deficiency of more than three percent (3%) between the amount shown to be due to the auditing Party and the amount actually paid for the period being audited, all actual and reasonable costs and expenses incurred by the auditing Party in connection with such audit shall be paid by the audited Party, along with the amount of any deficiency, within five (5) business days."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62152,
          62718
        ],
        "answer": "The exercise by any Party in whole or in part, at any time of the right to inspect and/or audit records and accounts or of any other right herein granted, or the acceptance by such Party of any statement or statements or the receipt and/or deposit by such Party, of any payment tendered by or on behalf of an audited Party shall be without prejudice to any rights or remedies of the accepting Party and such acceptance, receipt and/or deposit shall not preclude or prevent such accepting Party from thereafter disputing the accuracy of any such statement or payment."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62720,
          62988
        ],
        "answer": "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "What are the audit rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.95
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3089,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          59938,
          60146
        ],
        "text": "5.4 Audit Rights. The Parties (including Online BVI on behalf of the Online Group) agree to maintain records (i) of all information reasonably necessary to verify all calculations to be made under Section 8.3"
      },
      {
        "chunk_id": 3100,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62720,
          62988
        ],
        "text": "Each Party shall cause any Subsidiary or other Affiliate (including, without limitation, a Subsidiary or other Affiliate of the Online Group or Skype Group, as applicable) to grant to the other Party the audit rights granted hereunder with respect to such other Party."
      },
      {
        "chunk_id": 3093,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          61131,
          61579
        ],
        "text": ". Such audit shall be conducted at the premises where the audited Party maintains consolidated books of account; provided however, that the auditing Party may conduct all or any part of such audit at any of the audited Party's premises where any relevant books of account and/or records are located. During such audits, the auditing Party shall have the right to take extracts and/or make copies of the audited Party's records as it deems necessary"
      },
      {
        "chunk_id": 3097,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          62152,
          62570
        ],
        "text": "The exercise by any Party in whole or in part, at any time of the right to inspect and/or audit records and accounts or of any other right herein granted, or the acceptance by such Party of any statement or statements or the receipt and/or deposit by such Party, of any payment tendered by or on behalf of an audited Party shall be without prejudice to any rights or remedies of the accepting Party and such acceptance"
      },
      {
        "chunk_id": 3092,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          60675,
          61131
        ],
        "text": ". Not more than once per calendar quarter, each Party or its independent auditor (who shall be a certified public accountant) shall have the right, on not less than fifteen (15) calendar days prior notice and not during the first twenty (20) days after the close of any fiscal quarter of the other Parties, or within sixty (60) day of the close of such Parties' respective fiscal years, to audit the books of account and records of any and all such Parties"
      },
      {
        "chunk_id": 3094,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          61579,
          61665
        ],
        "text": ". Such audits shall be at the auditing Party's cost, except that, subject to Section 5"
      },
      {
        "chunk_id": 3210,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          87304,
          87781
        ],
        "text": "; and (iv) that it will not disclose such Confidential Information to any third party (including subcontractors and consultants) without the express written consent of the Disclosing Party, provided, however, that the Receiving Party may disclose the financial terms of this Agreement and/or any Statement of Work to its legal and business advisors and to potential investors, so long as such third parties have entered into a confidentiality agreement with the Receiving Party"
      },
      {
        "chunk_id": 3265,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101860,
          102352
        ],
        "text": ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be"
      },
      {
        "chunk_id": 3201,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          85202,
          85637
        ],
        "text": ".1 Each party to this Agreement acknowledges and agrees that by reason of its relationship to the other parties to this Agreement it will have access to and acquire knowledge from, material, data, systems and other information concerning the operation, business, financial affairs, products, customers and intellectual property of the other parties to this Agreement that may not be accessible or known to the general public, including"
      },
      {
        "chunk_id": 3095,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          61665,
          62106
        ],
        "text": ".5, if an audit by an independent accounting firm establishes a deficiency of more than three percent (3%) between the amount shown to be due to the auditing Party and the amount actually paid for the period being audited, all actual and reasonable costs and expenses incurred by the auditing Party in connection with such audit shall be paid by the audited Party, along with the amount of any deficiency, within five (5) business days.   16"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90347,
          91549
        ],
        "answer": "TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER, SHALL NOT INCLUDE COMPENSATION, REIMBURSEMENT OR DAMAGES ON ACCOUNT OF THE LOSS OF PRESENT OR PROSPECTIVE PROFITS, EXPENDITURES, DATA, OPPORTUNITY, ANTICIPATED SAVINGS, INVESTMENTS OR COMMITMENTS, WHETHER MADE IN ESTABLISHMENT, DEVELOPMENT OR MAINTENANCE OF REPUTATION OR GOODWILL OR FOR ANY OTHER REASON WHATSOEVER; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES. THE PARTIES ACKNOWLEDGE AND AGREE THAT NOTHING IN THIS SECTION 12.2 SHALL LIMIT A PARTY'S OBLIGATION TO PAY ANY AMOUNTS DUE AND OWING TO THE OTHER PARTY UNDER SECTION 5 ON OR BEFORE ANY DATE OF EXPIRATION OR TERMINATION HEREOF."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Is there uncapped liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3223,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90309,
          90338
        ],
        "text": "12.2 Limitation of Liability."
      },
      {
        "chunk_id": 3229,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91551,
          91570
        ],
        "text": "13. INDEMNIFICATION"
      },
      {
        "chunk_id": 3197,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          84812,
          84862
        ],
        "text": ", and shall not be liable for such material breach"
      },
      {
        "chunk_id": 3227,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91132,
          91320
        ],
        "text": "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
      },
      {
        "chunk_id": 3230,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91572,
          91600
        ],
        "text": "13.1 Company Indemnification"
      },
      {
        "chunk_id": 3221,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89493,
          89902
        ],
        "text": ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW"
      },
      {
        "chunk_id": 3276,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          104083,
          104568
        ],
        "text": ". The parties to this Agreement acknowledge that remedies at law or damages may be inadequate to the other parties to this Agreement to provide full compensation in the event of a material breach relating to the other parties' obligations, representations, and warranties hereunder, and each party to this Agreement shall therefore be entitled to seek injunctive relief or specific performance in the event of any actual or threatened material breach by a party to this Agreement.   27"
      },
      {
        "chunk_id": 3219,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89245,
          89329
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n12. DISCLAIMER & LIMITATION OF LIABILITY"
      },
      {
        "chunk_id": 3235,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          92693,
          93113
        ],
        "text": ". Such indemnification obligation of Tom Holding is conditioned upon Skype promptly notifying Tom Holding in writing setting forth with specificity the claim or action to which such indemnification obligation applies, and reasonable cooperation, information, and assistance in connection therewith. Tom Holding will have the right to control the defense of each such claim and any lawsuit or proceeding arising therefrom"
      },
      {
        "chunk_id": 3265,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          101860,
          102352
        ],
        "text": ", express or implied and whether negligently or innocently made) of any Person (whether a party to this Agreement or not) which is not expressly set out in this Agreement and the only remedy available in respect of any misrepresentation or untrue statement made to such party shall be a claim for breach of contract under this Agreement except to the extent that the misrepresentation or untrue statement is repeated in this Agreement in which case any remedies for misrepresentation shall be"
      }
    ]
  },
  {
    "query": "Consider the Co-Branding Agreement between Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., and Tel-Online Limited; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90347,
          91321
        ],
        "answer": "TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER, SHALL NOT INCLUDE COMPENSATION, REIMBURSEMENT OR DAMAGES ON ACCOUNT OF THE LOSS OF PRESENT OR PROSPECTIVE PROFITS, EXPENDITURES, DATA, OPPORTUNITY, ANTICIPATED SAVINGS, INVESTMENTS OR COMMITMENTS, WHETHER MADE IN ESTABLISHMENT, DEVELOPMENT OR MAINTENANCE OF REPUTATION OR GOODWILL OR FOR ANY OTHER REASON WHATSOEVER; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES."
      },
      {
        "file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          97579,
          97795
        ],
        "answer": "THE FOREGOING PROVISIONS OF THIS SECTION 13.5 STATE THE ENTIRE LIABILITY AND THE EXCLUSIVE REMEDY OF THE PARTIES TO THIS AGREEMENT WITH RESPECT TO INFRINGEMENT OR ALLEGED INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS."
      }
    ],
    "file_set": [
      "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "file_locator": "Co-Branding Agreement Skype Communications, Skype Technologies, TOM Online (BVI) Limited, TOM Online Inc., Tel-Online Limited",
        "similarity_score": 0.570210337638855,
        "only_question": "Is there a cap on liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 3223,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90309,
          90338
        ],
        "text": "12.2 Limitation of Liability."
      },
      {
        "chunk_id": 3219,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89245,
          89329
        ],
        "text": "Source: TOM ONLINE INC, 20-F, 5/1/2006\n\n\n\n\n\n12. DISCLAIMER & LIMITATION OF LIABILITY"
      },
      {
        "chunk_id": 3225,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          90344,
          90815
        ],
        "text": ".1 TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW, EXCEPT FOR THE WILFUL MISAPPROPRIATION OR INFRINGEMENT OF THE INTELLECTUAL PROPERTY OF A PARTY TO THIS AGREEMENT, OR THE OBLIGATIONS OF THE PARTIES TO THIS AGREEMENT PURSUANT TO SECTION 13, (A) THE LIABILITY OF ANY PARTY TO THIS AGREEMENT, IF ANY, FOR DAMAGES FOR ANY CLAIM OF ANY KIND WHATSOEVER AND REGARDLESS OF THE LEGAL THEORY, WITH REGARD TO THE RIGHTS GRANTED HEREUNDER OR THE SERVICES PERFORMED HEREUNDER"
      },
      {
        "chunk_id": 3197,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          84812,
          84862
        ],
        "text": ", and shall not be liable for such material breach"
      },
      {
        "chunk_id": 3229,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91551,
          91570
        ],
        "text": "13. INDEMNIFICATION"
      },
      {
        "chunk_id": 3227,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91132,
          91320
        ],
        "text": "; AND (B) IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTIES TO THIS AGREEMENT FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES"
      },
      {
        "chunk_id": 3230,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91572,
          91600
        ],
        "text": "13.1 Company Indemnification"
      },
      {
        "chunk_id": 3228,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          91320,
          91549
        ],
        "text": ". THE PARTIES ACKNOWLEDGE AND AGREE THAT NOTHING IN THIS SECTION 12.2 SHALL LIMIT A PARTY'S OBLIGATION TO PAY ANY AMOUNTS DUE AND OWING TO THE OTHER PARTY UNDER SECTION 5 ON OR BEFORE ANY DATE OF EXPIRATION OR TERMINATION HEREOF."
      },
      {
        "chunk_id": 3221,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          89493,
          89902
        ],
        "text": ". THE PARTIES TO THIS AGREEMENT EXPRESSLY DISCLAIM, AND HEREBY EXPRESSLY WAIVE, ALL OTHER WARRANTIES AND ALL OTHER CONDITIONS, TERMS AND UNDERTAKINGS WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, PERFORMANCE, QUALITY AND FITNESS FOR A PARTICULAR PURPOSE AND SUCH WARRANTIES, CONDITIONS, TERMS AND UNDERTAKINGS ARE EXCLUDED TO THE FULLEST EXTENT PERMITTED BY LAW"
      },
      {
        "chunk_id": 3276,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          104083,
          104568
        ],
        "text": ". The parties to this Agreement acknowledge that remedies at law or damages may be inadequate to the other parties to this Agreement to provide full compensation in the event of a material breach relating to the other parties' obligations, representations, and warranties hereunder, and each party to this Agreement shall therefore be entitled to seek injunctive relief or specific performance in the event of any actual or threatened material breach by a party to this Agreement.   27"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          44113,
          44438
        ],
        "answer": "The term of this Agreement shall begin as of the Effective Date and continue until Acceptance of all Deliverables   for Milestones #1 and #2 pursuant to Section 3.4 and completion of Milestone #3, unless earlier terminated under Section 8.2, as   provided for under the Other Agreements, or as mutually agreed by the Parties."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9985,
        "readability": "expert",
        "readability_score": 13.63
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1960,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          62496,
          62934
        ],
        "text": "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: /s/ Spencer Stiles By: /s/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 1821,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          18420,
          18876
        ],
        "text": ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S"
      },
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1765,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          0,
          426
        ],
        "text": "Execution Version Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions.   DEVELOPMENT AGREEMENT   This Development Agreement (\"this Agreement\") is entered into and effective as of September 30, 2019 (\"Effective   Date\") by and between Howmedica Osteonics Corp"
      },
      {
        "chunk_id": 1823,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          18953,
          19368
        ],
        "text": "(b) Milestone #2 - Within thirty (30) days following the date on which there is a design freeze of the Patient-Specific   Instrumentation for the KIB Product in accordance with the R&D Work Plan, Stryker shall pay to Conformis a total of three   million U.S dollars ($3,000,000).   3.6 Payment. Stryker shall make all payments to Conformis required herein by wire transfer in accordance with the Wire   Instructions"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          57013,
          57168
        ],
        "answer": "This Agreement shall be governed and construed in accordance with the laws of New York State   (without regard to the conflict of laws provisions thereof)."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9979,
        "readability": "expert",
        "readability_score": 13.63
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1960,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          62496,
          62934
        ],
        "text": "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: /s/ Spencer Stiles By: /s/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 1767,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          766,
          1196
        ],
        "text": ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
      },
      {
        "chunk_id": 1821,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          18420,
          18876
        ],
        "text": ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Are there any exceptions to competitive restrictions in this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19522,
          20563
        ],
        "answer": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates. For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 14.15
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      },
      {
        "chunk_id": 1821,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          18420,
          18876
        ],
        "text": ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S"
      },
      {
        "chunk_id": 1827,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          20211,
          20616
        ],
        "text": ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
      },
      {
        "chunk_id": 1767,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          766,
          1196
        ],
        "text": ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19522,
          20212
        ],
        "answer": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 14.76
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1767,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          766,
          1196
        ],
        "text": ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
      },
      {
        "chunk_id": 1827,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          20211,
          20616
        ],
        "text": ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      },
      {
        "chunk_id": 1856,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          28535,
          29027
        ],
        "text": "use only under this Agreement. Conformis waives any right it may have in law or equity to withhold Stryker's property.   (b) All Equipment furnished by Conformis to Stryker in connection with this Agreement: (i) shall only be used in the performance   of the R&D Program; (ii) shall remain the property of Conformis; and (iii) shall be disposed of or returned in good repair, normal   wear and tear excepted, by Stryker to Conformis at Conformis' direction and expense upon Conformis' request"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          31349,
          31969
        ],
        "answer": "Notwithstanding the foregoing, in the event that the applicable Party decides not to file at all or not to file a continuing or other   application to maintain the viability of the U.S part of a family of patents to which an application belongs, or decides to abandon or   discontinue the prosecution or maintenance of any of the Joint IP Rights, such Party shall notify the other Party thereof, and such   other Party may elect to continue the prosecution (including non-provisional application and PCT entry) or maintenance of such   Joint IP Rights at its sole expense and in the name(s) of both Stryker and Conformis"
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.84
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 6024,
        "filepath": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
        "span": [
          64510,
          64960
        ],
        "text": "(xii) any stockholders agreements, voting agreements, registrations rights agreements, co-sale agreements and any other similar Contracts between the Company and any holder of Company capital stock\u037e \n\n\n(xiii) the Joint Venture Agreements for the Material Clinic Joint Ventures\u037e \n\n\n(xiv) any Contract between the Company or any of its Subsidiaries and any Governmental Entity and that is material to the Company and its Subsidiaries, taken as a whole\u037e"
      },
      {
        "chunk_id": 1960,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          62496,
          62934
        ],
        "text": "IN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective   dates written below.   HOWMEDICA OSTEONICS CORP. CONFORMIS, INC.   By: /s/ Spencer Stiles By: /s/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019   [Signature Page to Development Agreement]   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 8860,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          209433,
          209931
        ],
        "text": "(viii)          any material Contract with any Person (A) pursuant to which Parent or any of its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which Parent or any of its Subsidiaries grants to any Person any right of first refusal, right of first negotiation"
      },
      {
        "chunk_id": 276,
        "filepath": "contractnli/IPTK-CO-MutualNon-DisclosureAgreement.txt",
        "span": [
          6505,
          6533
        ],
        "text": "rights under this Agreement."
      },
      {
        "chunk_id": 19341,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          155893,
          156389
        ],
        "text": "(viii) any Contract with any Person (A) pursuant to which the Company or its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which the Company or its Subsidiaries grants to any Person any right of first refusal, right of first negotiation, option to purchase"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does this contract provide for joint intellectual property ownership?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          21791,
          23305
        ],
        "answer": "All right, title and interest in and to the Improved Conformis Background IP and KIB Product IP (\"Joint IP\") shall be   owned jointly by the Parties. Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliates   to Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of the   APA. Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and   consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and   interest in and to the other Party of such Joint IP."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 15.88
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1846,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          25951,
          26333
        ],
        "text": ".   (b) Stryker acknowledges and agrees that, as between the Parties, Conformis owns all right, title and interest, including all   Intellectual Property rights, in and to Conformis Background IP and Conformis' Confidential Information, including any Conformis   Confidential Information underlying the Joint IP, and that, under this Agreement, Stryker shall acquire no right, title"
      },
      {
        "chunk_id": 1844,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          25364,
          25827
        ],
        "text": ".   (a) Conformis acknowledges and agrees that, as between the Parties, Stryker owns all right, title and interest, including all   Intellectual Property rights, within the Stryker Background IP and Stryker's Confidential Information, including any Stryker   Confidential Information underlying the Joint IP, and that, under this Agreement, except as expressly set forth herein, Conformis   shall acquire no right, title, or interest in or to any of the foregoing"
      },
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1833,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          21939,
          22344
        ],
        "text": ". Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but"
      },
      {
        "chunk_id": 1862,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          30977,
          31345
        ],
        "text": "and maintenance of the Joint IP Rights. In this regard, the prosecuting Party agrees to provide reasonable time for the non-   prosecuting party to review and comment prior to any deadline associated with such Patent. Conformis and Stryker shall be   equally responsible for costs and expenses of preparing, filing, prosecuting and maintaining any such Joint IP Rights"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          24651,
          24963
        ],
        "answer": "To the extent required and for the avoidance of doubt, Stryker hereby grants Conformis, and Conformis hereby   accepts, a non-exclusive license to the Stryker Background IP and Improved Stryker Background IP solely for purposes of   performing any obligations under this Agreement and the Distribution Agreement."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9991,
        "readability": "expert",
        "readability_score": 14.76
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1767,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          766,
          1196
        ],
        "text": ".\"   WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain   Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a   Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such   agreements are referred to herein as the \"Other Agreements\")"
      },
      {
        "chunk_id": 1818,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          17452,
          17798
        ],
        "text": ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith"
      },
      {
        "chunk_id": 1827,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          20211,
          20616
        ],
        "text": ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Does the licensee's affiliates have any licensing rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19522,
          20212
        ],
        "answer": "Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 14.39
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1827,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          20211,
          20616
        ],
        "text": ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
      },
      {
        "chunk_id": 1818,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          17452,
          17798
        ],
        "text": ".2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith"
      },
      {
        "chunk_id": 1833,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          21939,
          22344
        ],
        "text": ". Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or   its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker   and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the   other Party, but"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          38669,
          38834
        ],
        "answer": "EXCEPT FOR [**], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE   OTHER PARTY FOR [**], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCH   DAMAGES."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9992,
        "readability": "expert",
        "readability_score": 14.76
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1891,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          41340,
          41771
        ],
        "text": ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1895,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          42339,
          42832
        ],
        "text": ". To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification   obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and   expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of   the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations"
      },
      {
        "chunk_id": 1885,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          39353,
          39517
        ],
        "text": ". Conformis shall indemnify and hold harmless Stryker, its directors, officers, employees, Agents   and Affiliates and   19   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 1827,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          20211,
          20616
        ],
        "text": ". For purposes of clarity, the foregoing does not prevent   Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including   any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee   Implants outside the Buyer Field.   ARTICLE V   INTELLECTUAL PROPERTY   5.1 Inventions"
      }
    ]
  },
  {
    "query": "Consider the Development Agreement between Howmedica Osteonics Corp. (Stryker) and Conformis, Inc. for Patient-Specific Instrumentation; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          17393,
          17799
        ],
        "answer": "Such termination, together with the provisions of Section 5.2 of the License Agreement,   constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to   deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud,   willful misconduct, gross negligence or bad faith."
      },
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          38669,
          39102
        ],
        "answer": "EXCEPT FOR [**], IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE   OTHER PARTY FOR [**], EVEN IF SUCH PARTY WAS ADVISED OR AWARE OF THE POSSIBILITY OF SUCH   DAMAGES. CONFORMIS' LIABILITY ON A PER OCCURRENCE BASIS UNDER SECTION 7.3(A)(IV) SHALL NOT   EXCEED THE GREATER OF (I) $[**] AND (II) THE AMOUNT OF INSURANCE COVERAGE ACTUALLY PAID TO   CONFORMIS UNDER THEN-CURRENT INSURANCE POLICIES OF CONFORMIS IN RESPECT OF SUCH   DAMAGES."
      },
      {
        "file_path": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          41342,
          41589
        ],
        "answer": "Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement."
      }
    ],
    "file_set": [
      "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Development Agreement Howmedica Osteonics Corp. (Stryker) Conformis, Inc. Patient-Specific Instrumentation",
        "similarity_score": 0.252250611782074,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9991,
        "readability": "expert",
        "readability_score": 13.24
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1826,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19909,
          20211
        ],
        "text": ".5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a   Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The-   Shelf Implants of Conformis, an Acquirer or any of their Affiliates"
      },
      {
        "chunk_id": 1821,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          18420,
          18876
        ],
        "text": ". Stryker shall pay to Conformis the following milestone payments for the development   work to be conducted hereunder if and when the following milestones are met, as follows:   (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient-   Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a   total of two million U.S"
      },
      {
        "chunk_id": 1891,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          41340,
          41771
        ],
        "text": ". Notwithstanding   anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a   Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement.   (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents   and   20   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 1895,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          42339,
          42832
        ],
        "text": ". To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification   obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and   expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of   the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations"
      },
      {
        "chunk_id": 1825,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          19520,
          19909
        ],
        "text": ". Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from   developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf   Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section   2.3.3.4 or Section 2.3"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          36378,
          37095
        ],
        "answer": "The term of this Agreement shall automatically become effective upon the occurrence of (i) ETON executing a commercial supply agreement with a contract manufacturing organization within forty-five (45) days of the Execution Date, provided that ETON has exercised best efforts to execute such agreement and the failure to execute is solely caused by the refusal or inability of the proposed manufacturing organization to sign a reasonable agreement; and (ii) acceptance for review of the Dossier or marketing application for [ * * * ] by the FDA no later than September 2, 2019 (such date, the \"Effective Date\") and shall end upon the termination or expiration of the Agreement as set forth in Section 11 (the \"Term\")."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9981,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2271,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          16085,
          16511
        ],
        "text": ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4"
      },
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      },
      {
        "chunk_id": 2423,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          61221,
          61696
        ],
        "text": ". Field Pkwy, Suite 235 Deer Park, Illinois, USA Attention: Legal if to Aucta, to: Aucta Pharmaceuticals, Inc. 71 Suttons Lane Piscataway, NJ 08854 Attention: CEO 15.4 Relationship of Parties. The status of the Parties under this Agreement shall be that of independent contractors, without the authority to act on behalf of or bind each other. Nothing in this Agreement shall be construed as establishing a partnership or joint venture relationship between the Parties hereto"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          57519,
          57733
        ],
        "answer": "This Agreement shall be governed, interpreted and construed in accordance with the substantive laws of the Delaware, in the country of the United State of America, without regard to its conflict of laws principles."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.996,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2362,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43157,
          43422
        ],
        "text": ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales"
      },
      {
        "chunk_id": 2363,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43422,
          43899
        ],
        "text": ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights"
      },
      {
        "chunk_id": 2255,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11329,
          11820
        ],
        "text": ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a non-compete clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          15708,
          16057
        ],
        "answer": "During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ]"
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9987,
        "readability": "expert",
        "readability_score": 13.24
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 6013,
        "filepath": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
        "span": [
          60705,
          61192
        ],
        "text": "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15"
      },
      {
        "chunk_id": 2270,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          15680,
          16085
        ],
        "text": ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4"
      },
      {
        "chunk_id": 230,
        "filepath": "contractnli/GreenStorm%20NDCSC.txt",
        "span": [
          3782,
          4148
        ],
        "text": "The non-competition provisions of this Agreement are an essential and material part of the total agreement, by which the Parties agree they shall not use any advantages derivable from such confidential information in their own business or affairs, unless the same is done pursuant to a new agreement executed by all signatories to this document.\n5. NON-CIRCUMVENTION"
      },
      {
        "chunk_id": 7796,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          243190,
          243585
        ],
        "text": "(b)    is a non-competition or other agreement (including any exclusive license to, or covenant not to sue or assert claims based on, any Company Intellectual Property) that prohibits or otherwise restricts, in any material respect, the Company or any of its Subsidiaries from freely engaging in any business material to the Company and its Subsidiaries, taken as a whole, anywhere in the world;"
      },
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11332,
          11919
        ],
        "answer": "Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market, advertise, offer for sale or sell (collectively, \"Market\") the Products in and for the Territory."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 12.94
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2222,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          928,
          1420
        ],
        "text": "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
      },
      {
        "chunk_id": 2255,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11329,
          11820
        ],
        "text": ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
      },
      {
        "chunk_id": 4186,
        "filepath": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
        "span": [
          86634,
          87098
        ],
        "text": ". As of the Agreement Date, none of the Top Suppliers that grants or licenses any material rights in or to use any Intellectual Property that is incorporated into any Company Product has cancelled or otherwise terminated or materially and adversely altered the terms (including with respect to pricing) of or, to the Company\u2019s knowledge, threatened to cancel or otherwise terminate or materially and adversely alter the terms (including with respect to pricing) of"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Can this contract be terminated for convenience, and under what conditions?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40868,
          41104
        ],
        "answer": "ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 12.27
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      },
      {
        "chunk_id": 2356,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          41195,
          41608
        ],
        "text": ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc"
      },
      {
        "chunk_id": 21278,
        "filepath": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
        "span": [
          278294,
          278737
        ],
        "text": ". This Agreement may be terminated, in the case of clauses (a), (b), (e), (f) or (g) below, at any time prior to the Effective Time, whether before or after receipt of the Company Stockholder Approval or, in the case of clauses (c) or (d) below, at any time prior to receipt of the Company Stockholder Approval, as follows:   (a)            by mutual written consent of Parent and the Company;   (b)            by either Parent or the Company:"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2358,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          41934,
          42397
        ],
        "text": ". The objective of this clause is to provide reasonable assurance that a termination does not disrupt the supply of Product)s) to the market if possible and both parties shall work in good faith to try and avoid any disruption in the marketing or supply of Products during termination and transfer of Products sales back to Aucta. 11.5 Effect of Termination or Expiration: Surviving Obligations. 11.5.1 If this Agreement is terminated by ETON (i) under Section 11"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          63599,
          64087
        ],
        "answer": "Notwithstanding the foregoing, each Party may assign the rights and obligations under this Agreement in whole, without consent of the other Party, to a Third Party or Affiliate in connection with the transfer or sale of all or substantially all of its business or in the event of a merger, consolidation or change in control provided that the assignee assumes in writing and becomes directly obligated to the other Party to perform all of the obligations of assignor under this Agreement."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 11.16
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2356,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          41195,
          41608
        ],
        "text": ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc"
      },
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      },
      {
        "chunk_id": 1756,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          37488,
          37862
        ],
        "text": ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
      },
      {
        "chunk_id": 1880,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          37297,
          37596
        ],
        "text": ". To the   extent applicable, it is the intent of the Parties that ownership of all developments under this Agreement shall vest in the respective   Party by operation of law or by assignment prior to assignment to the other Party pursuant to Article V.   18   Source: CONFORMIS INC, 10-Q, 11/1/2019"
      },
      {
        "chunk_id": 9512,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          389981,
          390433
        ],
        "text": "(b)          No Party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the prior written consent of each other Party hereto, except that any of Parent or Merger Sub may transfer or assign its rights and obligations under this Agreement, in whole or from time to time in part, to one or more of its Affiliates at any time, in which case all references herein to Parent or Merger Sub, as applicable"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          63431,
          63598
        ],
        "answer": "The Parties shall not assign, encumber or otherwise transfer this Agreement or any part of it to any Third Party, without the prior written consent of the other Party."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9985,
        "readability": "expert",
        "readability_score": 13.24
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 11185,
        "filepath": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
        "span": [
          212878,
          213298
        ],
        "text": ".9 No Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of Law or otherwise) without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns"
      },
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2640,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64940,
          65306
        ],
        "text": "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
      },
      {
        "chunk_id": 2270,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          15680,
          16085
        ],
        "text": ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4"
      },
      {
        "chunk_id": 6013,
        "filepath": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
        "span": [
          60705,
          61192
        ],
        "text": "(iv) other than the Joint Venture Agreements, any Contract of the Company, any of its Subsidiaries or, to the knowledge of the Company, the Clinic Joint Ventures, that limits the ability of the Company, any of its Subsidiaries or a Clinic Joint Venture to compete in any line of business or with any Person or in any geographic area or during any period of time, in each case in any respect material to the Company, its Subsidiaries and the Clinic Joint Ventures, taken as a whole. \n\n\n15"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any revenue or profit-sharing arrangements?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          19365,
          19449
        ],
        "answer": "ETON shall pay to Aucta a royalty payment of [ * * * ] of Net Sales of the Products."
      },
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          37298,
          37468
        ],
        "answer": "Aucta should continue to receive 15% of Net Sales Royalty for as long as ETON is selling the Product(s) in the Territory, unless otherwise agreed to under this Agreement."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 14.15
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2275,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          17266,
          17726
        ],
        "text": ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
      },
      {
        "chunk_id": 2339,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          37094,
          37467
        ],
        "text": ". For avoidance of doubt, all rights conferred to ETON under this Agreement for the purpose of allowing ETON to Market the Product in the Territory shall continue until a Party terminates this Agreement. Aucta should continue to receive 15% of Net Sales Royalty for as long as ETON is selling the Product(s) in the Territory, unless otherwise agreed to under this Agreement"
      },
      {
        "chunk_id": 2222,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          928,
          1420
        ],
        "text": "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a minimum commitment required under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          19472,
          19826
        ],
        "answer": "If the amount of royalty payment under Section 6.3.1 is less than the amount of royalty payment under Section 6.3.2, then ETON shall pay Aucta the difference between royalty payments in Sections 6.3.1 and 6.3.2 within sixty (60) days of the calendar year end, but in no event shall the difference paid be greater than the minimum amount in Section 6.3.2."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9994,
        "readability": "expert",
        "readability_score": 12.89
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2271,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          16085,
          16511
        ],
        "text": ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4"
      },
      {
        "chunk_id": 5947,
        "filepath": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
        "span": [
          43327,
          43820
        ],
        "text": "(f) Except as contained in a Joint Venture Agreement or as would not be material to the Company and its Subsidiaries and Clinic Joint Ventures, taken as a whole, neither the Company nor any Subsidiary of the Company nor any Clinic Joint Venture may be required, by reason of (i) the execution, delivery and performance of this Agreement or the anticipated consummation of the transactions contemplated hereby or (ii) the passage of time, to purchase or redeem or to offer to purchase or redeem"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Does this contract include any volume restrictions?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          15708,
          16047
        ],
        "answer": "During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 13.63
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2271,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          16085,
          16511
        ],
        "text": ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4"
      },
      {
        "chunk_id": 2270,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          15680,
          16085
        ],
        "text": ". 3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] 4. MANUFACTURE AND SUPPLY 4"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2275,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          17266,
          17726
        ],
        "text": ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11332,
          11919
        ],
        "answer": "Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market, advertise, offer for sale or sell (collectively, \"Market\") the Products in and for the Territory."
      },
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          12185,
          12558
        ],
        "answer": "ETON, for itself and its Affiliates, hereby grants to Aucta in accordance with the terms and conditions of this Agreement, a right and license, to its trademark, including to its name and logo, that is owned or controlled by ETON or its Affiliates for Aucta (or its authorized Third Party) to make the packs, labels, and leaflets for the Products for sale in the Territory."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9985,
        "readability": "expert",
        "readability_score": 12.94
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2255,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11329,
          11820
        ],
        "text": ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
      },
      {
        "chunk_id": 2222,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          928,
          1420
        ],
        "text": "; WHEREAS, ETON desires to obtain an exclusive license to the Products, the Dossiers (later defined), and Aucta Background Intellectual Property (later defined) for Marketing the Products in the Territory, and Aucta is willing to grant such an exclusive license to ETON under the terms and conditions set forth herein; WHEREAS, ETON will pay Aucta certain milestone, royalty and licensing payments based on the sale of Products in the Territory under the terms and conditions set forth herein"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2362,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43157,
          43422
        ],
        "text": ".3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          21951,
          22250
        ],
        "answer": "In addition, within twenty-five (25) months after the termination or expiration of the Term and on a Product-by-Product basis, ETON shall perform a final \"true-up\" reconciliation and shall provide Aucta with a written report of such outlining the deductions specified in the definition of Net Sales."
      },
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          41372,
          41838
        ],
        "answer": "After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc. at Aucta's cost for such services, for a reasonable period of time as mutually determined by the Parties but not to exceed one hundred eighty (180) days following termination so that Aucta can get its own such services in place."
      },
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43092,
          43949
        ],
        "answer": "If this Agreement is terminated by Aucta under Section 11.2 or 11.3, then (a) ETON shall have the right to, and Aucta shall hereby grant ETON a license to, Market or otherwise dispose of any existing inventory of any Products then in ETON's possession subject to paying all Royalties and other amounts due hereunder for such sales, (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights, licenses within thirty (30) days of termination."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 11.74
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2356,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          41195,
          41608
        ],
        "text": ".4(b), ETON shall continue to market the Products as before notice of termination, receive revenue and pay associated costs for selling the Product(s) during any notice period. After termination is effective and Aucta assumes control of the Product, ETON will provide, to the extent practicable, transition services to Aucta to include assistance with Product distribution, processing of rebates, drug safety, etc"
      },
      {
        "chunk_id": 2355,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          40862,
          41195
        ],
        "text": ". (b) ETON has the right to terminate this Agreement after approval of the Dossier or marketing application for the Product (or added new product), at its sole discretion, upon providing one hundred eighty (180) days' written notice to Aucta. (c) If Aucta terminates under Section 11.2 or 11.3, or if ETON terminates under Section 11"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2271,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          16085,
          16511
        ],
        "text": ".1 ETON shall enter into a commercial supply agreement with a contract manufacturing organization and Aucta shall enter into a commercial supply agreement with an active pharmaceutical ingredient supplier within ninety (90) days from the Execution Date unless otherwise agreed to by the parties in writing. 4.2 If the terms of Aucta's commercial supply agreement with the active pharmaceutical ingredient supplier in Section 4"
      },
      {
        "chunk_id": 2363,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43422,
          43899
        ],
        "text": ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          23387,
          24269
        ],
        "answer": "Each Party shall permit an independent certified public accounting firm selected by the auditing Party and reasonably acceptable to the non-auditing Party, that has agreed to be bound by a confidentiality agreement reasonably acceptable to the Parties, to have access, during normal business hours and upon reasonable prior notice (not more often than once in any calendar year), to those books and records maintained by the non-auditing Party necessary for the auditing Party to verify the accuracy of the non-auditing Party's calculations under this Section 6 and/or cost of Product(s) for any period ending not more than two (2) years prior to the date of such request, subject to any limitations in scope necessary to comply with Applicable Law, Third Party confidentiality restrictions, or maintain legal privilege, including but not limited to Third Party pricing information."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9974,
        "readability": "expert",
        "readability_score": 12.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 1288,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          47843,
          48251
        ],
        "text": ". Audit Rights:   (a) The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm"
      },
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      },
      {
        "chunk_id": 2363,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          43422,
          43899
        ],
        "text": ", (b) Aucta may keep all the payments under Section 6 paid by ETON up to the point of termination and for ETON's disposal of remaining inventory and Aucta is free to commercialize or relicense the Product with no further obligations owed to ETON, (c) ETON shall refrain from holding itself out as Aucta's distributor, in particular, eliminate any reference to the Product and Aucta from its business, trade style and promotional material, and (d) ETON shall transfer all rights"
      },
      {
        "chunk_id": 2255,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          11329,
          11820
        ],
        "text": ".1 Aucta, for itself and its Affiliates, hereby grants to ETON in accordance with the terms and conditions of this Agreement, an exclusive (even as to and against Aucta in the Territory) right and license, including the right to sublicense, to the Products (or any components thereof), Dossiers, and all current and future Aucta Background Intellectual Property that is owned or controlled by Aucta or its Affiliates for ETON to develop, manufacture, import, use, promote, distribute, market"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          57234,
          57462
        ],
        "answer": "NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, NEITHER PARTY SHALL BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES, WHETHER FORESEEABLE OR NOT, THAT ARE IN ANY WAY RELATED TO THIS AGREEMENT."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.999,
        "readability": "expert",
        "readability_score": 11.63
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2297,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          24998,
          25409
        ],
        "text": ".1 At its sole cost and expense, Aucta shall be solely responsible and liable for any litigation in connection with the Product's development, and the Aucta Background Intellectual Property other than ANDA Litigation covered below in Section 7.5. 7.2 At its sole cost and expense, ETON shall be solely responsible and liable for any non-patent litigation in connection with its sales and marketing activities. 9"
      },
      {
        "chunk_id": 2397,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          53715,
          54087
        ],
        "text": "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law"
      },
      {
        "chunk_id": 2275,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          17266,
          17726
        ],
        "text": ".3 ETON shall have the sole and exclusive right to determine all terms and conditions of sale of the Products to its or its prospective consumers. 5.4 [ * * * ] 6. MILESTONES AND OTHER PAYMENTS 6.1 Licensing Fees. ETON shall pay to Aucta licensing fees of up to an amount of five million dollars ($5,000,000) based on the following payment schedule: (a) An amount of two million dollars ($2,000,000) within five (5) days of the Effective Date of this Agreement"
      },
      {
        "chunk_id": 2391,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          52551,
          52960
        ],
        "text": "; (ii) Aucta's manufacture, registration, handling, storage, use, transportation of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period of time commencing on or after the Effective Date and to the extent such is not attributable to ETON's breach of this Agreement or any Applicable Laws"
      },
      {
        "chunk_id": 3384,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          24989,
          25476
        ],
        "text": "9.2 Cap on Monetary Damages. EACH PARTY'S LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL NOT EXCEED AN AMOUNT EQUAL TO THE AGGREGATE AMOUNTS PAID OR PAYABLE TO LICENSOR IN THE TWELVE (12) MONTHS PRECEDING THE COMMENCEMENT OF THE CLAIM.   9.3 Exceptions. The provisions of Section 9.1 and Section 9.2 will not apply to limit the Licensee's indemnification obligations under Section 8.2, or in the case of Licensee's gross negligence or wilful misconduct.   10. Confidentiality"
      }
    ]
  },
  {
    "query": "Consider the Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc.; What are the insurance requirements under this contract?",
    "snippets": [
      {
        "file_path": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          30980,
          31581
        ],
        "answer": "At all times from the first commercial sale of any Product(s) or after the Effective Date through the date which is five (5) years after the final sale of such Product(s), the Parties will maintain general liability insurance in amounts that are reasonable and customary in the pharmaceutical industry, provided in no event shall the general liability insurance amounts be less than five million dollars ($5,000,000) per occurrence and ten million dollars ($10,000,000) in the aggregate limit of liability per year. The Parties shall provide written proof of such insurance to each other upon request."
      }
    ],
    "file_set": [
      "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Exclusive License Product Development Agreement Eton Pharmaceuticals, Inc. Aucta Pharmaceuticals, Inc.",
        "similarity_score": 0.5097159147262573,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.999,
        "readability": "expert",
        "readability_score": 12.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2317,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          30968,
          31444
        ],
        "text": ". INSURANCE At all times from the first commercial sale of any Product(s) or after the Effective Date through the date which is five (5) years after the final sale of such Product(s), the Parties will maintain general liability insurance in amounts that are reasonable and customary in the pharmaceutical industry, provided in no event shall the general liability insurance amounts be less than five million dollars ($5,000,000) per occurrence and ten million dollars ($10,000"
      },
      {
        "chunk_id": 2397,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          53715,
          54087
        ],
        "text": "; (ii) ETON's marketing, distribution, or sale of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period time commencing on or after the Effective Date and to the extent such is not attributable to Aucta's breach of this Agreement or any Applicable Law"
      },
      {
        "chunk_id": 2435,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          65235,
          65651
        ],
        "text": "Source: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nCONFIDENTIAL IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written, to be effective upon the Effective Date. ETON PHARMACEUTICALS, INC. By: Name: Title: AUCTA PHARMACEUTICALS, INC. By: Name: Title:\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\n\n\n\n\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019"
      },
      {
        "chunk_id": 2391,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          52551,
          52960
        ],
        "text": "; (ii) Aucta's manufacture, registration, handling, storage, use, transportation of any Product on or after the Effective Date, including, without limitation, any Claim for personal injury or death, to the extent such Third Party Claims arise from the period of time commencing on or after the Effective Date and to the extent such is not attributable to ETON's breach of this Agreement or any Applicable Laws"
      },
      {
        "chunk_id": 2219,
        "filepath": "cuad/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.txt",
        "span": [
          0,
          480
        ],
        "text": "Exhibit 10.1 Certain information identified by bracketed asterisks ([ * * * ]) has been omitted from this exhibit because it is both not material and would be competitively harmful if publicly disclosed. EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT THIS EXCLUSIVE LICENSE AND PRODUCT DEVELOPMENT AGREEMENT (this \"Agreement\") is entered into as of June 12, 2019 (the \"Execution Date\") by and between Eton Pharmaceuticals, Inc., a Delaware corporation with offices at 21925 W"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52592,
          52770
        ],
        "answer": "Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "What is the expiration date of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2576,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          43710,
          44081
        ],
        "text": "i. By the fifteenth (15th) day of the last month of the Term of the Agreement, ExxonMobil will have been invoiced for the actual charges incurred in all of the prior months of the Term of the Agreement, but the most recently issued invoice will not be due. Therefore, at such time ExxonMobil will not have yet paid for the last two (2) months of the Term of the Agreement"
      },
      {
        "chunk_id": 2575,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          43221,
          43708
        ],
        "text": "c) Subsequent Monthly Invoices. Within fifteen (15) days after the end of each calendar month that occurs during the remainder of the Term of the Agreement, subject to Paragraph 10.01(e), FCE will calculate and invoice ExxonMobil for the actual amounts incurred (for charges permitted in accordance with the respective Project Description(s)) during the immediately preceding calendar month.\n\nPage 11 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019\n\n\n\n\n\nd) End of Term of the Program."
      },
      {
        "chunk_id": 2578,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          44287,
          44673
        ],
        "text": "ii. Within fifteen (15) days after the end of the Term of the Agreement, FCE will issue an invoice (\"9th Inning Invoice\") for the actual charges incurred during the last month of the Term of the Agreement, subject to Paragraph 10.01(a). FCE will apply any balance of the Initial Payment remaining after the 8th Inning Invoice as a credit towards the amount due on the 9th Inning Invoice"
      },
      {
        "chunk_id": 2603,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52772,
          53150
        ],
        "text": "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
      },
      {
        "chunk_id": 2662,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71247,
          71593
        ],
        "text": ". Such books, records and accounts will be maintained for a period of at least three (3) years following the termination or expiration of this Agreement, provided there are no pending disputes between the Parties. In the case of a dispute, the books, records, and accounts will be maintained for one (1) year following resolution of such dispute."
      },
      {
        "chunk_id": 2765,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          104024,
          104227
        ],
        "text": "Project Name: __________________\n\nLAW-2019-3608\n\nFCE Agreement No. :____________\n\nDate: ________________________\n\nReceiving Company Name & Address\n\nAttention: ______________________\n\nDear ______________,"
      },
      {
        "chunk_id": 2602,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52354,
          52770
        ],
        "text": "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
      },
      {
        "chunk_id": 2724,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          90988,
          91110
        ],
        "text": ", but not beyond the date that is sixty (60) days after the expiration of the initial thirty (30) calendar day Cure Period"
      },
      {
        "chunk_id": 2676,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          75680,
          76063
        ],
        "text": "20.04 Future Work. This Agreement shall not constitute or imply any promise or intention: (a) to enter into any other agreement of any nature, (b) to make any purchase of products or services by either Party or its Affiliates, or (c) to make any commitment by either Party, its Affiliates, or licensees with respect to present or future marketing or supply of any product or service."
      },
      {
        "chunk_id": 2684,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78484,
          78557
        ],
        "text": "20.08 Severability. The provisions of this Agreement are deemed severable"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          62105,
          62301
        ],
        "answer": "The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "What is the governing law for this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2631,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          62084,
          62301
        ],
        "text": "13.01 Governing Law. The validity and interpretation of this Agreement and the legal relations of the Parties to it will be governed by the laws of the State of New York without recourse to its conflicts of law rules."
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2602,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52354,
          52770
        ],
        "text": "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
      },
      {
        "chunk_id": 2685,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78557,
          79000
        ],
        "text": ". The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of any other provision hereof which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are declared to be severable and the balance of this Agreement will be construed and enforced as if this Agreement did not contain such invalid or unenforceable provision."
      },
      {
        "chunk_id": 2438,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          647,
          1056
        ],
        "text": ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30"
      },
      {
        "chunk_id": 2643,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65950,
          66434
        ],
        "text": "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
      },
      {
        "chunk_id": 2656,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          69419,
          69905
        ],
        "text": "17.02 Compliance with Laws. All actions by each Party related to this Agreement will comply with applicable laws and regulations. Notwithstanding anything in this Agreement to the contrary, no provision will be interpreted or applied so as to require a Party or its Affiliates, to do, or to refrain from doing, anything which would constitute a violation of, or be penalized by, any applicable laws and regulations or result in a loss of economic benefit under such laws or regulations."
      },
      {
        "chunk_id": 2591,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          48853,
          49319
        ],
        "text": "1. the execution, delivery and performance of this Agreement by such Party does not conflict with any agreement, instrument or undertaking, oral or written, to which it is a party or by which it may be bound, and\n\n2. all necessary consents, approvals and authorizations of all governmental authorities and third parties required to be obtained by such Party in connection with the execution, delivery, and performance of this Agreement have been or will be obtained;"
      },
      {
        "chunk_id": 2645,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          66464,
          66883
        ],
        "text": "15.01 A Party will not be liable to the other Party and will not be considered in breach of this Agreement for delays or failures in performance resulting from causes beyond the reasonable control of that Party, including, but not limited to, acts of God, labor disputes or disturbances, material shortages or rationing, riots, acts of war, new governmental regulations, communication or utility failures, or casualties"
      },
      {
        "chunk_id": 2642,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65759,
          65948
        ],
        "text": ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any exceptions to competitive restrictions in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          4164,
          4462
        ],
        "answer": "Notwithstanding the foregoing, ExxonMobil hereby grants approval for FCE solely to conduct Authorized Work using Generation 1 Technology with Authorized Third Parties for Carbon Capture Applications and any Work using Generation 2 Technology solely for Power Applications and Hydrogen Applications."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Are there any exceptions to competitive restrictions in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.45
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2475,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          12469,
          12754
        ],
        "text": "4.05 Exceptions. For the purposes of this Agreement, the obligations of confidentiality and restricted use herein shall not apply to any information or materials to the extent the Receiving Party can establish by documentary evidence that one or more of the following exceptions apply:"
      },
      {
        "chunk_id": 2479,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          13789,
          14251
        ],
        "text": "The later occurrence of any one of the aforementioned exceptions will not excuse any failure to adequately protect Confidential Information pursuant to this Agreement prior to the existence of the exception. More specific Confidential Information will not be deemed to be within the foregoing exceptions merely because it is embraced by more general information that is publicly available or in the possession of Receiving Party pursuant to one of the exceptions"
      },
      {
        "chunk_id": 2714,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          87943,
          88359
        ],
        "text": "b) any Major Competitor is or becomes the beneficial owner by purchasing directly from FCE, voting securities representing ten percent (10%) or greater than the actual voting power of any such entity;\n\nc) the sale to any Major Competitor of all or substantially all of the business of FCE to which this Agreement relates (whether by merger, consolidation, sale of stock, sale of assets or other similar transaction);"
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2642,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65759,
          65948
        ],
        "text": ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement."
      },
      {
        "chunk_id": 2685,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78557,
          79000
        ],
        "text": ". The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of any other provision hereof which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are declared to be severable and the balance of this Agreement will be construed and enforced as if this Agreement did not contain such invalid or unenforceable provision."
      },
      {
        "chunk_id": 2480,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14251,
          14462
        ],
        "text": ". Also a combination of features will not be deemed within the foregoing exceptions merely because individual features are publicly available or in Receiving Party's possession pursuant to one of the exceptions."
      },
      {
        "chunk_id": 2683,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78295,
          78482
        ],
        "text": "20.07 Internal Conflict. In the event of a conflict between the provisions in the body of this Agreement and any Project Description, the terms of the body of this Agreement will control."
      },
      {
        "chunk_id": 2598,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51175,
          51554
        ],
        "text": ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
      },
      {
        "chunk_id": 2656,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          69419,
          69905
        ],
        "text": "17.02 Compliance with Laws. All actions by each Party related to this Agreement will comply with applicable laws and regulations. Notwithstanding anything in this Agreement to the contrary, no provision will be interpreted or applied so as to require a Party or its Affiliates, to do, or to refrain from doing, anything which would constitute a violation of, or be penalized by, any applicable laws and regulations or result in a loss of economic benefit under such laws or regulations."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a non-compete clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          3887,
          4163
        ],
        "answer": "During the Term of this Agreement, FCE will not conduct any Work using Generation 1 Technology in Carbon Capture Applications or any Work using Generation 2 Technology, independently or with third parties outside this Agreement, without prior written approval from ExxonMobil."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Is there a non-compete clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2674,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          74767,
          75198
        ],
        "text": "20.02 Independent Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement, or any course of action by either Party pursuant to this Agreement, will be construed or deemed to constitute or create a joint venture, partnership, agency or employment relationship between the Parties or between either Party and the employees or other representatives of the other Party."
      },
      {
        "chunk_id": 2640,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64940,
          65306
        ],
        "text": "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
      },
      {
        "chunk_id": 2598,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51175,
          51554
        ],
        "text": ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
      },
      {
        "chunk_id": 2676,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          75680,
          76063
        ],
        "text": "20.04 Future Work. This Agreement shall not constitute or imply any promise or intention: (a) to enter into any other agreement of any nature, (b) to make any purchase of products or services by either Party or its Affiliates, or (c) to make any commitment by either Party, its Affiliates, or licensees with respect to present or future marketing or supply of any product or service."
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2678,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          76409,
          76702
        ],
        "text": "20.05 Workplace Harassment. Each Party's employees, agents, and subcontractors who will perform work hereunder or communicate with the other Party's employees, agents, customers, or contractors will not engage in any harassment of the other Party's employees, agents, customers, or contractors"
      },
      {
        "chunk_id": 2714,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          87943,
          88359
        ],
        "text": "b) any Major Competitor is or becomes the beneficial owner by purchasing directly from FCE, voting securities representing ten percent (10%) or greater than the actual voting power of any such entity;\n\nc) the sale to any Major Competitor of all or substantially all of the business of FCE to which this Agreement relates (whether by merger, consolidation, sale of stock, sale of assets or other similar transaction);"
      },
      {
        "chunk_id": 2581,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          45418,
          45704
        ],
        "text": "10.02 Up-Front Exclusivity and Technology Access Payment. In exchange for FCE working exclusively with ExxonMobil during the Term of the Agreement, pursuant to Paragraph 2.03 (Work Exclusivity/Independent Work), and ExxonMobil's access to FCE Background Patents, pursuant to Paragraph 8"
      },
      {
        "chunk_id": 2741,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          96527,
          97003
        ],
        "text": "\"Major Competitor\" means a company with a market capitalization in excess of fifty billion United States dollars ($50 billion USD) and whose principal business involves exploration for, and/or production of, crude oil and/or natural gas, manufacture of petroleum products and/or transportation and/or sale of crude oil, natural gas, and/or petroleum products.\n\n\"Memorandum of Understanding\" means the non-binding agreement between ExxonMobil and FCE effective August 26, 2019."
      },
      {
        "chunk_id": 2628,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60895,
          61308
        ],
        "text": "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Can this contract be terminated for convenience, and under what conditions?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52909,
          53085
        ],
        "answer": "Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Can this contract be terminated for convenience, and under what conditions?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 9.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2603,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52772,
          53150
        ],
        "text": "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
      },
      {
        "chunk_id": 2623,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          58779,
          59115
        ],
        "text": "(B) To the maximum extent permitted under law, ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE commences a voluntary case under the Bankruptcy Code or a similar voluntary bankruptcy or insolvency proceeding in a non- U.S"
      },
      {
        "chunk_id": 2610,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          55083,
          55301
        ],
        "text": "12.04 Other Termination. ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control"
      },
      {
        "chunk_id": 2688,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          79396,
          79816
        ],
        "text": ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
      },
      {
        "chunk_id": 2625,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          59603,
          59978
        ],
        "text": ". In the event of termination under this Paragraph 12.05 and subject to ExxonMobil's waiver (in its sole discretion), any licenses granted to FCE under this Agreement that would otherwise survive termination will automatically terminate and any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
      },
      {
        "chunk_id": 2608,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54275,
          54737
        ],
        "text": ".01 (Force Majeure), the non- defaulting Party may give written notice of intent to terminate this Agreement, specifying the details of such default. Unless the defaulting Party has remedied such default within the Cure Period, this Agreement may be terminated, without penalty, payment or prejudice to claims then accrued, by written notice to the defaulting Party by the non-defaulting Party specifying the date of termination which will be of immediate effect"
      },
      {
        "chunk_id": 2684,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78484,
          78557
        ],
        "text": "20.08 Severability. The provisions of this Agreement are deemed severable"
      },
      {
        "chunk_id": 2604,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          53150,
          53535
        ],
        "text": ". In addition, if this Agreement is terminated by ExxonMobil, ExxonMobil will pay FCE reasonable non- refundable expenses incurred by FCE in satisfying authorized commitments entered into by FCE with third parties prior to receipt of the termination notice. FCE will uses its best efforts to minimize termination expenses and will give appropriate credit to ExxonMobil where applicable"
      },
      {
        "chunk_id": 2628,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60895,
          61308
        ],
        "text": "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);"
      },
      {
        "chunk_id": 2612,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          55721,
          56150
        ],
        "text": ". Notwithstanding anything else in this Agreement, in the event of termination under this Paragraph 12.04 ExxonMobil may terminate any licenses granted to FCE under this Agreement that would otherwise survive termination, taking into account the circumstances surrounding the Change in Control. Any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does this contract include any right of first refusal, right of first offer, or right of first negotiation?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          24538,
          24978
        ],
        "answer": "Notwithstanding the foregoing, in the event ExxonMobil decides not to prosecute, defend, enforce, maintain or decides to abandon any Program Patent, then ExxonMobil will provide notice thereof to FCE, and FCE will then have the right, but not the obligation, to prosecute or maintain the Program Patent and sole responsibility for the continuing costs, taxes, legal fees, maintenance fees and other fees associated with that Program Patent."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          27221,
          27611
        ],
        "answer": "During the Term of this Agreement and for two (2) years thereafter, in the event that either Party decides to sell or convey its interest in or otherwise dispose of any Prior JDA Project Patent to any Non-Affiliated Third Party, such Party will inform the other Party, who will then have the right of first refusal to purchase or otherwise acquire the sole interest at same or better terms."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Does this contract include any right of first refusal, right of first offer, or right of first negotiation?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 8.04
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2628,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60895,
          61308
        ],
        "text": "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);"
      },
      {
        "chunk_id": 2591,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          48853,
          49319
        ],
        "text": "1. the execution, delivery and performance of this Agreement by such Party does not conflict with any agreement, instrument or undertaking, oral or written, to which it is a party or by which it may be bound, and\n\n2. all necessary consents, approvals and authorizations of all governmental authorities and third parties required to be obtained by such Party in connection with the execution, delivery, and performance of this Agreement have been or will be obtained;"
      },
      {
        "chunk_id": 2581,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          45418,
          45704
        ],
        "text": "10.02 Up-Front Exclusivity and Technology Access Payment. In exchange for FCE working exclusively with ExxonMobil during the Term of the Agreement, pursuant to Paragraph 2.03 (Work Exclusivity/Independent Work), and ExxonMobil's access to FCE Background Patents, pursuant to Paragraph 8"
      },
      {
        "chunk_id": 2703,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          83945,
          84155
        ],
        "text": "\"Agreement\" means this agreement, together with the appendices attached to this agreement and any Project Descriptions, extensions, renewals, or amendments hereof agreed to in writing and signed by the Parties."
      },
      {
        "chunk_id": 2438,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          647,
          1056
        ],
        "text": ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30"
      },
      {
        "chunk_id": 2643,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65950,
          66434
        ],
        "text": "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
      },
      {
        "chunk_id": 2688,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          79396,
          79816
        ],
        "text": ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
      },
      {
        "chunk_id": 2603,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52772,
          53150
        ],
        "text": "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
      },
      {
        "chunk_id": 2690,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          80276,
          80366
        ],
        "text": ". Notwithstanding the foregoing, the status of the related agreements shall be as follows:"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What happens in the event of a change of control of one of the parties in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          55108,
          56015
        ],
        "answer": "ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control. Subject to requirements of applicable law, FCE will provide notice to ExxonMobil prior to, or promptly after, it becomes aware of any such Change in Control, and if prior notice is prohibited by applicable Law, as soon as practicable or after such notice is no longer prohibited, but in no event later than one (1) business day after any public announcement with respect to any such asset transfer or Change in Control. Notwithstanding anything else in this Agreement, in the event of termination under this Paragraph 12.04 ExxonMobil may terminate any licenses granted to FCE under this Agreement that would otherwise survive termination, taking into account the circumstances surrounding the Change in Control."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "What happens in the event of a change of control of one of the parties in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 8.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2630,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61661,
          62082
        ],
        "text": "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW"
      },
      {
        "chunk_id": 2718,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          89129,
          89614
        ],
        "text": "e) the approval by such entity's board of directors or shareholders of any reorganization or transaction that would cause any of the situations described in clauses (a) through (d) to occur; or\n\nf) the approval by the board of directors or other governing body or the shareholders or other equity holders of FCE of any plan or proposal for its liquidation or dissolution.\n\nThe occurrence or non-occurrence of a Change in Control does not alter or limit section 14.01 of this Agreement."
      },
      {
        "chunk_id": 2688,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          79396,
          79816
        ],
        "text": ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
      },
      {
        "chunk_id": 2640,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64940,
          65306
        ],
        "text": "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
      },
      {
        "chunk_id": 2658,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          70290,
          70439
        ],
        "text": ". Both Parties agree and understand that each will be responsible for ongoing compliance with all such applicable laws, regulations, and requirements"
      },
      {
        "chunk_id": 2608,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54275,
          54737
        ],
        "text": ".01 (Force Majeure), the non- defaulting Party may give written notice of intent to terminate this Agreement, specifying the details of such default. Unless the defaulting Party has remedied such default within the Cure Period, this Agreement may be terminated, without penalty, payment or prejudice to claims then accrued, by written notice to the defaulting Party by the non-defaulting Party specifying the date of termination which will be of immediate effect"
      },
      {
        "chunk_id": 2684,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78484,
          78557
        ],
        "text": "20.08 Severability. The provisions of this Agreement are deemed severable"
      },
      {
        "chunk_id": 2685,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78557,
          79000
        ],
        "text": ". The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of any other provision hereof which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are declared to be severable and the balance of this Agreement will be construed and enforced as if this Agreement did not contain such invalid or unenforceable provision."
      },
      {
        "chunk_id": 2712,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          87349,
          87480
        ],
        "text": "\"Change in Control\" means the occurrence of any one or more of the following at any time after the date hereof with respect to FCE:"
      },
      {
        "chunk_id": 2643,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65950,
          66434
        ],
        "text": "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64958,
          65187
        ],
        "answer": "The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65308,
          65948
        ],
        "answer": "Notwithstanding the foregoing, ExxonMobil may assign this Agreement to its Affiliates and FCE may assign this Agreement to any of its wholly-owned and wholly-controlled Affiliates, with prior written notice to the other Party, provided that (i) such assignment by FCE shall be void if at any point such Affiliate ceases to be both wholly-owned and wholly- controlled by FCE, (ii) Article 12, including but not limited to Paragraphs 12.03, 12.04 and 12.05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Is there an anti-assignment clause in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 11.93
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2640,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64940,
          65306
        ],
        "text": "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
      },
      {
        "chunk_id": 2642,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65759,
          65948
        ],
        "text": ".05, shall be applicable to both FCE and any Affiliate assignee of FCE, and (iii) no assignment pursuant to this sentence will relieve the Parties of their obligations under this Agreement."
      },
      {
        "chunk_id": 2643,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65950,
          66434
        ],
        "text": "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
      },
      {
        "chunk_id": 2682,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          77931,
          78293
        ],
        "text": "20.06 No Third Party Beneficiaries. No third parties are intended to be third party beneficiaries under this Agreement. None of the provisions of this Agreement will be enforceable by a third party. For the avoidance of doubt, permitted assignees of a Party pursuant to Article 14 (Assignment) will not be considered third parties for purposes of this Paragraph."
      },
      {
        "chunk_id": 2445,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          3249,
          3422
        ],
        "text": ". Neither Party makes any representations as to the number, frequency, or monetary value of the Projects, except as otherwise set forth herein or in any Project Description."
      },
      {
        "chunk_id": 2674,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          74767,
          75198
        ],
        "text": "20.02 Independent Contractors. The relationship between the Parties is that of independent contractors. Nothing contained in this Agreement, or any course of action by either Party pursuant to this Agreement, will be construed or deemed to constitute or create a joint venture, partnership, agency or employment relationship between the Parties or between either Party and the employees or other representatives of the other Party."
      },
      {
        "chunk_id": 2598,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51175,
          51554
        ],
        "text": ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
      },
      {
        "chunk_id": 2531,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          30670,
          30887
        ],
        "text": ". Nothing in this Paragraph 7.01(b)(2) will create an obligation on the part of ExxonMobil to grant FCE a right or license under Program Results if the Parties do not agree on the terms and conditions of such license."
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2685,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78557,
          79000
        ],
        "text": ". The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability of any other provision hereof which can be given effect without the invalid or unenforceable provision, and to this end the provisions of this Agreement are declared to be severable and the balance of this Agreement will be construed and enforced as if this Agreement did not contain such invalid or unenforceable provision."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; How is intellectual property ownership assigned in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          21614,
          21694
        ],
        "answer": "FCE will assign, and hereby assigns, to ExxonMobil ownership of Program Results."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          22711,
          23452
        ],
        "answer": "For Program Patents, if one or more employees or other representatives of FCE are determined to be inventors, then FCE will:\n\n(i) cause its employees, contractors, and consultants to render reasonable and timely assistance to ExxonMobil and its attorneys or agents;\n\n(ii) assign, and will cause its and its Affiliates' employees, contractors, and consultants to assign, its right, title, and interest in and to such Program Patent to ExxonMobil for filing; and\n\n(iii) cause its and its Affiliate employees, contractors, and consultants, to execute any documents as may be required to effect such assignments, or file, prosecute, and maintain any patent applications or patents that are based on, derived from, or protect such Program Patent."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "How is intellectual property ownership assigned in this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 12.86
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2614,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          56440,
          56740
        ],
        "text": "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code."
      },
      {
        "chunk_id": 2502,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          21215,
          21694
        ],
        "text": "ARTICLE 6 - OWNERSHIP / PROCUREMENT OF PROGRAM RESULTS\n\n6.01 Ownership of Program Results. ExxonMobil will solely own Program Information, Program Patents, and copyrightable works resulting from the Program (collectively, \"Program Results\"), irrespective of whether the Program Results are conceived, created, developed or acquired by employees or other representatives of FCE, ExxonMobil, or both. FCE will assign, and hereby assigns, to ExxonMobil ownership of Program Results."
      },
      {
        "chunk_id": 2516,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          25986,
          26390
        ],
        "text": "6.06 Joint Research Agreement. The Parties acknowledge and agree that this Agreement is a \"joint research agreement\" as defined in 35 U.S.C. \u00a7100(h). The specification of any patent application filed pursuant to this Agreement may contain (or may be amended to contain) language required to invoke 35 U.S.C. \u00a7102(b)(2)(C) and \u00a7102(c) as applicable. Notwithstanding anything to the contrary in Paragraph 5"
      },
      {
        "chunk_id": 2707,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          85125,
          85605
        ],
        "text": "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information."
      },
      {
        "chunk_id": 2532,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          30889,
          31210
        ],
        "text": "ARTICLE 8 - LICENSE TO BACKGROUND INFORMATION AND PATENTS\n\n8.01 Ownership Retained. Each Party will retain its title and ownership rights to its Background Information and Background Patents in all applicable jurisdictions.\n\n8.02 Grant of Rights to Background Information and Background Patents.\n\n(a) Grant to ExxonMobil."
      },
      {
        "chunk_id": 2520,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          27177,
          27610
        ],
        "text": "6.08 Disposal of Prior JDA Project Patents. During the Term of this Agreement and for two (2) years thereafter, in the event that either Party decides to sell or convey its interest in or otherwise dispose of any Prior JDA Project Patent to any Non-Affiliated Third Party, such Party will inform the other Party, who will then have the right of first refusal to purchase or otherwise acquire the sole interest at same or better terms"
      },
      {
        "chunk_id": 2593,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          49793,
          50288
        ],
        "text": "(c) all of its professional and technical personnel who perform services on or for all Projects are under written obligation:\n\n(1) not to disclose secret or confidential information except as authorized under this Agreement or by their employer;\n\n(2) to assign to their employer all Program Inventions; and\n\n(3) to assign to their employer sole ownership of copyrights to all copyrightable works created in connection with any Project.\n\nPage 13 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019"
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2581,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          45418,
          45704
        ],
        "text": "10.02 Up-Front Exclusivity and Technology Access Payment. In exchange for FCE working exclusively with ExxonMobil during the Term of the Agreement, pursuant to Paragraph 2.03 (Work Exclusivity/Independent Work), and ExxonMobil's access to FCE Background Patents, pursuant to Paragraph 8"
      },
      {
        "chunk_id": 2640,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          64940,
          65306
        ],
        "text": "14.01 Assignment. The Agreement is not assignable, including any assignment by operation of law (including but not limited to as a result of a merger or other corporate action), by either Party without the prior written consent of the other Party. Any and all assignments of this Agreement or of any part thereof not made in accordance with this Article will be void"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          27872,
          28506
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-transferable (except pursuant to Article 14 (Assignment)), non-sub-licensable (except as set forth in this Paragraph 7.01(a)) right and license to practice Program Results solely to conduct research and development for the Program. More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28858,
          29238
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Power Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          29609,
          30195
        ],
        "answer": "In the event ExxonMobil notifies FCE that it has formally decided not to pursue Generation 2 Technology for Carbon Capture Applications, then upon FCE's written request, ExxonMobil agrees to negotiate a grant to FCE, under commercially reasonable terms to be determined in good faith, a worldwide, non-exclusive, royalty-bearing (with the royalty to be negotiated), non-sub- licensable (except as set forth in this Paragraph 7.01(b)(2)), non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Carbon Capture Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          31270,
          31693
        ],
        "answer": "To the extent not already granted pursuant to the License Agreement, FCE grants ExxonMobil and its Affiliates a worldwide, non-exclusive, royalty-free, irrevocable, perpetual, sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in Carbon Capture Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          32204,
          33505
        ],
        "answer": "In the event FCE notifies ExxonMobil that it has formally decided not to pursue Generation 2 Technology for Power Applications, then upon ExxonMobil's written request, FCE agrees to negotiate a grant to ExxonMobil and its Affiliates, under commercially reasonable terms to be determined in good faith, a worldwide, royalty-bearing (with the royalty to be negotiated), non-exclusive, sub-licensable right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in any application outside of Carbon Capture Applications and Hydrogen Applications. More particularly, said right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in any application outside of Carbon Capture Applications and Hydrogen Applications will include the right to use, reproduce, and create derivative works of FCE Background Information under applicable copyrights and the right to make, use, import, and sell or offer to sell under the claims of FCE Background Patents. Nothing in this Paragraph 8.02(a)(2) will create an obligation on the part of FCE to grant ExxonMobil a license or right under FCE Background Patents or FCE Background Information if the Parties do not agree on the terms and conditions of such license."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          33598,
          34548
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty- free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in any applications outside of Carbon Capture Applications. More particularly, said right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in any applications outside of Carbon Capture Applications includes the right to use, reproduce, and create derivative works of ExxonMobil Background Information under applicable copyrights and the right to make, use, import, and sell or offer to sell under the claims of ExxonMobil Background Patents."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34734,
          35765
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub- licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications, solely to conduct Authorized Work with Authorized Third Parties. More particularly, said right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications includes the right to use, reproduce, and create derivative works of ExxonMobil Background Information under applicable copyrights and the right to make, use, and import (but not sell or offer to sell) under the claims of ExxonMobil Background Patents, solely to conduct Authorized Work with Authorized Third Parties"
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36019,
          36987
        ],
        "answer": "In the event that ExxonMobil fails to notify FCE before the end of the Term of the Agreement of ExxonMobil's intent to negotiate a subsequent or follow-on commercial agreement, ExxonMobil agrees to negotiate a grant to FCE, under commercially reasonable terms to be determined in good faith, a worldwide, royalty-free, non-exclusive, non-sub-licensable (except as set forth herein) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications. More particularly, said right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications will include the right to use, reproduce, and create derivative works of ExxonMobil Background Information under applicable copyrights and the right to make, use, import, and sell or offer to sell under the claims of ExxonMobil Background Patents."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          37482,
          37967
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in Power Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          38623,
          39638
        ],
        "answer": "In the event ExxonMobil notifies FCE that it has formally decided not to pursue Generation 2 Technology for Carbon Capture Applications, then upon FCE's written request, ExxonMobil agrees to grant to FCE, under commercially reasonable terms to be determined in good faith, a worldwide, royalty-bearing (with the royalty to be negotiated), non- exclusive, sub-licensable, right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in any application outside of Power Applications and Hydrogen Applications. More particularly, said right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in any application outside of Power Applications includes the right to use, reproduce, and create derivative works of ExxonMobil Background Information under applicable copyrights and the right to make, use, import, and sell or offer to sell under the claims of ExxonMobil Background Patents."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "What licenses are granted under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2707,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          85125,
          85605
        ],
        "text": "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information."
      },
      {
        "chunk_id": 2483,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14934,
          15122
        ],
        "text": ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
      },
      {
        "chunk_id": 2524,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28170,
          28630
        ],
        "text": ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable."
      },
      {
        "chunk_id": 2740,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          96368,
          96525
        ],
        "text": "\"License Agreement\" means the agreement between the Parties effective June 11, 2019 entitled License Agreement bearing ExxonMobil Document No. LAW-2019-3245."
      },
      {
        "chunk_id": 2627,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60445,
          60893
        ],
        "text": "o Article 8 (License to Background Information and Patents), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);\n\no Article 10 (Payment), but only to the extent there are continuing license and/or royalty share obligations pertaining to the commercial use of Program Results, Background Information and/or Background Patents;\n\no Article 11 (Representations, Warranties, Indemnities and Liabilities);"
      },
      {
        "chunk_id": 2545,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34547,
          34702
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2549,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          35765,
          35921
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2555,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36986,
          37402
        ],
        "text": ". The rights and licenses in this Paragraph (b)(1)(iii) will be extendable t o contractors performing work on behalf of FCE but will not otherwise sub-licensable. Nothing in this section will create an obligation on the part of ExxonMobil to grant FCE a license or right under ExxonMobil Background Patents or ExxonMobil Background Information if the Parties do not agree on the terms and conditions of such license."
      },
      {
        "chunk_id": 2614,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          56440,
          56740
        ],
        "text": "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code."
      },
      {
        "chunk_id": 2437,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          174,
          647
        ],
        "text": "TABLE OF CONTENTS ARTICLE 1 - DEFINITIONS 1 ARTICLE 2 - PROGRAM 1 ARTICLE 3 - PROGRAM GOVERNANCE 2 ARTICLE 4 - DISCLOSURE, CONFIDENTIALITY AND RESTRICTED USE 3 ARTICLE 5 - PUBLICITY AND PUBLICATIONS 5 ARTICLE 6 - OWNERSHIP / PROCUREMENT OF PROGRAM RESULTS 6 ARTICLE 7 -LICENSE TO PROGRAM RESULTS 7 ARTICLE 8 - LICENSE TO BACKGROUND INFORMATION AND PATENTS 8 ARTICLE 9 - INFRINGEMENT OF THIRD PARTY PATENTS 11 ARTICLE 10 - PAYMENT 11 ARTICLE 11 - REPRESENTATIONS, WARRANTIES"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are the licenses granted under this contract non-transferable?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          27872,
          28171
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-transferable (except pursuant to Article 14 (Assignment)), non-sub-licensable (except as set forth in this Paragraph 7.01(a)) right and license to practice Program Results solely to conduct research and development for the Program."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28507,
          28630
        ],
        "answer": "Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28858,
          29238
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Power Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          29609,
          30195
        ],
        "answer": "In the event ExxonMobil notifies FCE that it has formally decided not to pursue Generation 2 Technology for Carbon Capture Applications, then upon FCE's written request, ExxonMobil agrees to negotiate a grant to FCE, under commercially reasonable terms to be determined in good faith, a worldwide, non-exclusive, royalty-bearing (with the royalty to be negotiated), non-sub- licensable (except as set forth in this Paragraph 7.01(b)(2)), non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Carbon Capture Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          31270,
          31692
        ],
        "answer": "To the extent not already granted pursuant to the License Agreement, FCE grants ExxonMobil and its Affiliates a worldwide, non-exclusive, royalty-free, irrevocable, perpetual, sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in Carbon Capture Applications and Hydrogen Applications"
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          33598,
          34095
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty- free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in any applications outside of Carbon Capture Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34549,
          34702
        ],
        "answer": "All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34734,
          35202
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub- licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications,"
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          35767,
          35921
        ],
        "answer": "All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36019,
          36558
        ],
        "answer": "In the event that ExxonMobil fails to notify FCE before the end of the Term of the Agreement of ExxonMobil's intent to negotiate a subsequent or follow-on commercial agreement, ExxonMobil agrees to negotiate a grant to FCE, under commercially reasonable terms to be determined in good faith, a worldwide, royalty-free, non-exclusive, non-sub-licensable (except as set forth herein) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36988,
          37147
        ],
        "answer": "The rights and licenses in this Paragraph (b)(1)(iii) will be extendable t o contractors performing work on behalf of FCE but will not otherwise sub-licensable"
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          37482,
          37967
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in Power Applications and Hydrogen Applications."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Are the licenses granted under this contract non-transferable?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 13.9
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2483,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14934,
          15122
        ],
        "text": ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
      },
      {
        "chunk_id": 2524,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28170,
          28630
        ],
        "text": ". More particularly, said right and license to practice includes the right to use, reproduce, and create derivative works of Program Information under applicable copyrights and to make, use, and import (but not sell or offer to sell) under the claims of Program Patents, in each case solely for research and development for the Program. Said right and license may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable."
      },
      {
        "chunk_id": 2545,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34547,
          34702
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2549,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          35765,
          35921
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2521,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          27610,
          27768
        ],
        "text": ". Any sale of a Prior JDA Project Patent to a Non-Affiliated Third Party is subject to the licenses granted and other obligations set forth in this Agreement."
      },
      {
        "chunk_id": 2609,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54737,
          55081
        ],
        "text": ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith."
      },
      {
        "chunk_id": 2555,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36986,
          37402
        ],
        "text": ". The rights and licenses in this Paragraph (b)(1)(iii) will be extendable t o contractors performing work on behalf of FCE but will not otherwise sub-licensable. Nothing in this section will create an obligation on the part of ExxonMobil to grant FCE a license or right under ExxonMobil Background Patents or ExxonMobil Background Information if the Parties do not agree on the terms and conditions of such license."
      },
      {
        "chunk_id": 2490,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          16905,
          17401
        ],
        "text": ". However, notwithstanding anything else in this Paragraph, the Receiving Party may retain such documents and materials to the extent such documents and materials are identified as necessary for beneficial use of a further Project or a license granted herein and the Receiving Party has notified the Disclosing Party in writing of the need for such documents and materials. Any dispute over whether such documents and materials are necessary shall be escalated to senior management for resolution"
      },
      {
        "chunk_id": 2614,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          56440,
          56740
        ],
        "text": "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code."
      },
      {
        "chunk_id": 2612,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          55721,
          56150
        ],
        "text": ". Notwithstanding anything else in this Agreement, in the event of termination under this Paragraph 12.04 ExxonMobil may terminate any licenses granted to FCE under this Agreement that would otherwise survive termination, taking into account the circumstances surrounding the Change in Control. Any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Does the licensee's affiliates have any licensing rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          31270,
          31693
        ],
        "answer": "To the extent not already granted pursuant to the License Agreement, FCE grants ExxonMobil and its Affiliates a worldwide, non-exclusive, royalty-free, irrevocable, perpetual, sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in Carbon Capture Applications and Hydrogen Applications."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Does the licensee's affiliates have any licensing rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9996,
        "readability": "expert",
        "readability_score": 11.36
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2481,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14464,
          14525
        ],
        "text": "4.06 Disclosure to Affiliates, Contractors, and Sub-licensees"
      },
      {
        "chunk_id": 2701,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          83382,
          83556
        ],
        "text": "\"Affiliate(s)\" means any legal entity which, directly or indirectly, at the time in question, controls, is controlled by, or is under common control with the designated Party"
      },
      {
        "chunk_id": 2549,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          35765,
          35921
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(ii) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2545,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34547,
          34702
        ],
        "text": ". All rights and licenses in this Paragraph (b)(1)(i) may be extended to contractors performing work on behalf of FCE but are not otherwise sub-licensable."
      },
      {
        "chunk_id": 2483,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14934,
          15122
        ],
        "text": ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
      },
      {
        "chunk_id": 2609,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54737,
          55081
        ],
        "text": ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith."
      },
      {
        "chunk_id": 2630,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61661,
          62082
        ],
        "text": "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW"
      },
      {
        "chunk_id": 2555,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          36986,
          37402
        ],
        "text": ". The rights and licenses in this Paragraph (b)(1)(iii) will be extendable t o contractors performing work on behalf of FCE but will not otherwise sub-licensable. Nothing in this section will create an obligation on the part of ExxonMobil to grant FCE a license or right under ExxonMobil Background Patents or ExxonMobil Background Information if the Parties do not agree on the terms and conditions of such license."
      },
      {
        "chunk_id": 2560,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          38408,
          38560
        ],
        "text": ". The right and license in this Paragraph (b)(2)(i) may be extended to contractors performing work on behalf of FCE but is not otherwise sub-licensable."
      },
      {
        "chunk_id": 2707,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          85125,
          85605
        ],
        "text": "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are any of the licenses granted under this contract irrevocable or perpetual?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          28858,
          29238
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Power Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          31270,
          31693
        ],
        "answer": "To the extent not already granted pursuant to the License Agreement, FCE grants ExxonMobil and its Affiliates a worldwide, non-exclusive, royalty-free, irrevocable, perpetual, sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in Carbon Capture Applications and Hydrogen Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          33598,
          34095
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty- free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in any applications outside of Carbon Capture Applications."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          34734,
          35267
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub- licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications, solely to conduct Authorized Work with Authorized Third Parties."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          37482,
          37967
        ],
        "answer": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in Power Applications and Hydrogen Applications."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Are any of the licenses granted under this contract irrevocable or perpetual?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.81
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2609,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54737,
          55081
        ],
        "text": ". In the event of termination under this Paragraph 12.03 where FCE is the defaulting Party, FCE's royalty-free licenses described in Paragraph 7.01(b)(1), 8.02(b)(1)(i), 8.02 (b)(1)(ii), 8.02(b)(1)(iii), and 8.02(b)(2)(i) will immediately convert to royalty-bearing licenses, with the royalty rate to be negotiated by the Parties in good faith."
      },
      {
        "chunk_id": 2625,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          59603,
          59978
        ],
        "text": ". In the event of termination under this Paragraph 12.05 and subject to ExxonMobil's waiver (in its sole discretion), any licenses granted to FCE under this Agreement that would otherwise survive termination will automatically terminate and any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
      },
      {
        "chunk_id": 2626,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          59980,
          60443
        ],
        "text": "12.06 Continuing Rights and Obligations. Except as otherwise stated in this Agreement, the following Articles and Paragraphs will survive termination of this Agreement:\n\no Article 1 (Definitions);\n\no Article 4 (Disclosure, Confidentiality and Restricted Use);\n\no Article 6 (Procurement and Ownership of Program Results)\n\no Article 7 (License to Program Results), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);"
      },
      {
        "chunk_id": 2684,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          78484,
          78557
        ],
        "text": "20.08 Severability. The provisions of this Agreement are deemed severable"
      },
      {
        "chunk_id": 2627,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60445,
          60893
        ],
        "text": "o Article 8 (License to Background Information and Patents), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);\n\no Article 10 (Payment), but only to the extent there are continuing license and/or royalty share obligations pertaining to the commercial use of Program Results, Background Information and/or Background Patents;\n\no Article 11 (Representations, Warranties, Indemnities and Liabilities);"
      },
      {
        "chunk_id": 2612,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          55721,
          56150
        ],
        "text": ". Notwithstanding anything else in this Agreement, in the event of termination under this Paragraph 12.04 ExxonMobil may terminate any licenses granted to FCE under this Agreement that would otherwise survive termination, taking into account the circumstances surrounding the Change in Control. Any licenses granted to ExxonMobil under this Agreement that would otherwise survive termination will continue to survive termination."
      },
      {
        "chunk_id": 2707,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          85125,
          85605
        ],
        "text": "(a) owned or controlled by the designated Party or its Affiliates (in the sense of having the right to license without accounting to others); and\n\n(b) conceived, created, developed, or acquired by the designated Party or its Affiliates:\n\n(1) prior to the Effective Date of this Agreement; or\n\n(2) at any time, but independently of any Project prior to the termination of this Agreement.\n\nBackground Information includes Background Samples but does not include Program Information."
      },
      {
        "chunk_id": 2614,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          56440,
          56740
        ],
        "text": "(i) All rights and licenses granted to ExxonMobil and its Affiliates under or pursuant to this Agreement are, and will otherwise be deemed to be, for all purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to \"intellectual property\" as defined in section 101 of the Bankruptcy Code."
      },
      {
        "chunk_id": 2490,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          16905,
          17401
        ],
        "text": ". However, notwithstanding anything else in this Paragraph, the Receiving Party may retain such documents and materials to the extent such documents and materials are identified as necessary for beneficial use of a further Project or a license granted herein and the Receiving Party has notified the Disclosing Party in writing of the need for such documents and materials. Any dispute over whether such documents and materials are necessary shall be escalated to senior management for resolution"
      },
      {
        "chunk_id": 2483,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          14934,
          15122
        ],
        "text": ", and sub-licensees have agreed to be bound by confidentiality and limited use obligations no less protective of Disclosing Party's Confidential Information than the terms contained herein"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71249,
          71460
        ],
        "answer": "Such books, records and accounts will be maintained for a period of at least three (3) years following the termination or expiration of this Agreement, provided there are no pending disputes between the Parties."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Are there any services to be provided after the termination of this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.14
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2603,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52772,
          53150
        ],
        "text": "12.02 Early Termination. The Parties recognize that circumstances may arise where this Agreement's early termination would be desirable. Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice. In the event of early termination of a Project or this Agreement"
      },
      {
        "chunk_id": 2605,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          53535,
          53743
        ],
        "text": ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project."
      },
      {
        "chunk_id": 2602,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          52354,
          52770
        ],
        "text": "(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims.\n\nARTICLE 12 - TERM AND TERMINATION\n\n12.01 Term. Unless sooner terminated in accordance with this Article, this Agreement will continue in full force beginning on the Effective Date and ending two (2) years thereafter (\"Term\")."
      },
      {
        "chunk_id": 2604,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          53150,
          53535
        ],
        "text": ". In addition, if this Agreement is terminated by ExxonMobil, ExxonMobil will pay FCE reasonable non- refundable expenses incurred by FCE in satisfying authorized commitments entered into by FCE with third parties prior to receipt of the termination notice. FCE will uses its best efforts to minimize termination expenses and will give appropriate credit to ExxonMobil where applicable"
      },
      {
        "chunk_id": 2628,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          60895,
          61308
        ],
        "text": "o Article 12 (Term and Termination) to the extent any clause therein speaks to post termination rights and obligations;\n\no Article 13 (Arbitration and Governing Law);\n\no Article 14 (Assignment);\n\no Article 16 (Addresses and Notices);\n\nPage 16 of 31\n\nSource: FUELCELL ENERGY INC, 8-K, 11/6/2019\n\n\n\n\n\no Paragraph 17.03 (Export Controls and Trade Sanctions);\n\no Article 18 (Records and Audit);\n\no Article 19 (Taxes);"
      },
      {
        "chunk_id": 2578,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          44287,
          44673
        ],
        "text": "ii. Within fifteen (15) days after the end of the Term of the Agreement, FCE will issue an invoice (\"9th Inning Invoice\") for the actual charges incurred during the last month of the Term of the Agreement, subject to Paragraph 10.01(a). FCE will apply any balance of the Initial Payment remaining after the 8th Inning Invoice as a credit towards the amount due on the 9th Inning Invoice"
      },
      {
        "chunk_id": 2630,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61661,
          62082
        ],
        "text": "Any rights and obligations that have accrued to either Party against the other prior to the effective date of termination or expiration of this Agreement in any respect will survive such termination or expiration, and rights that have accrued to an Affiliate of a Party will continue regardless of any change in Affiliate status during the Term of this Agreement or thereafter.\n\nARTICLE 13 - ARBITRATION AND GOVERNING LAW"
      },
      {
        "chunk_id": 2438,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          647,
          1056
        ],
        "text": ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30"
      },
      {
        "chunk_id": 2688,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          79396,
          79816
        ],
        "text": ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
      },
      {
        "chunk_id": 2626,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          59980,
          60443
        ],
        "text": "12.06 Continuing Rights and Obligations. Except as otherwise stated in this Agreement, the following Articles and Paragraphs will survive termination of this Agreement:\n\no Article 1 (Definitions);\n\no Article 4 (Disclosure, Confidentiality and Restricted Use);\n\no Article 6 (Procurement and Ownership of Program Results)\n\no Article 7 (License to Program Results), subject to Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy);"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; What are the audit rights under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71615,
          72916
        ],
        "answer": "At the request of ExxonMobil, FCE will permit, at reasonable intervals and during regular business hours, during the Term of this Agreement and at least three (3) years thereafter, but no more than once per fiscal year, an independent certified public accounting firm of nationally recognized standing selected by ExxonMobil (and approved by FCE, which approval will not be unreasonably withheld) to inspect, during regular business hours, such books, records, and accounts and any part of the applicable operations and facilities of FCE relevant to this Agreement, and to have access to FCE's knowledgeable personnel, as may be necessary to determine the completeness and accuracy of any accounting and payments required to be made under this Agreement and compliance with other terms of this Agreement, subject to the following:\n\n(a) ExxonMobil and its employees or other representatives will have the right to reproduce for its internal records any of the documents kept by FCE in accordance with Paragraph 18.01 (Recordkeeping), such reproduced documents shall be subject to the confidentiality and use provisions contained in Article 4; and\n\n(b) all expenses of each such audit, including any pre-approved reasonable expenses incurred by FCE for such audit, will be for the account of ExxonMobil."
      },
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          72918,
          73083
        ],
        "answer": "FCE will cause any subcontractors to preserve documentation and allow ExxonMobil to audit such books, records, and accounts of subcontractors by way of auditing FCE."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "What are the audit rights under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 9.95
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2663,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71595,
          71613
        ],
        "text": "18.02 Audit Rights"
      },
      {
        "chunk_id": 2667,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          72447,
          72916
        ],
        "text": "(a) ExxonMobil and its employees or other representatives will have the right to reproduce for its internal records any of the documents kept by FCE in accordance with Paragraph 18.01 (Recordkeeping), such reproduced documents shall be subject to the confidentiality and use provisions contained in Article 4; and\n\n(b) all expenses of each such audit, including any pre-approved reasonable expenses incurred by FCE for such audit, will be for the account of ExxonMobil."
      },
      {
        "chunk_id": 2665,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          72074,
          72444
        ],
        "text": ", and accounts and any part of the applicable operations and facilities of FCE relevant to this Agreement, and to have access to FCE's knowledgeable personnel, as may be necessary to determine the completeness and accuracy of any accounting and payments required to be made under this Agreement and compliance with other terms of this Agreement, subject to the following"
      },
      {
        "chunk_id": 2438,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          647,
          1056
        ],
        "text": ", INDEMNITIES AND LIABILITIES 13 ARTICLE 12 - TERM AND TERMINATION 14 ARTICLE 13 - ARBITRATION AND GOVERNING LAW 17 ARTICLE 14 - ASSIGNMENT 18 ARTICLE 15 - FORCE MAJEURE 18 ARTICLE 16 - ADDRESSES AND NOTICES 18 ARTICLE 17 - COMPLIANCE 19 ARTICLE 18 - RECORDS AND AUDIT 20 ARTICLE 19 - TAXES 20 ARTICLE 20 - ADDITIONAL PROVISIONS 20 APPENDIX A - DEFINITIONS 24 APPENDIX B - SAMPLE PROJECT DESCRIPTION FORMAT 30"
      },
      {
        "chunk_id": 2664,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          71613,
          72074
        ],
        "text": ". At the request of ExxonMobil, FCE will permit, at reasonable intervals and during regular business hours, during the Term of this Agreement and at least three (3) years thereafter, but no more than once per fiscal year, an independent certified public accounting firm of nationally recognized standing selected by ExxonMobil (and approved by FCE, which approval will not be unreasonably withheld) to inspect, during regular business hours, such books, records"
      },
      {
        "chunk_id": 2629,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          61310,
          61659
        ],
        "text": "o Paragraphs 20.02 (Independent Contractors), 20.03 (Independent Entities), 20.06 (No Third-Party Beneficiaries), 20.07 (Internal Conflict), 20.08 (Severability), 20.09 (Amendments; Modification; Waiver), 20.10 (Integration), and 20.11 (Execution); and\n\no any rights and obligations contained in this Agreement which by their nature should continue."
      },
      {
        "chunk_id": 2643,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          65950,
          66434
        ],
        "text": "14.02 Assignees Bound. Any assignee permitted in Paragraph 14.01 (Assignment) will agree in writing to be bound by all the obligations of the assigning Party under this Agreement, and a copy of such written agreement will be promptly provided to the other Party. Any Party making an assignment of this Agreement as permitted in Paragraph 14.01 (Assignment) will remain bound by the continuing obligations of confidentiality and nonuse applicable to such Party prior to the assignment."
      },
      {
        "chunk_id": 2669,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          73085,
          73520
        ],
        "text": "18.03 Accurate Records. Both Parties agree that all records relating to any Project, including invoices, financial reports, accounting reports, and other financial records relating to any Project will be complete and reflect accurately the facts about all activities and transactions, and both Parties may rely on all such records as being complete and accurate in any further recordings and reports made by the Parties for any purpose"
      },
      {
        "chunk_id": 2661,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          70926,
          71247
        ],
        "text": "18.01 Recordkeeping. FCE will keep, or cause to be kept, true books, records, and accounts in accordance with Generally Accepted Accounting Principles and containing all information necessary for the accurate determination of all amounts payable to FCE under this Agreement, and any other obligations under this Agreement"
      },
      {
        "chunk_id": 2592,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          49321,
          49791
        ],
        "text": "(b) it owns or controls, in the same sense of having the right to license or convey, any Background Information to be provided to the other Party hereunder, and at the date of transmittal to the other Party, such Background Information in the Disclosing Party's good faith belief will not be subject to any encumbrances or restrictions on use by any third party that would materially affect the Receiving Party's exploitation of the rights granted in this Agreement; and"
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51979,
          52543
        ],
        "answer": "Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and\n\n(ii) its legal obligations to third parties wherein nothing in this Agreement is intended to impair a party's contribution and indemnity rights under law with respect to third party claims."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Is there uncapped liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "expert",
        "readability_score": 10.75
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2598,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51175,
          51554
        ],
        "text": ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
      },
      {
        "chunk_id": 2601,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51933,
          52352
        ],
        "text": "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and"
      },
      {
        "chunk_id": 2635,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          63309,
          63679
        ],
        "text": ". The arbitrators will decide all questions and settle all disputes strictly in accordance with the provisions of this Agreement, including the relevant indemnities and liability limitations. The arbitrators will have no authority to award exemplary or punitive damages, and the arbitral panel will certify in the decision that no part of the award includes such damages"
      },
      {
        "chunk_id": 2596,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          50918,
          51139
        ],
        "text": ".04 (EXCEPTIONS TO LIMITATIONS ON LIABILITY). NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, IS MADE REGARDING SUCH INFORMATION AND MATERIAL,  OR ITS COMPLETENESS, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE."
      },
      {
        "chunk_id": 2484,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          15122,
          15327
        ],
        "text": ". The Receiving Party will be liable to the Disclosing Party for any unauthorized disclosure or misuse of the Disclosing Party's Confidential Information by such Affiliates, contractors, and sub-licensees."
      },
      {
        "chunk_id": 2605,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          53535,
          53743
        ],
        "text": ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project."
      },
      {
        "chunk_id": 2645,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          66464,
          66883
        ],
        "text": "15.01 A Party will not be liable to the other Party and will not be considered in breach of this Agreement for delays or failures in performance resulting from causes beyond the reasonable control of that Party, including, but not limited to, acts of God, labor disputes or disturbances, material shortages or rationing, riots, acts of war, new governmental regulations, communication or utility failures, or casualties"
      },
      {
        "chunk_id": 2599,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51554,
          51886
        ],
        "text": ", strict liability or otherwise regardless of whether the possibility of such losses or damages have been made known to the first Party, and each Party hereby expressly waives all such rights and remedies, except for breach of any confidentiality or restricted use provisions of this Agreement and except as provided in Paragraph 11"
      },
      {
        "chunk_id": 2608,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54275,
          54737
        ],
        "text": ".01 (Force Majeure), the non- defaulting Party may give written notice of intent to terminate this Agreement, specifying the details of such default. Unless the defaulting Party has remedied such default within the Cure Period, this Agreement may be terminated, without penalty, payment or prejudice to claims then accrued, by written notice to the defaulting Party by the non-defaulting Party specifying the date of termination which will be of immediate effect"
      },
      {
        "chunk_id": 2570,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          41185,
          41664
        ],
        "text": "9.03 Settlements. Each Party may resolve any risk or threat, or settle any suits or action related to use of any Program Results, without the prior approval of the other Party unless such resolution or settlement would cause the other Party to be: (a) obligated to make any payment or part with any tangible or intangible property right, or (b) obligated to assume any obligations with respect thereto, or (c) subject to any injunction.\n\nARTICLE 10 -PAYMENT\n\n10.01 Project Costs."
      }
    ]
  },
  {
    "query": "Consider the Joint Development Agreement between FuelCell Energy, Inc. and ExxonMobil Research and Engineering Company for Molten Carbonate Fuel Cells; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51177,
          51931
        ],
        "answer": "In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort, strict liability or otherwise regardless of whether the possibility of such losses or damages have been made known to the first Party, and each Party hereby expressly waives all such rights and remedies, except for breach of any confidentiality or restricted use provisions of this Agreement and except as provided in Paragraph 11.04 (Exceptions to Limitations of Liability)."
      }
    ],
    "file_set": [
      "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "file_locator": "Joint Development Agreement FuelCell Energy, Inc. ExxonMobil Research Engineering Company Molten Carbonate Fuel Cells",
        "similarity_score": 0.6406280994415283,
        "only_question": "Is there a cap on liability under this contract?"
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9997,
        "readability": "non-expert",
        "readability_score": 7.59
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2598,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51175,
          51554
        ],
        "text": ". In no event will either Party be liable to the other Party under this Agreement for any consequential, indirect, special, incidental, punitive or exemplary loss or damage, including, without limitation, business interruption, cost of capital, loss of anticipated revenues and profits, loss of goodwill or increased operating costs, whether arising from contract, warranty, tort"
      },
      {
        "chunk_id": 2601,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51933,
          52352
        ],
        "text": "11.04 Exceptions to Limitations of Liability. Notwithstanding anything to the contrary in this Agreement, each Party will bear full responsibility, without limit, for the following:\n\n(i) Gross Negligence or Willful Misconduct attributable to its personnel, and, in no event, will a Party be required to release or indemnify the other Party for Gross Negligence or Willful Misconduct attributable to the other Party; and"
      },
      {
        "chunk_id": 2605,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          53535,
          53743
        ],
        "text": ". The total amount paid FCE under this Agreement or for a Project, including all amounts paid following termination, will not exceed the maximum authorized charge specified in this Agreement or for a Project."
      },
      {
        "chunk_id": 2596,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          50918,
          51139
        ],
        "text": ".04 (EXCEPTIONS TO LIMITATIONS ON LIABILITY). NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, IS MADE REGARDING SUCH INFORMATION AND MATERIAL,  OR ITS COMPLETENESS, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE."
      },
      {
        "chunk_id": 2600,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51886,
          51931
        ],
        "text": ".04 (Exceptions to Limitations of Liability)."
      },
      {
        "chunk_id": 2645,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          66464,
          66883
        ],
        "text": "15.01 A Party will not be liable to the other Party and will not be considered in breach of this Agreement for delays or failures in performance resulting from causes beyond the reasonable control of that Party, including, but not limited to, acts of God, labor disputes or disturbances, material shortages or rationing, riots, acts of war, new governmental regulations, communication or utility failures, or casualties"
      },
      {
        "chunk_id": 2608,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          54275,
          54737
        ],
        "text": ".01 (Force Majeure), the non- defaulting Party may give written notice of intent to terminate this Agreement, specifying the details of such default. Unless the defaulting Party has remedied such default within the Cure Period, this Agreement may be terminated, without penalty, payment or prejudice to claims then accrued, by written notice to the defaulting Party by the non-defaulting Party specifying the date of termination which will be of immediate effect"
      },
      {
        "chunk_id": 2599,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          51554,
          51886
        ],
        "text": ", strict liability or otherwise regardless of whether the possibility of such losses or damages have been made known to the first Party, and each Party hereby expressly waives all such rights and remedies, except for breach of any confidentiality or restricted use provisions of this Agreement and except as provided in Paragraph 11"
      },
      {
        "chunk_id": 2688,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          79396,
          79816
        ],
        "text": ". Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof; nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege."
      },
      {
        "chunk_id": 2635,
        "filepath": "cuad/FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.txt",
        "span": [
          63309,
          63679
        ],
        "text": ". The arbitrators will decide all questions and settle all disputes strictly in accordance with the provisions of this Agreement, including the relevant indemnities and liability limitations. The arbitrators will have no authority to award exemplary or punitive damages, and the arbitral panel will certify in the decision that no part of the award includes such damages"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          15301,
          15523
        ],
        "answer": "The term of this Agreement shall commence on the Effective Date and shall continue for the longer of the first anniversary of the Effective Date or the duration of the Manufacturing and Distribution Agreement (the \"Term\")."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9901,
        "readability": "expert",
        "readability_score": 13.78
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2212,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          26594,
          26923
        ],
        "text": "The parties set forth below have executed this Agreement as of the Effective Date. REED'S: COMPANY: Reed's, Inc. B C Marketing Concepts Inc., dba Full Sail Brewing Company By: /s/ John Bello By: /s/ Cory Comstock Name: John Bello Name: Cory Comstock Title: CEO Title: CEO Address: Address: Reed's, Inc. B C Marketing Concepts Inc"
      },
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          20132,
          20392
        ],
        "answer": "This Agreement shall be governed by, and any dispute arising hereunder shall be determined in accordance with, the laws of State of New York (without giving effect to conflict of laws principles) including all matters of construction, validity and performance."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9894,
        "readability": "expert",
        "readability_score": 13.78
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      },
      {
        "chunk_id": 2143,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5957,
          6423
        ],
        "text": ". Each party shall ensure that all persons performing work under this Agreement on its behalf shall have the requisite experience, training, skill and other qualifications needed to develop the Recipes, Deliverables and Specifications. Company shall keep the Development Committee informed of the progress of the development of the Recipes and Deliverables and such other matters as any member of the Development Committee may reasonably request from time to time. 2"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          4229,
          4761
        ],
        "answer": "In exchange for Company's contributions and obligations under this Agreement, Reed's grants Company the exclusive right to manufacture, package, promote, sell and distribute the Products (if and to the extent approved by the Development Committee), subject to the terms and conditions of a separate Manufacturing and Distribution Agreement to be entered into by the parties concurrently with this Agreement, as it may be amended, modified, supplemented or restated from time to time (the \"Manufacturing and Distribution Agreement\")."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 14.79
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      },
      {
        "chunk_id": 2190,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          19237,
          19510
        ],
        "text": ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          19512,
          19962
        ],
        "answer": "Company may not assign or transfer its rights or obligations under this Agreement, whether by operation of law, contract or otherwise, without the prior written consent of Reed's, which shall not be unreasonably withheld (it being understood that a purported assignment to a Reed's competitor identified or referred to in Exhibit D of the Manufacturing and Distribution Agreement shall be considered to be a reasonable basis for withholding consent)."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.996,
        "readability": "expert",
        "readability_score": 15.0
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2190,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          19237,
          19510
        ],
        "text": ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
      },
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2191,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          19510,
          19961
        ],
        "text": ". Company may not assign or transfer its rights or obligations under this Agreement, whether by operation of law, contract or otherwise, without the prior written consent of Reed's, which shall not be unreasonably withheld (it being understood that a purported assignment to a Reed's competitor identified or referred to in Exhibit D of the Manufacturing and Distribution Agreement shall be considered to be a reasonable basis for withholding consent)"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; How is intellectual property ownership assigned in this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          8327,
          8372
        ],
        "answer": "Reed's will exclusively own all Deliverables."
      },
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          8374,
          8696
        ],
        "answer": "ompany will and hereby does, without further consideration, irrevocably assign to Reed's any and all worldwide right, title or interest that Company may now or hereafter possess in or to the Deliverables in perpetuity (or the maximum period permitted by Applicable Laws and Regulations) and Reed's accepts such assignment."
      },
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          10186,
          11082
        ],
        "answer": "Company acknowledges and agrees that all Intellectual Property created by Company, its affiliates, representatives, or agents in connection with or resulting from any work or services related to the Products, including the Deliverables (\"Work Product\"), but excluding the Neutral Alcohol Beverage Base and excluding the Company's general know-how and independently developed production processes not specifically related to the Products, have been specially ordered and commissioned by Reed's, are works-made-for-hire from the moment of creation and that all such Work Product is and will be the sole and exclusive property of Reed's. To the extent not a work-for- hire, Company, its employees, subcontractors and agents hereby sell, assign and transfer to Reed's all right, title and interest in and to the Work Product, including without limitation, all rights to Intellectual Property therein."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9763,
        "readability": "expert",
        "readability_score": 15.19
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2129,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          1836,
          2170
        ],
        "text": ". Company Intellectual Property includes but is not limited to Company's know-how and independently developed recipes and alcohol beverage production processes, including the Company's proprietary composition of or recipe for the neutral alcohol beverage base that contributes alcohol to the Products (\"Neutral Alcohol Beverage Base\")"
      },
      {
        "chunk_id": 2137,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          3767,
          4227
        ],
        "text": ". (f) \"Reed's Intellectual Property\" means all Intellectual Property that: (i) was owned or developed by Reed's prior to the execution of this Agreement; (ii) was or is independently developed by Reed's without contribution or assistance from Company or Company's Intellectual Property; and (iii) the Recipe. (g) \"Specifications\" means the specifications for the Products to be developed by the Development Committee (as defined in Section 3). 2. Consideration"
      },
      {
        "chunk_id": 3041,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          45975,
          46220
        ],
        "text": "4.2.3.2. If any intellectual property rights that are subject to legal protection are created or developed jointly by the Parties as a result of the collaboration under this Agreement, such intellectual property rights shall be owned as follows:"
      },
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2152,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          8195,
          8695
        ],
        "text": ". 6. Intellectual Property. (a) Ownership of Intellectual Property. (i) Company will create and provide to Reed's the Deliverables. Reed's will exclusively own all Deliverables. Company will and hereby does, without further consideration, irrevocably assign to Reed's any and all worldwide right, title or interest that Company may now or hereafter possess in or to the Deliverables in perpetuity (or the maximum period permitted by Applicable Laws and Regulations) and Reed's accepts such assignment"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there uncapped liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          17591,
          18213
        ],
        "answer": "EXCEPT WITH RESPECT TO THE INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 9 WITH REGARD TO CLAIMS BY THIRD PARTIES, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS OR REVENUES OR DIMINUTION IN VALUE ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH ANY BREACH OF THIS AGREEMENT OR CLAIM HEREUNDER, REGARDLESS OF (A) WHETHER SUCH DAMAGES WERE FORESEEABLE, (B) WHETHER OR NOT IT WAS ADVISED OF THE POSSIBLITY OF SUCH DAMAGES, AND (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT OR OTHERWISE) UPON WHICH THE CLAIM IS BASED."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9979,
        "readability": "expert",
        "readability_score": 14.79
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      },
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2140,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          4760,
          5254
        ],
        "text": ". Company shall be responsible for all costs relating to the development of the Recipes and Deliverables, except for costs and expenses relating to the involvement of Reed's personnel and contractors. 3. Development Committee. Representatives of Company and Reed's, as identified in Exhibit B, shall meet regularly to discuss and approve development milestones for the Products, the Recipes, Deliverables, Specifications and other topics as identified in Exhibit B (the \"Development Committee\")"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          17591,
          18213
        ],
        "answer": "EXCEPT WITH RESPECT TO THE INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 9 WITH REGARD TO CLAIMS BY THIRD PARTIES, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS OR REVENUES OR DIMINUTION IN VALUE ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH ANY BREACH OF THIS AGREEMENT OR CLAIM HEREUNDER, REGARDLESS OF (A) WHETHER SUCH DAMAGES WERE FORESEEABLE, (B) WHETHER OR NOT IT WAS ADVISED OF THE POSSIBLITY OF SUCH DAMAGES, AND (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT OR OTHERWISE) UPON WHICH THE CLAIM IS BASED."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9976,
        "readability": "expert",
        "readability_score": 13.44
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2140,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          4760,
          5254
        ],
        "text": ". Company shall be responsible for all costs relating to the development of the Recipes and Deliverables, except for costs and expenses relating to the involvement of Reed's personnel and contractors. 3. Development Committee. Representatives of Company and Reed's, as identified in Exhibit B, shall meet regularly to discuss and approve development milestones for the Products, the Recipes, Deliverables, Specifications and other topics as identified in Exhibit B (the \"Development Committee\")"
      }
    ]
  },
  {
    "query": "Consider the Recipe Development Agreement between Reed's, Inc. and B C Marketing Concepts Inc. for Ginger-Based Alcohol Beverages; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          9148,
          9500
        ],
        "answer": "Company agrees that it will not at any time contest the ownership or validity of any Reed's Intellectual Property or Deliverables, nor register or attempt to register any rights with respect to Reed's Intellectual Property, nor do anything that would jeopardize or diminish Reed's rights to or the value of Reed's Intellectual Property or Deliverables."
      },
      {
        "file_path": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          9692,
          10120
        ],
        "answer": "Reed's shall not at any time acquire any rights, title or interest in Company's Intellectual Property. Reed's agrees that it will not at any time contest the ownership or validity of any Company Intellectual Property, nor register or attempt to register any rights with respect to Company Intellectual Property, nor do anything that would jeopardize or diminish Company's rights to or the value of Company Intellectual Property."
      }
    ],
    "file_set": [
      "ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Recipe Development Agreement Reed's, Inc. B C Marketing Concepts Inc. Ginger-Based Alcohol Beverages",
        "similarity_score": 0.3078541159629822,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9987,
        "readability": "expert",
        "readability_score": 13.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2124,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          415,
          810
        ],
        "text": ". Reed's is engaged in the business of developing recipes for ginger-based non- alcohol beverage products. Reed's desires to engage Company, and Company desires to be engaged, to participate and assist in the development of formulas for ginger-based flavored alcohol beverage products for Reed's (the \"Products\") as identified in Exhibit A. AGREEMENT The parties agree as follows: 1. Definitions"
      },
      {
        "chunk_id": 2141,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          5254,
          5626
        ],
        "text": ". The final Recipes, Deliverables and Specifications for the Products must be agreed to in writing by at least one member of the Development Committee from each of Reed's and Company. 4. Rights and Obligations. (a) The parties will collaborate to develop commercial production-ready Products according to the Specifications as may be developed by the Development Committee"
      },
      {
        "chunk_id": 2123,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          0,
          415
        ],
        "text": "RECIPE DEVELOPMENT AGREEMENT This Recipe Development Agreement (this \"Agreement\") is made between Reed's, Inc., a Delaware corporation (\"Reed's\") and B C Marketing Concepts Inc., dba Full Sail Brewing Company, an Oregon corporation (\"Company\"), effective as of October 11, 2019 (the \"Effective Date\"). RECITALS Company is engaged in the business of developing recipes for and manufacturing alcohol beverage products"
      },
      {
        "chunk_id": 2145,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          6469,
          6964
        ],
        "text": "(b) Company shall promptly disclose to the Development Committee any prospective or actual new Intellectual Property related to the Products or Product-specific production processes, whether developed solely by Company or jointly by the Company and Reed's, except with regard to the Neutral Alcohol Beverage Base, and except with regard to the Company's general know-how and independently developed production processes not specifically related to the Products. 5. Representations and Warranties"
      },
      {
        "chunk_id": 2190,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          19237,
          19510
        ],
        "text": ". This Agreement does not constitute and shall not be construed as constituting a partnership or joint venture or grant of a franchise between Reed's and Company. Neither party shall have the right to bind the other party to any obligations to third parties. 13. Assignment"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          17984,
          18303
        ],
        "answer": "This agreement begins on the Commencement Date and, subject to clause 11.2, shall continue for an initial term of one (1) years (Initial Term) and indefinitely after that until terminated by either party giving at least twelve (12) months' prior written notice to expire on or after the expiry date of the initial term."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9981,
        "readability": "expert",
        "readability_score": 13.72
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 2177,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          16123,
          16318
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
      },
      {
        "chunk_id": 1278,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          44980,
          45380
        ],
        "text": ". Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          17984,
          18303
        ],
        "answer": "This agreement begins on the Commencement Date and, subject to clause 11.2, shall continue for an initial term of one (1) years (Initial Term) and indefinitely after that until terminated by either party giving at least twelve (12) months' prior written notice to expire on or after the expiry date of the initial term."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9951,
        "readability": "expert",
        "readability_score": 13.72
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 3358,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17621,
          17964
        ],
        "text": ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the notice period required to terminate the renewal?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          17984,
          18303
        ],
        "answer": "This agreement begins on the Commencement Date and, subject to clause 11.2, shall continue for an initial term of one (1) years (Initial Term) and indefinitely after that until terminated by either party giving at least twelve (12) months' prior written notice to expire on or after the expiry date of the initial term."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9993,
        "readability": "expert",
        "readability_score": 14.33
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 2177,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          16123,
          16318
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
      },
      {
        "chunk_id": 1496,
        "filepath": "cuad/CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.txt",
        "span": [
          22066,
          22220
        ],
        "text": "This Agreement may be terminated by either party at the expiration of its term or any renewal term upon thirty (30) days written notice to the other party"
      },
      {
        "chunk_id": 1588,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          16084,
          16582
        ],
        "text": ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          30821,
          31046
        ],
        "answer": "This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with Ohio law."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9974,
        "readability": "expert",
        "readability_score": 13.72
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1115,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26531,
          27006
        ],
        "text": "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          12823,
          12960
        ],
        "answer": "The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted under this agreement."
      },
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          21828,
          22212
        ],
        "answer": "Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee)."
      },
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26015,
          26529
        ],
        "answer": "The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier. The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9989,
        "readability": "expert",
        "readability_score": 14.98
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1544,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          3352,
          3713
        ],
        "text": "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 1114,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26383,
          26529
        ],
        "text": ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What licenses are granted under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          11688,
          11910
        ],
        "answer": "The Supplier hereby grants to the Distributor the non-exclusive right, in the Territory, to use the Trade Marks in the promotion, advertisement and sale of the Products, subject to, and for the duration of, this agreement."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.999,
        "readability": "expert",
        "readability_score": 14.7
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 12683,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          135611,
          135875
        ],
        "text": ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)"
      },
      {
        "chunk_id": 1756,
        "filepath": "cuad/IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.txt",
        "span": [
          37488,
          37862
        ],
        "text": ", and (ii) Licensor may assign its rights and obligations in this Agreement to its Affiliates or subsidiaries and either party may assign this Agreement in its entirety to any purchaser of all or substantially all of its business or assets pertaining to the line of business to which this Agreement relates or to any Affiliate of the party without the other party's approval"
      },
      {
        "chunk_id": 12969,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          213515,
          213999
        ],
        "text": "; (B) licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business; (C) licenses granted in connection with talent agreements and the development of in-store displays, creative visual merchandising, marketing and advertising assets, and related branded content entered into in the Ordinary Course of Business; (D) licenses granted in connection with the production of co-branded or third-party products in the Ordinary Course of Business"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22429,
          23058
        ],
        "answer": "At the Supplier's option, on termination of this agreement:\n\n(a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or\n\n(b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products;"
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9995,
        "readability": "expert",
        "readability_score": 13.55
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1588,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          16084,
          16582
        ],
        "text": ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
      },
      {
        "chunk_id": 1102,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22241,
          22488
        ],
        "text": "12.1 Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of termination.\n\n10\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\n12.2 At the Supplier's option, on termination of this agreement:"
      },
      {
        "chunk_id": 1101,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          21824,
          22239
        ],
        "text": "(n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\n\n12. Effectsof termination"
      },
      {
        "chunk_id": 2177,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          16123,
          16318
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; What are the insurance requirements under this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16264,
          16342
        ],
        "answer": "The Supplier shall add the distributor to their current insurance certificate."
      },
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16978,
          17227
        ],
        "answer": "During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.999,
        "readability": "expert",
        "readability_score": 14.35
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 1083,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16262,
          16342
        ],
        "text": ". The Supplier shall add the distributor to their current insurance certificate."
      },
      {
        "chunk_id": 1086,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16973,
          17364
        ],
        "text": "10.3 During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective. The Supplier shall provide a copy of the insurance policy to the Distributor on request.\n\n8\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019"
      },
      {
        "chunk_id": 5187,
        "filepath": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
        "span": [
          92170,
          92659
        ],
        "text": "(ix)  that is between the Company or any of its Subsidiaries, on the one hand, and the Company or another one of its Subsidiaries, on the other hand, or that otherwise would be required to be filed as an intercompany or\n\n\n\n\n\n\n\n\n________________\n\n\naffiliate agreement with an Insurance Regulator; \n\n\n(x) that involve or could reasonably be expected to involve aggregate payments or receipts by or to the Company or any of its Subsidiaries in excess of $3,000,000 in any twelve-month period;"
      },
      {
        "chunk_id": 1559,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          7985,
          8091
        ],
        "text": ". The Distributor and Company, as applicable, make the following representations, warranties and covenants"
      }
    ]
  },
  {
    "query": "Consider the Distributorship Agreement between Signature Orthopaedics Pty Ltd and CPM Medical Consultants LLC for Medical Products; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          12966,
          13125
        ],
        "answer": "The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their validity or the goodwill of the Supplier."
      }
    ],
    "file_set": [
      "FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributorship Agreement Signature Orthopaedics Pty Ltd CPM Medical Consultants LLC Medical Products",
        "similarity_score": 0.5468978881835938,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9994,
        "readability": "expert",
        "readability_score": 14.05
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1043,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          0,
          417
        ],
        "text": "EXHIBIT 10.43 Dated 29/3/18\n\nDistributorship agreement\n\nbetween\n\nSignature Orthopaedics Pty Ltd\n\nAnd\n\nCPM Medical Consultants LLC\n\nSource: FUSE MEDICAL, INC., 10-K, 3/21/2019\n\n\n\n\n\nEXHIBIT 10.43 THIS AGREEMENT is dated\n\nParties\n\n(1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW\n\n(2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080.\n\nBackground"
      },
      {
        "chunk_id": 12683,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          135611,
          135875
        ],
        "text": ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)"
      },
      {
        "chunk_id": 14667,
        "filepath": "maud/HMS Holdings Corp._Veritas Capital.txt",
        "span": [
          103313,
          103766
        ],
        "text": ", covenant not to sue or other rights under any Company IP, other than any non-exclusive outbound license entered into in the ordinary course of business, in the case of each of the foregoing clauses (A) and (B), in each case, that could not be replaced on commercially reasonable terms, excluding any standard non- disclosure, end-user, customer, confidentiality or consulting agreements, in each case as entered into in the ordinary course of business"
      },
      {
        "chunk_id": 1379,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          74375,
          74418
        ],
        "text": ". Representations, Warranties and Covenants"
      },
      {
        "chunk_id": 16261,
        "filepath": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
        "span": [
          261459,
          261897
        ],
        "text": ". Each Party agrees that (a) its respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other Parties, in accordance with and subject to the terms of this Agreement, and (b) this Agreement is not intended to, and does not, confer upon any Person other than the Parties any rights or remedies, including the right to rely upon the representations and warranties set forth herein"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14759,
          14890
        ],
        "answer": "This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9675,
        "readability": "expert",
        "readability_score": 12.06
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1620,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          25696,
          26084
        ],
        "text": "12\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\n\n\n\n\n\nIN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date:\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 2100,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          26436,
          26855
        ],
        "text": ". NO ACTIONS, REGARDLESS OF FORM, ARISING OUT OF THIS AGREEMENT, MAY BE BROUGHT BY DISTRIBUTOR MORE THAN ONE (1) YEAR AFTER THE CAUSE OF ACTION HAS ARISEN. 14. NOTICES 14.1 All notices required or permitted hereunder shall be in writing and shall be delivered (a) by facsimile, (b) personally, or (c) mailed by certified or registered mail, return receipt requested and postage prepaid, addressed to the addressed below"
      },
      {
        "chunk_id": 1588,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          16084,
          16582
        ],
        "text": ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
      },
      {
        "chunk_id": 12702,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          140592,
          141087
        ],
        "text": "(xiii) any Contract with any of the twenty (20) largest product and/or raw materials suppliers of the Company and its Subsidiaries, taken as a whole, determined on the basis of payments made to the applicable supplier by the Company and its Subsidiaries, taken as a whole, for the 12-month period ended January 31, 2019 (collectively, the \u201cMaterial Suppliers\u201d) that has a term greater than one year and is not terminable without penalty upon notice of ninety (90) days or less, other than quotes"
      },
      {
        "chunk_id": 7703,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          213914,
          214348
        ],
        "text": ".1(b) (i) shall not be available to any party hereto if the failure of such party (or any Affiliate of such party) to fulfill any obligation under this Agreement has been a principal cause of or primarily resulted in the failure of the Effective Time to occur on or before the Outside Date, (ii) if the Marketing Period shall have commenced but not have been completed by the date that is three Business Days prior to the Outside Date"
      },
      {
        "chunk_id": 2177,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          16123,
          16318
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
      },
      {
        "chunk_id": 19321,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          150658,
          151151
        ],
        "text": ", 2019 and ending on the date of this Agreement regarding (A) the recall, market withdrawal or replacement of any Company Product sold or intended to be sold by the Company or its Subsidiaries (other than recalls, withdrawals or replacements that are not material to the Company and its Subsidiaries, taken as a whole), (B) a material change in the marketing classification or a material change in the labeling of any such Company Products, (C) a termination or suspension of the manufacturing"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the renewal term for this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14924,
          15142
        ],
        "answer": "Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9926,
        "readability": "expert",
        "readability_score": 12.06
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 3358,
        "filepath": "cuad/GopageCorp_20140221_10-K_EX-10.1_8432966_EX-10.1_Content License Agreement.txt",
        "span": [
          17621,
          17964
        ],
        "text": ". Thereafter, this Agreement shall renew automatically for one (1) additional three (3) year period (the \"Renewal Term\" and collectively, together with the Initial Term, the \"Term\") unless either party provides the other with written notice of non-renewal at least ninety (90) days before the expiration of the Initial Term].   6.2 Termination"
      },
      {
        "chunk_id": 1142,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          3583,
          4062
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 1145,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4744,
          5215
        ],
        "text": ": (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5"
      },
      {
        "chunk_id": 723,
        "filepath": "cuad/EdietsComInc_20001030_10QSB_EX-10.4_2606646_EX-10.4_Co-Branding Agreement.txt",
        "span": [
          24985,
          25342
        ],
        "text": ". This agreement shall automatically renew for additional successive terms of twelve (12) months each at the end of the Initial Term (\"Renewal Terms\"), unless either party notifies the other in writing at least sixty (60) days prior to the end of the Initial Term. As used in this agreement, \"Term\" shall mean the Initial Term and the Renewal Terms, if any."
      },
      {
        "chunk_id": 1139,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          2695,
          3120
        ],
        "text": "1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\""
      },
      {
        "chunk_id": 1144,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          4396,
          4744
        ],
        "text": ".   (c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term\") on the same terms and conditions for the initial Term except that"
      },
      {
        "chunk_id": 12702,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          140592,
          141087
        ],
        "text": "(xiii) any Contract with any of the twenty (20) largest product and/or raw materials suppliers of the Company and its Subsidiaries, taken as a whole, determined on the basis of payments made to the applicable supplier by the Company and its Subsidiaries, taken as a whole, for the 12-month period ended January 31, 2019 (collectively, the \u201cMaterial Suppliers\u201d) that has a term greater than one year and is not terminable without penalty upon notice of ninety (90) days or less, other than quotes"
      },
      {
        "chunk_id": 1620,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          25696,
          26084
        ],
        "text": "12\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\n\n\n\n\n\nIN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date:\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          20473,
          20727
        ],
        "answer": "This Agreement is a contract under the laws of the State of Florida and for all purposes shall be governed by and construed in accordance with the substantive laws of the State of Florida, without regard to its principles of conflicts of laws provisions."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9874,
        "readability": "expert",
        "readability_score": 12.06
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1565,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          9457,
          9896
        ],
        "text": ". (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees"
      },
      {
        "chunk_id": 1104,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22916,
          23335
        ],
        "text": "(b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and\n\n(c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 1115,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26531,
          27006
        ],
        "text": "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
      },
      {
        "chunk_id": 1542,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2706,
          3093
        ],
        "text": "(b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents"
      },
      {
        "chunk_id": 1539,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2085,
          2523
        ],
        "text": ". Distributor shall limit its activities with respect to the Products to Customers located within the Territory and refrain from selling or otherwise transferring, directly or indirectly, the Products to any person outside the Territory, without the express written consent of Company. Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a most favored nation clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          5674,
          6133
        ],
        "answer": "Such Prices and Volume Discount Prices shall only be subject to increase once per year on each anniversary date of this Agreement, provided (i) Company provides Distributor with at least Ninety (90) days prior written notice of any such increase, and (ii) such increase does not exceed 5% of the preceding year's Prices, except for reasons of force majeure, (Chapter 10), and Volume Discount Prices nor the lowest price charged to others for the same Product."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9474,
        "readability": "expert",
        "readability_score": 12.82
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 17005,
        "filepath": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
        "span": [
          168170,
          168537
        ],
        "text": ", (C) contains any provision that requires the purchase of all or any portion of the Company\u2019s or any of its Subsidiaries\u2019 requirements from any Third Party or (D) grants \u201cmost favored nation\u201d rights, except in the case of each of clauses (A), (B), (C) and (D) for such rights and provisions that are not material to the Company and its Subsidiaries, taken as a whole"
      },
      {
        "chunk_id": 4160,
        "filepath": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
        "span": [
          78874,
          79343
        ],
        "text": ":   (i)                 a Contract granting a \u201cmost favored nation\u201d or most favored customer pricing to any Person, or any Contract providing for the grant of exclusive material sales, distribution, marketing or other exclusive rights, rights of first refusal, rights of first negotiation or similar rights and/or terms to any Person, or materially limiting the right of the Company or any of its Subsidiaries to engage in any line of business or in any geographic area"
      },
      {
        "chunk_id": 19336,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          154395,
          154893
        ],
        "text": ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through third parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
      },
      {
        "chunk_id": 8559,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          126124,
          126622
        ],
        "text": ", (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of the Company or any of its Subsidiaries to sell, market, distribute, promote, manufacture, develop, commercialize, or test or research any Company Product, directly or indirectly through Third Parties, in any material respect, or that would so limit or purport to limit the ability of Parent or any of its Affiliates to sell, market, distribute"
      },
      {
        "chunk_id": 9779,
        "filepath": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
        "span": [
          70628,
          71035
        ],
        "text": ", any Routine Services Contracts entered into in the ordinary course of business), (D) provides for \u201cexclusivity\u201d or any similar requirement in favor of any Person or group of Persons or in any geographical area or (E) requiring the Company or any of its Affiliates (including, following the Closing, Parent or any of its Affiliates) to conduct any business on a \u201cmost favored nations\u201d basis with any Person"
      },
      {
        "chunk_id": 7802,
        "filepath": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
        "span": [
          245120,
          245440
        ],
        "text": "(h)    includes material pricing or margin representations that provide \u201cmost favored nation\u201d or similar material representations with respect to pricing; \n\n\n(i)    restricts payment of dividends or distributions in respect of the Company Common Stock or other equity interests of the Company or any of its Subsidiaries;"
      },
      {
        "chunk_id": 15637,
        "filepath": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
        "span": [
          79746,
          80078
        ],
        "text": ";   (iii)          any Contract with a customer that obligates the Company or its Subsidiaries to conduct business with any third party on an exclusive basis or that contains \u201cmost favored nation\u201d or similar covenants in a respect or to a degree that is material to the Company and the Company Subsidiaries, taken as a whole;   -21-"
      },
      {
        "chunk_id": 11577,
        "filepath": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
        "span": [
          106880,
          107222
        ],
        "text": ".0 million; (vi) each Contract that contains any \u201cmost favored nation\u201d or most favored customer provision, call or put option, preferential right or rights of first or last offer, negotiation or refusal, in each case other than those contained in any Contract in which such provision is solely for the benefit of any of the Acquired Companies"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include an exclusivity agreement?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1721,
          2086
        ],
        "answer": "Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein."
      },
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2371,
          2524
        ],
        "answer": "Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9885,
        "readability": "expert",
        "readability_score": 13.02
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 8855,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          207942,
          208440
        ],
        "text": "(iv)          any material Contract other than exclusive distributor agreements and employee agreements that (A) limits or purports to limit, in any material respect, the freedom of Parent or any of its Subsidiaries to engage or compete in any line of business or with any Person or in any area, (B) contains material exclusivity or \u201cmost favored nation\u201d obligations or restrictions or (C) contains any other provisions that restrict the ability of Parent or any of its Subsidiaries to sell, market"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a clause preventing the solicitation of customers in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2525,
          2653
        ],
        "answer": "The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9979,
        "readability": "expert",
        "readability_score": 12.92
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1540,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2523,
          2653
        ],
        "text": ". The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor."
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1115,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26531,
          27006
        ],
        "text": "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there an anti-assignment clause in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          22142,
          22356
        ],
        "answer": "Neither Party shall assign, pledge or otherwise transfer any of its rights, interest or obligations hereunder, whether by operation of law or otherwise, without the prior express written consent of the other Party."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.6559,
        "readability": "expert",
        "readability_score": 13.38
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1544,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          3352,
          3713
        ],
        "text": "; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement"
      },
      {
        "chunk_id": 1114,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26383,
          26529
        ],
        "text": ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      },
      {
        "chunk_id": 510,
        "filepath": "contractnli/IBC-PMS-NDA-agreement.txt",
        "span": [
          17553,
          17951
        ],
        "text": "(f) This Agreement shall be binding upon and inure to the benefit of each party\u2019s respective successors and lawful assigns; provided, however, that Vendor may not assign this Agreement (whether by operation of law, sale of securities or assets, merger or otherwise), in whole or in part, without the prior written approval of IBC. Any purported assignment in violation of this Section shall be void"
      },
      {
        "chunk_id": 1543,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          3093,
          3352
        ],
        "text": ". Distributor may appoint, with prior approval of the Company, sub-agents, sub-distributors, sub-representatives or other persons to act on Distributor's behalf or to otherwise perform any of Distributor's obligations under this Agreement within the Territory"
      },
      {
        "chunk_id": 3269,
        "filepath": "cuad/TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.txt",
        "span": [
          102509,
          102767
        ],
        "text": "14.4 Assignment. This Agreement may not be assigned by a party to this Agreement to any other Person without the express written approval of the other parties to this Agreement and any attempt at assignment in violation of this section shall be null and void"
      },
      {
        "chunk_id": 16935,
        "filepath": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
        "span": [
          148072,
          148425
        ],
        "text": "(h)               Neither the Company nor any of its Subsidiaries is party to, or bound by, or has any obligation under, any Tax allocation, apportionment, sharing or assignment agreement other than (i) agreements solely among the Company and its Subsidiaries and (ii) customary commercial contracts the primary purpose of which does not relate to Taxes"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any price restrictions or controls specified in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          5674,
          6133
        ],
        "answer": "Such Prices and Volume Discount Prices shall only be subject to increase once per year on each anniversary date of this Agreement, provided (i) Company provides Distributor with at least Ninety (90) days prior written notice of any such increase, and (ii) such increase does not exceed 5% of the preceding year's Prices, except for reasons of force majeure, (Chapter 10), and Volume Discount Prices nor the lowest price charged to others for the same Product."
      },
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          26135,
          26433
        ],
        "answer": "Subject to Company's right to increase the price only once per year per the terms and restrictions contained in the Agreement, and Company's right to decrease the price at any time upon notice, the Products shall be sold by Company to Distributor at the following Prices and Volume Discount Prices."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9991,
        "readability": "expert",
        "readability_score": 12.58
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1558,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          7561,
          7985
        ],
        "text": ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1044,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          419,
          838
        ],
        "text": "The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement.\n\nAgreed terms\n\n1. Definitions and interpretation\n\n1.1 The definitions and rules of interpretation in this clause apply in this agreement."
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Does this contract include any volume restrictions?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          10024,
          10395
        ],
        "answer": "In addition to any other responsibilities stated in this Agreement, Company will: (a) Provide, at Distributor's reasonable request and without charge, up to 10 hours of training with regard to any characteristics of the Products that Distributor deems reasonably necessary for Distributor and its employees and agents to fulfill the purposes of Distributor's appointment,"
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9943,
        "readability": "expert",
        "readability_score": 13.7
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1114,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26383,
          26529
        ],
        "text": ". The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent."
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; How is intellectual property ownership assigned in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          19937,
          20115
        ],
        "answer": "Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.994,
        "readability": "expert",
        "readability_score": 13.72
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1601,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          19742,
          20236
        ],
        "text": ". Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12"
      },
      {
        "chunk_id": 510,
        "filepath": "contractnli/IBC-PMS-NDA-agreement.txt",
        "span": [
          17553,
          17951
        ],
        "text": "(f) This Agreement shall be binding upon and inure to the benefit of each party\u2019s respective successors and lawful assigns; provided, however, that Vendor may not assign this Agreement (whether by operation of law, sale of securities or assets, merger or otherwise), in whole or in part, without the prior written approval of IBC. Any purported assignment in violation of this Section shall be void"
      },
      {
        "chunk_id": 1542,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          2706,
          3093
        ],
        "text": "(b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1836,
        "filepath": "cuad/ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement.txt",
        "span": [
          22596,
          23029
        ],
        "text": ". Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees   to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate   such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make   any appropriate assignments to it"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1538,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          1719,
          2085
        ],
        "text": ". Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein"
      },
      {
        "chunk_id": 1104,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22916,
          23335
        ],
        "text": "(b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and\n\n(c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;"
      },
      {
        "chunk_id": 1073,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          12524,
          12960
        ],
        "text": "(b) The Products, do not infringe any intellectual property rights of any third parties and the Supplier agrees to indemnify and hold harmless the Distributor against any clauses by a third party for infringement of intellectual property rights in relation to the Products or the Trade marks .\n\n9.6 The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted under this agreement."
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Are there any services to be provided after the termination of this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          16158,
          16569
        ],
        "answer": "In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.997,
        "readability": "expert",
        "readability_score": 12.15
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1588,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          16084,
          16582
        ],
        "text": ". 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1101,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          21824,
          22239
        ],
        "text": "(n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\n\n12. Effectsof termination"
      },
      {
        "chunk_id": 1565,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          9457,
          9896
        ],
        "text": ". (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees"
      },
      {
        "chunk_id": 1104,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22916,
          23335
        ],
        "text": "(b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and\n\n(c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a cap on liability under this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          18177,
          18358
        ],
        "answer": "IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INDIRECT, EXEMPLARY OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT OR PURCHASE OR USE OF THE PRODUCTS."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.5837,
        "readability": "expert",
        "readability_score": 11.82
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1082,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16163,
          16262
        ],
        "text": ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor"
      },
      {
        "chunk_id": 2098,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          25732,
          25969
        ],
        "text": "13. LIMITATION OF LIABILITIES 13.1 Limitation of Liabilities. IN NO EVENT SHALL JRVS'S LIABILITY ARISING OUT OF THIS AGREEMENT EXCEED THE AMOUNT RECEIVED BY JRVS FROM THE DISTRIBUTOR HEREUNDER FOR THE PRODUCT GIVING RISE TO THE LIABILITY"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1558,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          7561,
          7985
        ],
        "text": ". Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; What is the duration of any warranties provided in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          6837,
          7027
        ],
        "answer": "Within Seven (7) days of receipt of such Products, Distributor will notify Company of any shortages, defects, non-conformance, and Company will promptly replace such Products free of charge."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.8905,
        "readability": "expert",
        "readability_score": 12.58
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1103,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          22490,
          22914
        ],
        "text": "(a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or"
      },
      {
        "chunk_id": 1985,
        "filepath": "cuad/FulucaiProductionsLtd_20131223_10-Q_EX-10.9_8368347_EX-10.9_Content License Agreement.txt",
        "span": [
          7307,
          7351
        ],
        "text": "5. Producer's Representations and Warranties"
      },
      {
        "chunk_id": 1556,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          6605,
          7089
        ],
        "text": ". Distributor will promptly inspect the Products upon receipt at Distributor's facility to determine whether any Products included in the shipment are in short supply, defective, or otherwise not in conformance with this Agreement. Within Seven (7) days of receipt of such Products, Distributor will notify Company of any shortages, defects, non-conformance, and Company will promptly replace such Products free of charge. Title to the Products shall pass to Distributor upon delivery"
      }
    ]
  },
  {
    "query": "Consider the Distributor Agreement between B & C General Warehouse Corporation LLC and Distributor for Coffee Products; Is there a covenant not to sue included in this contract?",
    "snippets": [
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          19316,
          19742
        ],
        "answer": "Distributor shall not dispute or contest for any reason whatsoever, directly or indirectly, during the term of this Agreement and thereafter, the validity, ownership or enforceability of any of the trademarks of Company, nor directly or indirectly attempt to acquire or damage the value of the goodwill associated with any of the trademarks of Company, nor counsel, procure or assist any third Party to do any of the foregoing"
      },
      {
        "file_path": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          19744,
          19936
        ],
        "answer": "Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company."
      }
    ],
    "file_set": [
      "GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Distributor Agreement B & C General Warehouse Corporation LLC Distributor Coffee Products",
        "similarity_score": 0.46982359886169434,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "verbose",
        "complexity_score": 0.9754,
        "readability": "expert",
        "readability_score": 12.58
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1082,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          16163,
          16262
        ],
        "text": ", except to the extent the liability arises as a result of the wilful misconduct of the Distributor"
      },
      {
        "chunk_id": 1533,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          0,
          351
        ],
        "text": "Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \"Agreement\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\"Company\"), and XXXXXXXXXXXXXXXXXXXXX (\"Distributor\")"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 12683,
        "filepath": "maud/TIFFANY_&_CO._LVMH_MOE\u2560\u00eaT_HENNESSY-LOUIS_VUITTON.txt",
        "span": [
          135611,
          135875
        ],
        "text": ", and covenants not to sue (other than non-exclusive licenses granted to other Persons in the Ordinary Course of Business consistent with past practice and licenses granted in connection with distribution agreements entered into in the Ordinary Course of Business)"
      }
    ]
  },
  {
    "query": "Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the expiration date of this contract?",
    "snippets": [
      {
        "file_path": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          22480,
          22696
        ],
        "answer": "This Agreement shall become effective upon the date first written above and shall remain in full force and effect for a period of two years (2), unless earlier terminated pursuant to the provisions in this Agreement."
      }
    ],
    "file_set": [
      "ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Non-Exclusive Distributor Agreement iMine Corporation Sunwai Technology Cryptocurrency Mining Rigs",
        "similarity_score": 0.5170678496360779,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.8945,
        "readability": "expert",
        "readability_score": 14.39
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2026,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          0,
          438
        ],
        "text": "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")"
      },
      {
        "chunk_id": 2122,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          34131,
          34461
        ],
        "text": "Source: IMINE CORP, S-1, 7/25/2018\n\n\n\n\n\nIN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE FIRST WRITTEN ABOVE. Sunwai Technology iMine Corporation\n\n/s/ Sei-Peng Tu /s/ Daniel Tsai By: Sei-Peng Tu By: Daniel Tsai Title: President Title: Chief Executive Officer 9\n\nSource: IMINE CORP, S-1, 7/25/2018"
      },
      {
        "chunk_id": 2027,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          438,
          829
        ],
        "text": ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1"
      },
      {
        "chunk_id": 2031,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          2069,
          2442
        ],
        "text": ". or international intellectual property, unfair competition or trade secret laws. 1.7 \"Products\" shall mean the products offered by JRVS for sale to the Distributor; the Products shall include iMine cryptocurrency mining rigs and its parts and components. 1.8 \"Territory\" shall mean the geographic area of Taiwan. 2. APPOINTMENT 2.1 Appointment of Nonexclusive Distributor"
      },
      {
        "chunk_id": 1583,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          14699,
          15158
        ],
        "text": "7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination"
      },
      {
        "chunk_id": 1620,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          25696,
          26084
        ],
        "text": "12\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\n\n\n\n\n\nIN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date:\n\nSource: GENTECH HOLDINGS, INC., 1-A, 8/8/2019"
      },
      {
        "chunk_id": 2177,
        "filepath": "cuad/ReedsInc_20191113_10-Q_EX-10.4_11888303_EX-10.4_Development Agreement.txt",
        "span": [
          16123,
          16318
        ],
        "text": ". Either party may terminate this Agreement upon written notice if the Manufacturing and Distribution Agreement terminates prior to the first anniversary of the Effective Date. 9. Indemnification"
      },
      {
        "chunk_id": 4186,
        "filepath": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
        "span": [
          86634,
          87098
        ],
        "text": ". As of the Agreement Date, none of the Top Suppliers that grants or licenses any material rights in or to use any Intellectual Property that is incorporated into any Company Product has cancelled or otherwise terminated or materially and adversely altered the terms (including with respect to pricing) of or, to the Company\u2019s knowledge, threatened to cancel or otherwise terminate or materially and adversely alter the terms (including with respect to pricing) of"
      },
      {
        "chunk_id": 1105,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          23337,
          23696
        ],
        "text": "12.3 For the purposes of clause 12.2(a) the current market value in respect of Products shall be the price that the Products are ordinarily supplied as at the date of termination of this agreement.\n\n12.4 Subject to clause 12.2, all other rights and licences of the Distributor under this agreement shall terminate on the termination date.\n\n13. Confidentiality"
      },
      {
        "chunk_id": 1278,
        "filepath": "cuad/MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.txt",
        "span": [
          44980,
          45380
        ],
        "text": ". Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein"
      }
    ]
  },
  {
    "query": "Consider the Non-Exclusive Distributor Agreement between iMine Corporation and Sunwai Technology for Cryptocurrency Mining Rigs; What is the governing law for this contract?",
    "snippets": [
      {
        "file_path": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          32817,
          32974
        ],
        "answer": "This Agreement shall be governed by and construed pursuant to the laws of the State of Indiana, U.S.A., without reference to principals of conflicts of laws."
      }
    ],
    "file_set": [
      "ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt"
    ],
    "query_rewriter": [
      {
        "best_file_path": "",
        "file_locator": "Non-Exclusive Distributor Agreement iMine Corporation Sunwai Technology Cryptocurrency Mining Rigs",
        "similarity_score": 0.5170678496360779,
        "only_question": ""
      }
    ],
    "feature_extraction": [
      {
        "complexity": "vague",
        "complexity_score": 0.9492,
        "readability": "expert",
        "readability_score": 14.39
      }
    ],
    "retrieved_chunks_unranked": [
      {
        "chunk_id": 2027,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          438,
          829
        ],
        "text": ". RECITAL WHEREAS, Distributor desires to be, a nonexclusive distributor of JRVS for certain cryptocurrency mining rig products; JRVS wishes to sell its products through Distributor on a continuing basis on the terms and conditions set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual agreements and covenants, JRVS and the Distributor agree as follows: 1. DEFINITIONS 1"
      },
      {
        "chunk_id": 2031,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          2069,
          2442
        ],
        "text": ". or international intellectual property, unfair competition or trade secret laws. 1.7 \"Products\" shall mean the products offered by JRVS for sale to the Distributor; the Products shall include iMine cryptocurrency mining rigs and its parts and components. 1.8 \"Territory\" shall mean the geographic area of Taiwan. 2. APPOINTMENT 2.1 Appointment of Nonexclusive Distributor"
      },
      {
        "chunk_id": 2026,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          0,
          438
        ],
        "text": "EXHIBIT 10.5 NON-EXCLUSIVE DISTRIBUTOR AGREEMENT This Non-Exclusive Distributor Agreement (the \"Agreement\") is made and entered into as of this 19th day of July 2018, by and between iMine Corporation, (hereinafter referred to as \"JRVS\") and SUNWAI Technology, a Taiwanese company, with its principal office at 6th Floor, No. 258, Section 3, Nanjing East Road, Songshan District, Taipei 10051 (hereinafter referred to as the \"Distributor\")"
      },
      {
        "chunk_id": 1113,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26010,
          26383
        ],
        "text": "16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier"
      },
      {
        "chunk_id": 2036,
        "filepath": "cuad/ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt",
        "span": [
          3791,
          4288
        ],
        "text": ". The Distributor shall not, during the term of this Agreement, directly or indirectly market, sell, distribute, solicit orders within the Territory for any products which are competitive with the iMine Products unless JRVS consents thereto in writing in advance, based upon the Distributor's full disclosure of the material facts in seeking such consent. Any such marketing, sale, distribution or solicitation of the competitive products is considered to be a material breach of this Agreement. 3"
      },
      {
        "chunk_id": 1115,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          26531,
          27006
        ],
        "text": "16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: -\n\n(a) disclose fully in writing all material facts relating to the dealing\n\n(b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\n\n16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\n\n17. Freedom to contract"
      },
      {
        "chunk_id": 1564,
        "filepath": "cuad/GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt",
        "span": [
          8994,
          9457
        ],
        "text": ". (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement"
      },
      {
        "chunk_id": 1073,
        "filepath": "cuad/FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt",
        "span": [
          12524,
          12960
        ],
        "text": "(b) The Products, do not infringe any intellectual property rights of any third parties and the Supplier agrees to indemnify and hold harmless the Distributor against any clauses by a third party for infringement of intellectual property rights in relation to the Products or the Trade marks .\n\n9.6 The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted under this agreement."
      },
      {
        "chunk_id": 8860,
        "filepath": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
        "span": [
          209433,
          209931
        ],
        "text": "(viii)          any material Contract with any Person (A) pursuant to which Parent or any of its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which Parent or any of its Subsidiaries grants to any Person any right of first refusal, right of first negotiation"
      },
      {
        "chunk_id": 19341,
        "filepath": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
        "span": [
          155893,
          156389
        ],
        "text": "(viii) any Contract with any Person (A) pursuant to which the Company or its Subsidiaries may be required to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval, sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events, or (B) under which the Company or its Subsidiaries grants to any Person any right of first refusal, right of first negotiation, option to purchase"
      }
    ]
  }
]